Update February 1 - February 7, 2021, Dr. Peter J. Lansberg MD, PhD

Weekly COVID-19 Literature Update will keep you up-to-date with all recent PubMed publications categorized by relevant topics

COVID-19 publications - Week 05 2021 1328 Publications

PubMed based Covid-19 weekly literature update For those interested in receiving weekly updates click here For questions and requests for topics to add send an e-mail [email protected]

Reliable on-line resources for Covid 19

WHO Cochrane Daily dashbord BMJ Country Guidance The Lancet Travel restriction New England Journal of Medicine Covid Counter JAMA Covid forcasts Cell CDC Science AHA Oxford Universtiy Press ESC Cambridge Univeristy Press EMEA Springer Nature Evidence EPPI Elsevier Wikipedia Wiley Cardionerds - COVID-19 PLOS Genomic epidemiology LitCovid NIH-NLM Oxygenation Ventilation toolkit SSRN (Pre-prints) German (ICU) bed capacity COVID reference (Steinhauser Verlag) COVID-19 Projections tracker Retracted papers AAN - Neurology resources COVID-19 risk tools - Apps COVID-19 resources (Harvard) Web app for SARS-CoV2 mutations COVID-19 resources (McMasters) COVID-19 resources (NHLBI) COVID-19 resources (MEDSCAPE) COVID-19 Diabetes (JDRF) COVID-19 TELEMEDICINE (BMJ) Global Causes of death (Johns Hopkins) COVID-19 calculators (Medscap)

Guidelines NICE Guidelines Covid-19 Korean CDC Covid-19 guidelines Flattening the curve - Korea IDSA COVID-19 Guidelines Airway Management Clinical Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation Guidelines Performing Procedures on Patients With Known or Suspected COVID-19 (ASA, 2020) OSHA Guidance on Preparing the Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant Devices, and Air Purifiers (FDA, 2020) Breast Cancer Patient Triage Guidelines (CPBCC, 2020) clinical guidance for adult Belgian patients with suspected or confirmed COVID-19 National Covid-19 Testing Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography guidance

Trials & Registries CAPACITY European registry COVID 19 patients WHO launches global megatrial FDA launches Convalescent plasma trial Lets Beat Covid-19 Survey to help plan hospital services COVID IBD registry Google mobility reports per country COVID 19 World's largest trial of potential coronavirus treatments rolled out across the UK Pregnancy Registry (US) ICNARC report on COVID-19 in critical care - NHS April 24 COVID-19 Human Genetics - Biobanks COVID19 settings of transmission database COVID-19 prevention network Covid-Plex trial - (plasma exchange & convalescent plasma trial)

The Covid-Plex trial is an investigator initiated, multicenter, parallel-group, open-label randomized clinical trial aiming to randomize patients with severe COVID-19 to standard care or standard care plus plasmapheresis and convalescent plasma.

If you are interested to participate Please contact Wladimir Szpirt, Nicholas Carlson Anders, or Perner Bo Feldt-Rasmussen. Depts. Of Intensive Care Therapy and Nephrology, Copenhagen University Hospital Rigshospitalet, Denmark

Covid-Plex trial

Mainstream Media New York Times - Corona update How Merck, a Vaccine Titan, Lost the Covid Race WHO Panel Recommends AstraZeneca Vaccine Despite Variant Concerns U.K. residents may not be allowed to travel abroad until all adults are vaccinated. Half of U.S. Coronavirus Deaths Have Come Since Nov. 1 Could a Single Vaccine Work Against All Coronaviruses? People With Dementia Are Twice as Likely to Get Covid, Huge Study Finds Coronavirus Variants and Mutations A Few Covid Vaccine Recipients Developed a Rare Blood Disorder Coronavirus Vaccine Tracker Coronavirus Drug and Treatment Tracker

Washington Post - Corona update

France is seeing a baby bust nine months after its first covid lockdown No quarantine needed who have received both shots of coronavirus vaccine, Masks should fit better or be doubled up to protect against coronavirus variants, U.K. coronavirus restrictions to include hotel quarantines, threats of fines and prison Denmark says it has U.K. coronavirus variant under control, for now CDC weighs coronavirus testing requirement for flights, industry voices opposition Variants mean the coronavirus is here to stay — but perhaps as a lesser threat What we know about how the coronavirus started, and why it matters ‘Coronaphobia’: Covid anxiety has a name. Here’s how to cope.

Guardian - Corona update ‘It’s impossible to pay’: the UK residents trapped overseas by quarantine rules Coronavirus live: international travel 'biggest factor in death rate' US could have averted 40% of Covid deaths, says panel examining Trump's policies Before you compare the Covid vaccines, here are five things to know Vaccination passports are nothing new – and the sooner we have them

Key Articles

1. Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis. J. Clin. Apher. 2021; Vegivinti CTR, Pederson JM, Saravu K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544910 The potential benefit of convalescent plasma therapy in COVID-19 seems self- evident based on a long experience of using this approach in other infectious diseases. This meta-analysis screened 859 (!) studies and identified 15 articles that fit the inclusion criteria. Overall total mortality was significantly reduced, OR: 0.59 (0.44-0.78; P<0.001), but two key RCTs failed to support this. Clinical improvement was favorable in patients treated with convalescent plasma, OR:2.02 (1.54-2.65; P<0.001). No differences in duration of hospital stay were observed, MD=-0.49 (-3.11 to 2.12; P=0.713)

2. Cardiac arrest in COVID-19: characteristics and outcomes of in- and out- of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation. Eur Heart J 2021; Sultanian P, Lundgren P, Strömsöe A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543259 Patients with COVID-19 infections are at increased risk for (fatal) cardiovascular complications partly because of the pathophysiological driving forces of the SARS-CoV2 viral infection and partly because of avoidance to seek proper medical care. Data from the National Swedish Registry for Cardiopulmonary Resuscitation was used to analyse the impact of COVID-19 on in- and out-of- hospital cardiac arrests. . COVID-19 was involved in ≥10% of OHCAs and 16% of IHCAs. The 30-day mortality increased 3.4-fold in OHCA and 2.3-fold in IHCA.

3. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung 2021; 50:357-360Salabei JK, Fishman TJ, Asnake ZT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524866 Coagulopathies are frequently observed COVID-19 (fatal) complications. This review shares recent insights into the potential etiologies, from direct cytotoxicity, activation of pro-inflammatory molecules, e.g., cytokines, to endothelial cell dysfunction. The authors point out that the observed clinical and laboratory characteristics are distinctly different from sepsis and ARDS associated coagulopathy. Institution specific guidelines for prophylactic anticoagulation are recommended to address the specific needs of the different patient populations cared for.

4. COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue. Emerg Microbes Infect 2021:1-30Xi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522893

5. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. Heart Lung 2021; 50:329-333Turgay Yıldırım Ö, Kaya Ş. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524862

6. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth 2021; 21:108Servante J, Swallow G, Thornton JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546624

7. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun 2021; 6:3Peymani P, Dehesh T, Aligolighasemabadi F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521322

8. Prevalence of SARS-CoV-2 in children from a cohort of 2192 patients. Monatsschr. Kinderheilkd. 2021; 169:46-51Meyer M, Rübsteck E, Lehmann C et al.

9. High-dose vitamin D versus placebo to prevent complications in COVID- 19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Trials 2021; 22:111Mariani J, Tajer C, Antonietti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522946

10. The Incidence, Prognosis and Laboratory Indicators of Venous Thromboembolism in Hospitalized Patients with COVID-19: A Systematic Review and Meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; Liu Y, Cai J, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529719

11. Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention. Front Cardiovasc Med 2020; 7:599334Liu H, Wang Z, Sun H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537347

12. Beneficial Effect of Statins in COVID-19-Related Outcomes: A National Population-Based Cohort Study. Arterioscler. Thromb. Vasc. Biol. 2021:Atvbaha120315551Lee HY, Ahn J, Park J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535790

13. Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report. Eur Heart J Case Rep 2021; 5:ytaa475Colombier S, Mahendiran T, Niclauss L, Kirsch M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33542974

14. Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity. Antioxidants (Basel) 2021; 10Cho KH, Kim JR, Lee IC, Kwon HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535459

15. Steroid harms if given early in COVID-19 viraemia. BMJ Case Rep. 2021; 14Arora K, Panda PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541971

Basic Science (68 articles)

1. Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters. ACS Chem Neurosci 2021; Urata S, Maruyama J, Kishimoto-Urata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522795 2. Crystal structure, Hirshfeld surface analysis, DFT and mol-ecular docking investigation of 2-(2-oxo-1,3-oxazolidin-3-yl)ethyl 2-[2-(2-oxo-1,3-oxazolidin-3- yl)eth-oxy]quinoline-4-carboxyl-ate. Acta Crystallogr E Crystallogr Commun 2021; 77:28-33Bouzian Y, Baydere C, Dege N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520278 3. Prediction of SARS-CoV Interaction with Host Proteins during Lung Aging Reveals a Potential Role for TRIB3 in COVID-19. Aging Dis 2021; 12:42-49de Moraes D, Paiva BVB, Cury SS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532126 4. Interferon Stimulates ACE2 Expression in Pediatric Airway Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2021; Salka K, Abutaleb K, Chorvinsky E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544656 5. Genetic Conservation of SARS-CoV-2 RNA Replication Complex in Globally Circulating Isolates and Recently Emerged Variants from Humans and Minks Suggests Minimal Pre-Existing Resistance to Remdesivir. Antiviral Res 2021:105033Martin R, Li J, Parvangada A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549572 6. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI- 202012/01. Arch Med Res 2021; Rahimi F, Talebi Bezmin Abadi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526352 7. Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2). Biocatal Agric Biotechnol 2021; 32:101924Neupane NP, Karn AK, Mukeri IH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527003 8. Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2). Biocatal Agric Biotechnol 2021; 32:101924Neupane NP, Karn AK, Mukeri IH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527003 9. RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif. Biochem. Biophys. Res. Commun. 2021; 545:75-80Aldhumani AH, Hossain MI, Fairchild EA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33545635 10. One Year of SARS-CoV-2: How Much Has the Virus Changed? Biology (Basel) 2021; 10Vilar S, Isom DG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530355 11. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 2021; 15:8Santana MVS, Silva-Jr FP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33531083 12. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe 2021; Lin JW, Tang C, Wei HC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548198 13. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 2021; Liu Z, VanBlargan LA, Bloyet LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535027 14. Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease. Chem. Phys. 2021; 542:111080Liu J, Zhai Y, Liang L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519023 15. Exploring the new potential antiviral constituents of Moringa oliefera for SARS-COV-2 pathogenesis: An in silico molecular docking and dynamic studies. Chem. Phys. Lett. 2021; 767:138379Muhammad S, Hassan SH, Al-Sehemi AG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518774 16. Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study. Chemometr Intell Lab Syst 2020; 206:104172Masand VH, Akasapu S, Gandhi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518858 17. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019. Clin. Ther. 2021; Benarroch Y, Juttukonda L, Sabharwal V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541739 18. Cluster analysis of coronavirus sequences using computational sequence descriptors: With applications to SARS, MERS and SARS-CoV-2 (CoVID-19). Curr. Comput. Aided Drug Des. 2021; Vračko M, Basak SC, Dey T, Nandy A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530913 19. Molecular Elucidation and Therapeutic Targeting for combating COVID19: Current Scenario and Future Prospective. Curr. Mol. Med. 2021; Suchita W, Tilotma S, Saurabh S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535951 20. Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19. Curr. Pharm. Des. 2021; Chauhan PS, Yadav D, Dubey A, Jin JO. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535945 21. Isoelectric point determination by imaged CIEF of commercially available SARS-CoV-2 proteins and the hACE2 receptor. Electrophoresis 2021; Krebs F, Scheller C, Grove-Heike K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533060 22. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerg Microbes Infect 2021:1-38Ye ZW, Yuan S, Chan JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538646 23. Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020. Euro Surveill 2021; 26Larsen HD, Fonager J, Lomholt FK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541485 24. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19. Front Bioeng Biotechnol 2020; 8:582953Morenikeji OB, Bernard K, Strutton E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520952 25. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS- CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19. Front Cardiovasc Med 2020; 7:623012Jha PK, Vijay A, Halu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521069 26. In silico Screening of Natural Compounds as Potential Inhibitors of SARS- CoV-2 Main Protease and Spike RBD: Targets for COVID-19. Front Mol Biosci 2020; 7:599079Teli DM, Shah MB, Chhabria MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542917 27. Serum Renin Levels Increase With Age in Boys Resulting in Higher Renin Levels in Young Men Compared to Young Women, and Soluble Angiotensin- Converting Enzyme 2 Correlates With Renin and Body Mass Index. Front. Physiol. 2020; 11:622179Jehpsson L, Sun J, Nilsson PM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519526 28. SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical? Gastroenterology 2021; Nowak JK, Kalla R, Satsangi J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549534 29. Genetic variations among SARS-CoV-2 strains isolated in China. Gene Rep 2020; 21:100925Ahmed-Abakur EH, Alnour TMS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521384 30. Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes. Gene Rep 2021; 23:101020Siddiqe R, Ghosh A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521382 31. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies. Genes Dis 2020; Li S, Wang W, Li T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521209 32. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis 2020; Zhang J, Garrett S, Sun J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521210 33. Comparison of pre-analytical characteristics for molecular and serological diagnostics of COVID-19. GMS Hyg Infect Control 2021; 16:Doc03Wendt R, Nickel O, Kalbitz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520604 34. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon 2021; 7:e06133Al-Mulla F, Mohammad A, Al Madhoun A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532652 35. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients. Immunol. Invest. 2021:1-8Batchu S, Yu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533266 36. Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease. Inform Med Unlocked 2021; 23:100515Balmeh N, Mahmoudi S, Fard NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521241 37. Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: Synthesis and characterization. Inorg. Chem. Commun. 2021; 126:108472Refat MS, Sedayo AA, Sayqal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531865 38. Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids. Int J Mol Sci 2021; 22Ahmad Mulyadi Lai HI, Chou SJ, Chien Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525682 39. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. Int J Nanomedicine 2021; 16:539-560Varahachalam SP, Lahooti B, Chamaneh M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519200 40. Application of Nanotechnology in the COVID-19 Pandemic. Int J Nanomedicine 2021; 16:623-649Yang D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531805 41. How glycobiology can help us treat and beat the COVID-19 pandemic. J Biol Chem 2021:100375Lardone RD, Garay YC, Parodi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548227 42. Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS- CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis. J Biomol Struct Dyn 2021:1-32Gupta A, Ahmad R, Siddiqui S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526003 43. Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases. J Biomol Struct Dyn 2021:1-12Tekpinar M, Yildirim A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525993 44. Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study. J King Saud Univ Sci 2021; 33:101297Khayrani AC, Irdiani R, Aditama R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519145 45. Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease. J. Mol. Liq. 2021; 322:114999Somboon T, Mahalapbutr P, Sanachai K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518853 46. Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19. J. Mol. Struct. 2021; 1231:129979Hussein RK, Elkhair HM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518801 47. In silico assessment and sonochemical synthesis of 2-alkynyl 3- chloropyrazines as prospective ligands for SARS-CoV-2. J. Mol. Struct. 2021; 1231:129981Satyanarayana MV, Reddy AG, Yedukondalu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518802 48. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J. Neuroimmune Pharmacol. 2021:1-19Machhi J, Shahjin F, Das S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544324 49. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach. J Tradit Complement Med 2021; Rangsinth P, Sillapachaiyaporn C, Nilkhet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520685 50. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. J Transl Autoimmun 2021; 4:100083Agresti N, Lalezari JP, Amodeo PP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521616 51. Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2. JCI Insight 2021; Chouchane L, Grivel JC, Farag E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529170 52. A Booster Dose Enhances Immunogenicity of the COVID-19 Vaccine Candidate ChAdOx1 nCoV-19 in Aged Mice. Med (N Y) 2020; Silva-Cayetano A, Foster WS, Innocentin S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521747 53. Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study. Microb. Pathog. 2021; 152:104762Khan AA, Baildya N, Dutta T, Ghosh NN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524563 54. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients. Microb. Pathog. 2021:104779Shahbazi M, Moulana Z, Sepidarkish M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548481 55. Comprehensive and systemic optimization for improving the yield of SARS- CoV-2 spike pseudotyped virus. Mol Ther Methods Clin Dev 2021; 20:350-356Fu X, Tao L, Zhang X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521163 56. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Molecules 2021; 26Muhseen ZT, Hameed AR, Al-Hasani HMH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525411 57. Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV- 2 Druggable Targets. Molecules 2021; 26Romeo I, Mesiti F, Lupia A, Alcaro S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530467 58. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021; 7Mone P, Gambardella J, Wang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540664 59. Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics. Open Forum Infect Dis 2020; 7:ofaa403Colavita F, Lapa D, Carletti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527081 60. A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells. Pathogens 2021; 10Pısıl Y, Shida H, Miura T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540924 61. Genome composition and genetic characterization of SARS-CoV-2. Saudi J. Biol. Sci. 2021; Al-Qaaneh AM, Alshammari T, Aldahhan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519278 62. In-silico network-based analysis of drugs used against COVID-19: Human well- being study. Saudi J. Biol. Sci. 2021; Attique Z, Ali A, Hamza M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519272 63. A theoretical exploration of the origin and early evolution of a pandemic. Sci Bull (Beijing) 2020; Ruan Y, Wen H, He X, Wu CI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520335 64. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19. Sci China Life Sci 2021:1-15Luo J, Liang S, Jin F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521857 65. In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19. Virusdisease 2021:1-9Kumar V, Kancharla S, Jena MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532517 66. Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients. Viruses 2021; 13Deschler S, Kager J, Erber J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546489 67. Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic. Viruses 2021; 13Hosie MJ, Hofmann-Lehmann R, Hartmann K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530620 68. BIN1 rs744373 SNP and COVID-19 mortality. World Acad Sci J 2021; 3Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521641

Biomarkers - Genetics (148 articles)

1. COVID-19 Antibody Tests and Their Limitations. ACS Sens 2021; Liu G, Rusling JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544999 2. Hematological manifestations and complications of COVID-19. Adv Clin Exp Med 2021; 30:101-107Erdinc B, Sahni S, Gotlieb V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529513 3. Childhood Adversity and Perceived Distress from the COVID-19 Pandemic. Advers Resil Sci 2021:1-4Shreffler KM, Joachims CN, Tiemeyer S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527096 4. Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19. Aging Dis 2021; 12:61-71Li S, Cao Z, Yang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532128 5. Detection of SARS-CoV-2 using real-time polymerase chain reaction in different clinical specimens: A critical review. Allergol. Immunopathol. (Madr.) 2021; 49:159-164Muhammad A, Ameer H, Haider SA, Ali I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528945 6. Hematologic changes predict clinical outcome in recovered patients with COVID-19. Ann. Hematol. 2021:1-15Mao J, Dai R, Du RC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523290 7. Persistent Hypokalemia post SARS-coV-2 infection, is it a life-long complication? Case report. Ann Med Surg (Lond) 2021; 62:358-361Alnafiey MO, Alangari AM, Alarifi AM, Abushara A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527042 8. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta- analysis. Ann Palliat Med 2021; Xie J, Wang Q, Xu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548996 9. Genetic Conservation of SARS-CoV-2 RNA Replication Complex in Globally Circulating Isolates and Recently Emerged Variants from Humans and Minks Suggests Minimal Pre-Existing Resistance to Remdesivir. Antiviral Res 2021:105033Martin R, Li J, Parvangada A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549572 10. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI- 202012/01. Arch Med Res 2021; Rahimi F, Talebi Bezmin Abadi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526352 11. The prognostic effect of brain natriuretic peptide levels on outcomes of hospitalized patients with COVID-19. Avicenna J Med 2021; 11:20-26Abdeen Y, Kaako A, Alnabulsi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520785 12. Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic. Best Pract. Res. Clin. Rheumatol. 2021:101660Parikh BA, Farnsworth CW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518410 13. The interplay between neutrophils, complement, and microthrombi in COVID- 19. Best Pract. Res. Clin. Rheumatol. 2021:101661Zuo Y, Kanthi Y, Knight JS, Kim AHJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526325 14. RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif. Biochem. Biophys. Res. Commun. 2021; 545:75-80Aldhumani AH, Hossain MI, Fairchild EA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33545635 15. Sequence-specific and multiplex detection of COVID-19 virus (SARS-CoV-2) using proofreading enzyme-mediated probe cleavage coupled with isothermal amplification. Biosens. Bioelectron. 2021; 178:113041Ding S, Chen G, Wei Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545551 16. Fluorescence polarization system for rapid COVID-19 diagnosis. Biosens. Bioelectron. 2021; 178:113049Lee CY, Degani I, Cheong J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540323 17. Development of multiplexed reverse-transcription loop-mediated isothermal amplification for detection of SARS-CoV-2 and influenza viral RNA. Biotechniques 2021; Zhang Y, N AT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535813 18. Development of multiplexed reverse-transcription loop-mediated isothermal amplification for detection of SARS-CoV-2 and influenza viral RNA. Biotechniques 2021; Zhang Y, Tanner NA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535813 19. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection. BMC Infect. Dis. 2021; 21:141Yang Y, Hu X, Xiong L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535989 20. A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding? BMJ Case Rep. 2021; 14Tuan J, Spichler-Moffarah A, Ogbuagu O. http://www.ncbi.nlm.nih.gov/pubmed/? term=33542020 21. The relationship between obesity, hemoglobin A1c and the severity of COVID- 19 at an urban tertiary care center in New York City: a retrospective cohort study. BMJ Open 2021; 11:e044526Randhawa G, Syed KA, Singh K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518528 22. Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report. Brain Behav Immun Health 2021:100212Bonaccorso S, Ricciardi A, Ouabbou S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527097 23. COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders. Brain Behav Immun Health 2021; 11:100196Quincozes-Santos A, Rosa RL, Tureta EF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521688 24. Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study. Cancers (Basel) 2021; 13Lee J, Park SS, Kim TY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530509 25. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response. Cell Host Microbe 2021; Lin JW, Tang C, Wei HC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548198 26. Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization. Cell Host Microbe 2021; Liu Z, VanBlargan LA, Bloyet LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535027 27. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med 2021; 2:100166Chevrier S, Zurbuchen Y, Cervia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521697 28. Structure features of peptide-type SARS-CoV main protease inhibitors: Quantitative structure activity relationship study. Chemometr Intell Lab Syst 2020; 206:104172Masand VH, Akasapu S, Gandhi A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518858 29. Using High Sensitivity Cardiac Troponin Values in Patients with SARS-CoV-2 Infection (COVID-19): The Padova Experience. Clin. Biochem. 2021; De Michieli L, Babuin L, Vigolo S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529580 30. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA. Clin. Biochem. 2021; Thomas SN, Altawallbeh G, Zaun C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539808 31. Can erythrocytes behavior in microcirculation help the understanding the physiopathology and improve prevention and treatment for covid-19? Clin. Hemorheol. Microcirc. 2021; Farber PL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33523046 32. Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients. Clin Immunol 2021:108682Núñez I, Priego-Ranero Á A, García-González HB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549831 33. Interpretation of SARS-CoV-2 replication according to RT-PCR crossing threshold value. Clin Microbiol Infect 2021; Marot S, Calvez V, Louet M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524586 34. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders. Clin Sci (Lond) 2021; 135:535-554Cao X, Song LN, Yang JK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533405 35. Automatic Screening of COVID-19 Using an Optimized Generative Adversarial Network. Cognit. Comput. 2021:1-16Goel T, Murugan R, Mirjalili S, Chakrabartty DK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520007 36. Cluster analysis of coronavirus sequences using computational sequence descriptors: With applications to SARS, MERS and SARS-CoV-2 (CoVID-19). Curr. Comput. Aided Drug Des. 2021; Vračko M, Basak SC, Dey T, Nandy A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530913 37. Prognostic bioindicators in severe COVID-19 patients. Cytokine 2021; 141:155455Bergantini L, Bargagli E, d'Alessandro M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548798 38. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID- 19. Cytokine 2021; 141:155428Sayah W, Berkane I, Guermache I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550165 39. Monocyte CD169 expression in COVID-19 patients upon intensive care unit admission. Cytometry A 2021; Ortillon M, Coudereau R, Cour M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547747 40. Oro- And nasopharyngeal swab for detection of SARS-CoV-2 - Step-by-step approach. Deutsche Medizinische Wochenschrift 2021; Kunstein A, Dröβler L, Nia AM et al. 41. Automated molecular testing of saliva for SARS-CoV-2 detection. Diagn. Microbiol. Infect. Dis. 2021; 100:115324Matic N, Lawson T, Ritchie G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529938 42. Evaluation of four laboratory-based SARS-CoV-2 IgG antibody immunoassays. Diagn. Microbiol. Infect. Dis. 2021; 100:115313Tanis J, Vancutsem E, Piérard D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548855 43. SARS-CoV-2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in COVID-19 endemic areas: prospective cross-sectional study in Japan. Dig Endosc 2021; Miyake S, Ashikari K, Kato S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548095 44. SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020. Emerg Infect Dis 2021; 27Letizia AG, Ge Y, Goforth CW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529569 45. Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting. Eur J Clin Microbiol Infect Dis 2021:1-9Müller L, Ostermann PN, Walker A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534090 46. A review on human body fluids for the diagnosis of viral infections: scope for rapid detection of COVID-19. Expert Rev Mol Diagn 2021:1-12Adigal SS, Rayaroth NV, John RV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523770 47. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic. Biol. Med. 2021; 165:184-190Gadotti AC, Lipinski AL, Vasconcellos FT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524532 48. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19. Front Bioeng Biotechnol 2020; 8:582953Morenikeji OB, Bernard K, Strutton E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520952 49. Microfluidic Point-of-Care Testing: Commercial Landscape and Future Directions. Front Bioeng Biotechnol 2020; 8:602659Sachdeva S, Davis RW, Saha AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520958 50. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS- CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19. Front Cardiovasc Med 2020; 7:623012Jha PK, Vijay A, Halu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521069 51. Does Angiotensin II Peak in Response to SARS-CoV-2? Front. Immunol. 2020; 11:577875Xavier LL, Neves PFR, Paz LV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519802 52. ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Infection in COVID-19 Patients. Front Med (Lausanne) 2020; 7:563893Fan C, Lu W, Li K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521006 53. Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic. Front Med (Lausanne) 2020; 7:584888Fan H, Cai J, Tian A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521010 54. Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation. Front Med (Lausanne) 2020; 7:589080Lin J, Dai W, Li W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537325 55. An Overview of Nucleic Acid Testing for the Novel Coronavirus SARS-CoV-2. Front Med (Lausanne) 2020; 7:571709Wang H, Li G, Zhao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537322 56. The Utility of Specific Antibodies Against SARS-CoV-2 in Laboratory Diagnosis. Front. Microbiol. 2020; 11:603058Fu Y, Pan Y, Li Z, Li Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519745 57. Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies. Front. Microbiol. 2020; 11:628281Kubo S, Ohtake N, Miyakawa K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519790 58. Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain. Front Pediatr 2020; 8:617039Fernández-Cooke E, Grasa CD, Domínguez-Rodríguez S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537269 59. Controlling COVID-19 Pandemic: A Mass Screening Experience in Saudi Arabia. Front Public Health 2020; 8:606385Khan AA, Alahdal HM, Alotaibi RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537280 60. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020; 8:582932Mehta OP, Bhandari P, Raut A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520910 61. Genetic variations among SARS-CoV-2 strains isolated in China. Gene Rep 2020; 21:100925Ahmed-Abakur EH, Alnour TMS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521384 62. Genome-wide in silico identification and characterization of Simple Sequence Repeats in diverse completed SARS-CoV-2 genomes. Gene Rep 2021; 23:101020Siddiqe R, Ghosh A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521382 63. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis 2020; Zhang J, Garrett S, Sun J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521210 64. Comparison of pre-analytical characteristics for molecular and serological diagnostics of COVID-19. GMS Hyg Infect Control 2021; 16:Doc03Wendt R, Nickel O, Kalbitz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520604 65. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. Hum Genomics 2021; 15:10Hu J, Li C, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536081 66. Dynamic changes in monocytes subsets in COVID-19 patients. Hum. Immunol. 2020; Qin S, Jiang Y, Wei X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33531264 67. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum. Reprod. 2021; Gacci M, Coppi M, Baldi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522572 68. What do we know about the antibody responses to SARS-CoV-2? Immunobiology 2021; 226:152054Lagunas-Rangel FA, Chávez-Valencia V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524881 69. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients. Immunol. Invest. 2021:1-8Batchu S, Yu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533266 70. Asymptomatic SARS COV-2 carriers among nursing home staff: A source of contamination for residents? Infect Dis Now 2021; Bayle C, Cantin D, Vidal JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521774 71. ABO phenotype and SARS-CoV-2 infection: Is there any correlation? Infect Genet Evol 2021:104751Mathew A, Vignesh Balaji E, Pai SRK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540085 72. Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction. Int Dairy J 2021:105002Oshiro S, Tada T, Mizutani N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526960 73. Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity. Int Immunopharmacol 2021; 93:107390Kabak M, Çil B, Hocanlı I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529907 74. Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: analysis of 944 patients in Apulia, Italy. Int J Infect Dis 2021; Sangineto M, Arena F, De Nittis R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545362 75. Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19. Int. J. Med. Sci. 2021; 18:1207-1215Ding R, Yang Z, Huang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526982 76. Is liver involvement overestimated in COVID-19 patients? A meta-analysis. Int. J. Med. Sci. 2021; 18:1285-1296Li G, Yang Y, Gao D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526990 77. Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids. Int J Mol Sci 2021; 22Ahmad Mulyadi Lai HI, Chou SJ, Chien Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525682 78. Summary of the Available Molecular Methods for Detection of SARS-CoV-2 during the Ongoing Pandemic. Int J Mol Sci 2021; 22Arena F, Pollini S, Rossolini GM, Margaglione M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525651 79. The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective. Int J Mol Sci 2021; 22Kwaan HC, Lindholm PF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525440 80. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021; Khoshkam Z, Aftabi Y, Stenvinkel P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520309 81. Insights into the evaporation characteristics of saliva droplets and aerosols: Levitation experiments and numerical modeling. J Aerosol Sci 2021; 154:105760Lieber C, Melekidis S, Koch R, Bauer HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518792 82. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J Autoimmun 2021; 118:102596Zhou Y, Zhang J, Wang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540371 83. The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection. J Cannabis Res 2020; 2:23Sainz-Cort A, Heeroma JH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526121 84. Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health. J. Clin. Endocrinol. Metab. 2021; Racine-Brzostek SE, Yang HS, Jack GA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524125 85. Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR. J Eur Acad Dermatol Venereol 2021; García-Gil MF, Monte-Serrano J, García García M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539560 86. Does COVID-19 antibody serology testing correlate with disease severity? An analytical descriptive retrospective study. J Family Med Prim Care 2020; 9:5705- 5710Ghoraba MA, Hazazi AM, Albadi MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532418 87. COVID-19: Lab medicine expect due respect. J Family Med Prim Care 2020; 9:5437-5438Ghosh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532375 88. Altered blood cell traits underlie a major genetic locus of severe COVID-19. J Gerontol A Biol Sci Med Sci 2021; Zhou J, Sun Y, Huang W, Ye K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530099 89. Targets and assay types for COVID-19 diagnosis. J. Immunoassay Immunochem. 2020; 41:946-959Bostan M, Ataman M, Bostan IS, Bleotu C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539260 90. Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR- Based DETECTR. J Infect Dis 2021; 223:206-213Brandsma E, Verhagen H, van de Laar TJW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535237 91. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses. J Infect Dis 2021; 223:192-196Harris BHL, Zuhair M, Di Giovannantonio M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535238 92. Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality. J Inflamm Res 2021; 14:199-216Mdkhana B, Saheb Sharif-Askari N, Ramakrishnan RK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531826 93. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death. J. Leukoc. Biol. 2021; Belaid B, Lamara Mahammad L, Mihi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527487 94. The Association of Viral load and Disease Severity in Children with COVID-19. J Med Virol 2021; Aykac K, Cura Yayla BC, Ozsurekci Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547815 95. Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection. J Med Virol 2021; Ciotti M, Maurici M, Pieri M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527409 96. Self-collected saliva for SARS-CoV-2 detection: a prospective study in the emergency room. J Med Virol 2021; Echavarria M, Reyes NS, Rodriguez PE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527375 97. Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein. J Med Virol 2021; Koh H, Moh AMC, Yeoh E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527464 98. Diagnostic Performance of SARS-CoV-2 IgM/IgG Rapid Test Kits for the Detection of the Novel Coronavirus in Ethiopia. J Multidiscip Healthc 2021; 14:171-180Sisay A, Tesfaye A, Desale A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536760 99. Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians. J. Paediatr. Child Health 2021; Haeusler GM, De Abreu Lourenco R, Bakos C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533525 100. Comparison of hematological parameters and perinatal outcomes between COVID-19 pregnancies and healthy pregnancy cohort. J. Perinat. Med. 2021; 49:141-147Erol Koç EM, Fındık RB, Akkaya H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544531 101. Acceptance of a Symptom-Based Approach for COVID-19 rtRT-PCR Testing to Conserve Resources in a Lower Middle-Income Setting. J. Prim. Care Community Health 2021; 12:2150132720987711Islam S, Akther T, Nasif MAO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525985 102. COVID-19 patients often show high-titer non-platelet-activating anti- PF4/heparin IgG antibodies. J Thromb Haemost 2021; Brodard J, Kremer Hovinga JA, Fontana P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550713 103. An alternate prospect in detecting presymptomatic and asymptomatic COVID- 19 carriers through odor differentiation by HeroRATs. J. Vet. Behav. 2021; 42:26-29Adekanmbi AJ, Olude MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519319 104. Evaluation of a real-time RT-PCR panel for detection of SARS-CoV-2 in bat guano. J. Vet. Diagn. Invest. 2021:1040638721990333Anis E, Turner G, Ellis JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522461 105. Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir. Jpn. J. Infect. Dis. 2021; Manosuthi W, Jeungsmarn S, Okada P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518623 106. Characteristics and Outcomes of COVID-19 in Patients with ANCA associated vasculitis. Kidney Int Rep 2020; Kant S, Raman G, Damera P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521401 107. SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19. Kidney Med 2021; 3:54-59.e51Prendecki M, Clarke C, McKinnon T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521621 108. Genetic Variation, Diet, Inflammation, and the Risk for COVID-19. Lifestyle Genom 2021:1-6Simopoulos AP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530084 109. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res 2021; Higuera-de la Tijera F, Servín-Caamaño A, Reyes-Herrera D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520337 110. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Med (N Y) 2021; Liu H, Chen J, Yang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521746 111. SalivaDirect: A Simplified and Flexible Platform to Enhance SARS-CoV-2 Testing Capacity. Med (N Y) 2020; Vogels CBF, Watkins AE, Harden CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521748 112. Interleukin 6 and depression in patients affected by Covid-19. Med Clin (Barc) 2020; Serrano García A, Montánchez Mateo J, Franch Pato CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549331 113. The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol Open 2021; 9:100079Moin ASM, Sathyapalan T, Atkin SL, Butler AE. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521617 114. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients. Microb. Pathog. 2021:104779Shahbazi M, Moulana Z, Sepidarkish M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548481 115. Letter to the Editor: Microbiota in the Respiratory System-A Possible Explanation to Age and Sex Variability in Susceptibility to SARS-CoV-2. Microbiol Insights 2021; 14:1178636120988604Shah V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519207 116. Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration. Microorganisms 2021; 9Pedro N, Silva CN, Magalhães AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540596 117. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021; 7Mone P, Gambardella J, Wang X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540664 118. Virological Characterization of the First 2 COVID-19 Patients Diagnosed in Italy: Phylogenetic Analysis, Virus Shedding Profile From Different Body Sites, and Antibody Response Kinetics. Open Forum Infect Dis 2020; 7:ofaa403Colavita F, Lapa D, Carletti F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527081 119. The challenges of COVID-19 testing in Africa: the Ethiopian experience. Pan Afr. Med. J. 2021; 38:6Mulu A, Bekele A, Abdissa A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520075 120. SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients: a retrospective observational study. Pathog Dis 2021; 79Bhattacharya B, Kumar R, Meena VP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537743 121. Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?-Clues from exotic animal reservoirs. Pathog Dis 2021; 79Shankar EM, Che KF, Yong YK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537740 122. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID- 19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits. Pathogens 2021; 10Al-Jighefee HT, Yassine HM, Nasrallah GK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546341 123. A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells. Pathogens 2021; 10Pısıl Y, Shida H, Miura T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540924 124. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies. Pediatr. Cardiol. 2021; Gerber N, Flynn PA, Holzer RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547936 125. COVID-19: Does the blood type determine how severe disease progression is? Pneumologie 2021; 75:14. 126. Evolution of Specimen Self-Collection in the COVID-19 Era: Implications for Population Health Management of Infectious Disease. Popul Health Manag 2021; 24:S26-s34Cockerill FR, Wohlgemuth JG, Radcliff J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544647 127. Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP. Proc Natl Acad Sci U S A 2021; 118Naydenova K, Muir KW, Wu LF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526596 128. Robust Testing in Outpatient Settings to Explore COVID-19 Epidemiology: Disparities in Race/Ethnicity and Age, Salt Lake County, Utah, 2020. Public Health Rep. 2021:33354920988612Ahmed SM, Shah RU, Fernandez V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541222 129. Implementation, adherence, and results of systematic SARS-CoV-2 testing for asymptomatic patients treated at a tertiary care regional radiation oncology network. Radiat Oncol 2021; 16:28Prabhu RS, Dhakal R, Hicks AS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541359 130. Numerical study of fractional order COVID-19 pandemic transmission model in context of ABO blood group. Results Phys 2021; 22:103852Higazy M, Allehiany FM, Mahmoud EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520615 131. Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: a consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group). Rev. Endocr. Metab. Disord. 2021; Fernandez Martinez A, Barajas Galindo D, Ruiz Sanchez J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547563 132. Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points. RNA Biol. 2021; Pinilla L, Benitez ID, González J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530819 133. Genome composition and genetic characterization of SARS-CoV-2. Saudi J. Biol. Sci. 2021; Al-Qaaneh AM, Alshammari T, Aldahhan R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519278 134. The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia. Saudi J. Biol. Sci. 2020; Mahallawi WH, Al-Zalabani AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519277 135. Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts. Scand. J. Prim. Health Care 2021:1- 5Norheim AJ, Borud EK, Lind A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544016 136. Early warning of COVID-19 via wastewater-based epidemiology: potential and bottlenecks. Sci Total Environ 2021; 767:145124Zhu Y, Oishi W, Maruo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548842 137. Paper biosensors for detecting elevated IL-6 levels in blood and respiratory samples from COVID-19 patients. Sens. Actuators B Chem. 2021; 330:129333Adrover-Jaume C, Alba-Patiño A, Clemente A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519090 138. Predictors of SARS-CoV-2 Positivity Based on RT-PCR Swab Tests at a Drive- Through Outpatient Clinic for COVID-19 Screening in Japan. Tohoku J. Exp. Med. 2021; 253:101-108Ishii T, Kushimoto S, Katori Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536379 139. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada. Transfusion 2021; Saeed S, Drews SJ, Pambrun C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527398 140. Full-length title: Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: an investigational study. Travel Med Infect Dis 2021:101980Colson P, Levasseur A, Gautret P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535105 141. Recent Advances in Nanomaterials based Biosensors for Point of Care (PoC) Diagnosis of Covid-19 - A Minireview. Trends Analyt. Chem. 2021:116205Gowri A, Kumar NA, Anand S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531721 142. Electrochemical Sensing: A Prognostic Tool in the Fight Against COVID-19. Trends Analyt. Chem. 2021:116198Kotru S, Klimuntowski M, Ridha H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518850 143. The potential of electrochemistry for the detection of coronavirus-induced infections. Trends Analyt. Chem. 2020; 133:116081Lim RRX, Bonanni A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518851 144. A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome. Virology 2021; 556:79-86Detsika MG, Ampelakiotou K, Grigoriou E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550117 145. Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality. Viruses 2021; 13Dumonteil E, Fusco D, Drouin A, Herrera C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540576 146. Association of the ABO blood group with SARS-CoV-2 infection in a community with low infection rate. Vox Sang 2021; Kotila TR, Alonge TO, Fowotade A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529391 147. A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic. Vox Sang 2021; Liu H, Liu L, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529377 148. BIN1 rs744373 SNP and COVID-19 mortality. World Acad Sci J 2021; 3Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521641

Children (48 articles)

1. Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy. Acta Diabetol 2021:1-4Marigliano M, Maffeis C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532867 2. The impact of face masks on children - a mini review. Acta Paediatr 2021; Martin E, Stefan O, Reinhold K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533522 3. Childhood Adversity and Perceived Distress from the COVID-19 Pandemic. Advers Resil Sci 2021:1-4Shreffler KM, Joachims CN, Tiemeyer S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527096 4. Managing food allergy immunotherapy in children during the COVID-19 pandemic. Allergol. Immunopathol. (Madr.) 2021; 49:150-152Barni S, Giovannini M, Sarti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528943 5. The ongoing impact of COVID-19 on asthma and pediatric emergency health- seeking behavior in the Bronx, an epicenter. Am J Emerg Med 2021; 43:109- 114Levene R, Fein DM, Silver EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550101 6. Covid-19 presenting as a bulging fontanelle. Am J Emerg Med 2021; 43:81- 82Schiff J, Brennan C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548683 7. Interferon Stimulates ACE2 Expression in Pediatric Airway Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2021; Salka K, Abutaleb K, Chorvinsky E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544656 8. Job stress in paediatric ICU staff caring for adult COVID-19 patients: An observational study during the first COVID-19 wave. Anaesth Crit Care Pain Med 2021:100810Poncelet G, Le Bourgeois F, Nicolas-Robin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540126 9. Emergency high ligation in a suspected COVID-19 pediatric patient with incarcerated inguinal hernia: A case report. Ann Med Surg (Lond) 2021; 62:261- 264Gunadi, Makkadafi M, Fauzi AR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520222 10. One Year of SARS-CoV-2: How Much Has the Virus Changed? Biology (Basel) 2021; 10Vilar S, Isom DG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530355 11. A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19. BMC Infect. Dis. 2021; 21:133Remppis J, Ganzenmueller T, Kohns Vasconcelos M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522901 12. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection. BMC Infect. Dis. 2021; 21:141Yang Y, Hu X, Xiong L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535989 13. Viral time capsule: a global photo-elicitation study of child and adolescent mental health professionals during COVID-19. Child Adolesc Psychiatry Ment Health 2021; 15:5Herrington OD, Clayton A, Benoit L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531051 14. The Impact of COVID-19 on the Adaptive Functioning, Behavioral Problems, and Repetitive Behaviors of Italian Children with Autism Spectrum Disorder: An Observational Study. Children (Basel) 2021; 8Siracusano M, Segatori E, Riccioni A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540683 15. The Impact of COVID-19 on the Interrelation of Physical Activity, Screen Time and Health-Related Quality of Life in Children and Adolescents in Germany: Results of the Motorik-Modul Study. Children (Basel) 2021; 8Wunsch K, Nigg C, Niessner C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540824 16. A Three-Step, Single Session Therapy Intervention for COVID-Related Anxiety in a Pediatric Emergency Department. Cureus 2020; 12:e12371Lee DP, Simpson SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527052 17. The effects of COVID-19 restrictions on physical activity and mental health of children and young adults with physical and/or intellectual disabilities. Disabil Health J 2021:101064Theis N, Campbell N, De Leeuw J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549499 18. Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea. Emerg Infect Dis 2021; 27Choe YJ, Choi EH, Choi JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539720 19. Covid-19 in Children and Young Adolescents in Al Ain, United Arab Emirates- a Retrospective Cross-Sectional Study. Front Pediatr 2020; 8:603741Elghoudi A, Aldhanhani H, Ghatasheh G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537264 20. Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain. Front Pediatr 2020; 8:617039Fernández-Cooke E, Grasa CD, Domínguez-Rodríguez S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537269 21. Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis? Front Pediatr 2020; 8:595539Piccaluga PP, Malerba G, Navari M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537261 22. COVID-19: Considerations for Children and Families During the Pandemic. Front Pediatr 2020; 8:600721Tang B, Alam D, Rakib MU, Li M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520892 23. [Perceptions and experiences of 7-8 year old schoolchildren in the Basque Country during the COVID-19 health alert]. Gac. Sanit. 2020; Tíscar-González V, Santiago-Garín J, Moreno-Casbas T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518413 24. Caregiving in Quarantine: Evaluating the Impact of the Covid-19 Pandemic on Adult Child Informal Caregivers of a Parent. Gerontol Geriatr Med 2021; 7:2333721421990150Archer J, Reiboldt W, Claver M, Fay J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532515 25. Responses to Coronavirus Pandemic in Early Childhood Services Across Five Countries in the Asia-Pacific Region: OMEP Policy Forum. Int J Early Child 2021:1-18Park E, Logan H, Zhang L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518791 26. COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health 2021; 18Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530624 27. Glycemic control in type 1 diabetes children and teenagers around lockdown for COVID-19: a continuous glucose monitoring based observational study. J Diabetes Investig 2021; Wu X, Luo S, Zheng X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539665 28. Olfactory and Gustatory dysfunction in Pediatric Population with Coronavirus Disease (COVID-19). J. Investig. Allergol. Clin. Immunol. 2021:0Bernaola Abraira M, Bartha De Las Peñas I, López-Araujo GA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522490 29. Limited Benefit of Facility Isolation and the Rationale for Home Care in Children with Mild COVID-19. J Korean Med Sci 2021; 36:e45Yun KW, Kim KM, Kim YK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527787 30. The Association of Viral load and Disease Severity in Children with COVID-19. J Med Virol 2021; Aykac K, Cura Yayla BC, Ozsurekci Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547815 31. COVID-19 Pandemic and Its Impact on Pediatric Dentistry in Austria: Knowledge, Perception and Attitude Among Pediatric Dentists in a Cross- Sectional Survey. J Multidiscip Healthc 2021; 14:161-169Bekes K, Ritschl V, Stamm T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531814 32. Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians. J. Paediatr. Child Health 2021; Haeusler GM, De Abreu Lourenco R, Bakos C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533525 33. Paediatric appendicitis during the COVID-19 pandemic. J. Paediatr. Child Health 2021; Sheath C, Abdelrahman M, MacCormick A, Chan D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527572 34. Challenges faced by mothers caring for children with leukaemia during COVID-19 pandemic: A qualitative study. J. Pediatr. Nurs. 2021; Atout M, Tarawneh FS, Al-Kharabsheh A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526289 35. COVID-19 presenting as intussusception in infants: A case report with literature review. J Pediatr Surg Case Rep 2021; 66:101779Athamnah MN, Masade S, Hamdallah H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520650 36. Enteric fever and COVID-19 co-infection in a teenager returning from Pakistan. J Travel Med 2021; Ayoubzadeh SI, Isabel S, Coomes EA, Morris SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550371 37. The Incidence, Prognosis and Laboratory Indicators of Venous Thromboembolism in Hospitalized Patients with COVID-19: A Systematic Review and Meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; Liu Y, Cai J, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529719 38. Use of masks by children to prevent infection with SARS-CoV-2: Consensus statement of the German Society for Pediatric Infectious Diseases (DGPI), the Professional Association of Pediatricians (BVKJ), the German Society for Pediatric and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Society for Social Pediatrics and Adolescent Medicine (DGSPJ), the Southern German Society for Pediatric and Adolescent Medicine (SGKJ) and the German Society for Pediatric and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP). Monatsschr. Kinderheilkd. 2021; 169:52-56Huppertz HI, Berner R, Schepker R et al. 39. Prevalence of SARS-CoV-2 in children from a cohort of 2192 patients. Monatsschr. Kinderheilkd. 2021; 169:46-51Meyer M, Rübsteck E, Lehmann C et al. 40. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA. mSphere 2021; 6Smith BK, Janowski AB, Danis JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536325 41. Neuroinflammation and Brain Development: Possible Risk Factors in COVID- 19-Infected Children. Neuroimmunomodulation 2021:1-7da Silva Chagas L, Sandre PC, de Velasco PC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530091 42. Childhood Obesity and COVID-19 Lockdown: Remarks on Eating Habits of Patients Enrolled in a Food-Education Program. Nutrients 2021; 13Nicodemo M, Spreghini MR, Manco M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530570 43. Should children of cancer patients attend daycare centers or schools during the COVID-19 pandemic? Onkologe 2021; Bremen R, Petermann-Meyer A, Ernstmann N et al. 44. Social vulnerability and COVID-19: A call to action for paediatric clinicians. Paediatr. Child Health 2021; 26:1-3Prodanuk M, Wagner S, Orkin J, Noone D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537103 45. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies. Pediatr. Cardiol. 2021; Gerber N, Flynn PA, Holzer RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547936 46. Paediatric dental care during and post-COVID-19 era: changes and challenges ahead. Pediatr Dent J 2021; Luo W, Lee GH, Nalabothu P, Kumar H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531735 47. COVID-19 in Pediatric Patients: Observations from the Initial Phase of the Global Pandemic in Rhode Island. R I Med J (2013) 2021; 104:55-60Levin RA, Tsao HS, Amanullah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517602 48. How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography. Turk J Med Sci 2021; Şaylan Çevİk B, Arici Ş, ErgenÇ Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517608

Clinical Features (68 articles)

1. DELAYED ONSET OF CENTRAL HYPOCORTISOLISM IN A PATIENT RECOVERING FROM COVID-19. AACE Clin Case Rep 2020; Chua MWJ, Chua MPW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521254 2. Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review. Adv Clin Exp Med 2021; 30:109-114Czubak J, Stolarczyk K, Orzeł A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529514 3. Covid-19 presenting as a bulging fontanelle. Am J Emerg Med 2021; 43:81- 82Schiff J, Brennan C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548683 4. How does Covid-19 infection affect smell? Am. J. Otolaryngol. 2021; 42:102912Henkin RI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540233 5. Cutaneous manifestations of COVID-19 in the Franche-Comté region of France: A monocentric study. Ann. Dermatol. Venereol. 2021; Jacquin-Porretaz C, Ducournau A, Dupond AS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541738 6. The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study. Ann Palliat Med 2021; 10:672-680Chen Y, Geng Y, Xu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545796 7. Clinical characteristics and risk factors for mortality in patients with coronavirus disease 2019 in intensive care unit: a single- center, retrospective, observational study in China. Ann Palliat Med 2021; Sai F, Liu X, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548994 8. Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis. Ann Palliat Med 2021; Xiang G, Xie L, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549005 9. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta- analysis. Ann Palliat Med 2021; Xie J, Wang Q, Xu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548996 10. Swallowing and voice outcomes in patients hospitalised with COVID-19: An observational cohort study. Arch. Phys. Med. Rehabil. 2021; Archer SK, Iezzi CM, Gilpin L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529610 11. Characteristics and prognostic factors of COVID-19 among infected cases: a nationwide Tunisian analysis. BMC Infect. Dis. 2021; 21:140Harizi C, Cherif I, Najar N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535971 12. A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19. BMC Infect. Dis. 2021; 21:133Remppis J, Ganzenmueller T, Kohns Vasconcelos M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522901 13. Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infect. Dis. 2021; 21:134Temperoni C, Grieco S, Pasquini Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522907 14. Clinical characteristics of hospitalized mild/moderate COVID-19 patients with a prolonged negative conversion time of SARS-CoV-2 nucleic acid detection. BMC Infect. Dis. 2021; 21:141Yang Y, Hu X, Xiong L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535989 15. COVID-19 infection in the palatine tonsil tissue and detritus: the detection of the virus compartment with RT-PCR. BMJ Case Rep. 2021; 14Kadriyan H, Dirja BT, Suryani D, Yudhanto D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547127 16. Dilemma of countering happy hypoxaemia COVID-19 patients. BMJ Case Rep. 2021; 14Kobayashi K, Takaoka H, Hirano T, Inoue T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541978 17. Autonomic function test during the COVID-19 pandemic: is it safe and sound? Clin. Auton. Res. 2021:1-2Guaraldi P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528657 18. Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID-19 Infection. Clin. Auton. Res. 2021:1-3Lamotte G, Benarroch EE, Coon EA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528656 19. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput. Biol. Med. 2021; 130:104210Suri JS, Agarwal S, Gupta SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550068 20. Peritonsillar Phlegmon: An Addition to the Spectrum of COVID-19. Cureus 2020; 12:e12369Khan MAA, Rosal N, Iqbal I, Minalyan A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527050 21. Short-term outpatient follow-up of COVID-19 patients: A multidisciplinary approach. EClinicalMedicine 2021:100731de Graaf MA, Antoni ML, Ter Kuile MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532720 22. A single-center observational study on clinical features and outcomes of 21 SARS-CoV-2-infected neonates from India. Eur. J. Pediatr. 2021:1-12Nanavati R, Mascarenhas D, Goyal M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544233 23. Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis. Front Public Health 2020; 8:561264He X, Cheng X, Feng X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520906 24. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020; 8:582932Mehta OP, Bhandari P, Raut A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520910 25. Clinical Features, Inpatient Trajectories and Frailty in Older Inpatients with COVID-19: A Retrospective Observational Study. Geriatrics (Basel) 2021; 6Osuafor CN, Davidson C, Mackett AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535520 26. Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study. Graefes Arch Clin Exp Ophthalmol 2021:1-9Savastano MC, Gambini G, Cozzupoli GM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33523252 27. COVID-19 and geriatric population: from pathophysiology to clinical perspectives. Horm. Mol. Biol. Clin. Investig. 2021; Bansod S, Ahirwar AK, Sakarde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544506 28. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum. Reprod. 2021; Gacci M, Coppi M, Baldi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522572 29. Olfactory and Gustatory Alterations in Covid-19 Patients: A Tertiary Care Covid-19 Centre Inpatient Experience. Indian J Otolaryngol Head Neck Surg 2021:1-5Koul D, Begh RA, Kalsotra P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532344 30. In the emerging evidence base on coronavirus disease 2019 and loss of smell, how many preprint papers are subsequently published? Int Forum Allergy Rhinol 2021; Walsh ME, Hopkins C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33539666 31. Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19. Int J Cardiol Heart Vasc 2021; 32:100719Shmueli H, Shah M, Ebinger JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521240 32. Clinical Characteristics and Reproduction Number of Coronavirus Disease (COVID-19) Cases in Markazi Province in Iran. Int J Community Based Nurs Midwifery 2021; 9:18-29Moradzadeh R, Zamanian M, Amini S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521146 33. Incubation period of COVID-19: a meta-analysis. Int J Infect Dis 2021; Elias C, Sekri A, Leblanc P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548553 34. The characteristics of 527 discharged COVID-19 patients undergoing long- term follow-up in China. Int J Infect Dis 2021; Zhang J, Xu J, Zhou S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540129 35. How to classify the covid-19 phenotype: a response from "the first soldier in the first trench" in Lombardy, north-western Italy. J Biol Regul Homeost Agents 2021; 35Gallenga CE, Contini C, Tana M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525862 36. Loss of Smell and Taste Can Accurately Predict COVID-19 Infection: A Machine-Learning Approach. J Clin Med 2021; 10Callejon-Leblic MA, Moreno- Luna R, Del Cuvillo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546319 37. Association between periodontitis and severity of COVID-19 infection: a case- control study. J. Clin. Periodontol. 2021; Marouf N, Cai W, Said KN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527378 38. Chilblain-like lesions and COVID-19: second wave, second outbreak. J Eur Acad Dermatol Venereol 2021; Piccolo V, Bassi A, Russo T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545745 39. Does COVID-19 antibody serology testing correlate with disease severity? An analytical descriptive retrospective study. J Family Med Prim Care 2020; 9:5705- 5710Ghoraba MA, Hazazi AM, Albadi MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532418 40. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS- CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses. J Infect Dis 2021; 223:192-196Harris BHL, Zuhair M, Di Giovannantonio M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535238 41. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms. J Inflamm Res 2021; 14:175-189Khan MA, Khan ZA, Charles M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519225 42. Pathophysiological Mechanisms and Management of Patients with Long-time Anosmia related to COVID-19. J Intern Med 2021; Lechien JR, Chiesa-Estomba CM, Hans S, Saussez S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527593 43. Clinical Features of Patients who had two COVID-19 Episodes: A European Multicenter Case-series. J Intern Med 2021; Lechien JR, Chiesa-Estomba CM, Radulesco T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527495 44. Olfactory and Gustatory dysfunction in Pediatric Population with Coronavirus Disease (COVID-19). J. Investig. Allergol. Clin. Immunol. 2021:0Bernaola Abraira M, Bartha De Las Peñas I, López-Araujo GA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522490 45. Reversible Taste Loss in a COVID-19 Patient With Preexisting Chronic Smell Impairment. J Investig Med High Impact Case Rep 2021; 9:2324709621990765Klein H, Karni N, Israel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535814 46. Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis. J Ophthalmic Vis Res 2021; 16:103-112Nasiri N, Sharifi H, Bazrafshan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520133 47. Pain Symptoms in Patients with Coronavirus Disease (COVID-19): A Literature Review. J. Pain Res. 2021; 14:147-159Weng LM, Su X, Wang XQ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531833 48. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities 2021:1- 11Muhammad R, Ogunti R, Ahmed B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33538998 49. A German AWMF's S2e/realist synthesis and meta-narrative snapshot of craniomaxillofacial manifestations in COVID-19 patients: Rapid living update on 1 January 2021. J Stomatol Oral Maxillofac Surg 2021; Pitak-Arnnop P, Meningaud JP, Sirintawat N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524604 50. Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir. Jpn. J. Infect. Dis. 2021; Manosuthi W, Jeungsmarn S, Okada P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518623 51. Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case- control study. Med Clin (Engl Ed) 2020; 155:327-334Ke C, Yu C, Yue D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521303 52. Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain. Med Clin (Engl Ed) 2021; 156:61-64Ninchritz-Becerra E, Soriano-Reixach MM, Mayo-Yánez M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521313 53. Clinical features of neurological patients with coronavirus 2019: an observational study of one centre. Neurol. Neurochir. Pol. 2021; Zielińska-Turek J, Jasińska A, Kołakowska J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528832 54. Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide. Neurol Sci 2021:1-4Yetkin MF, Yetkin NA, Akcakoyunlu M, Mirza M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534122 55. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? Nutrition 2020; 85:111115Balmant BD, Torrinhas RS, Rocha IM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545540 56. Clinical Symptoms Among Ambulatory Patients Tested for SARS-CoV-2. Open Forum Infect Dis 2021; 8:ofaa576Chung JR, Kim SS, Jackson ML et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537361 57. COVID-19 Clinical Phenotypes: Presentation and Temporal Progression of Disease in a Cohort of Hospitalized Adults in Georgia, United States. Open Forum Infect Dis 2021; 8:ofaa596da Silva JF, Hernandez-Romieu AC, Browning SD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537363 58. Relative Frequency and Risk Factors of COVID-19 Related Headache in a Sample of Egyptian Population: A Hospital Based Study. Pain Med. 2021; Hussein M, Fathy W, Eid RA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544857 59. Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic. Pain Rep 2021; 6:e884Attal N, Martinez V, Bouhassira D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537521 60. Asymptomatic SARS-CoV-2 infection: is it all about being refractile to innate immune sensing of viral spare-parts?-Clues from exotic animal reservoirs. Pathog Dis 2021; 79Shankar EM, Che KF, Yong YK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537740 61. Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation. Pharmaceutics 2021; 13Joyce M, McGrath JA, Mac Giolla Eain M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540764 62. Fever as a predictor of adverse outcomes in COVID-19. QJM 2021; Ws Chew N, Nicholas Ngiam J, Meng Tham S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533902 63. COVID-19 in Pediatric Patients: Observations from the Initial Phase of the Global Pandemic in Rhode Island. R I Med J (2013) 2021; 104:55-60Levin RA, Tsao HS, Amanullah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517602 64. Characteristics and outcomes in hospitalized COVID-19 patients during the first 28 days of the spring and autumn pandemic waves in Milan: An observational prospective study. Respir. Med. 2021; 178:106323Radovanovic D, Pini S, Franceschi E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545499 65. A comparison of characteristics and outcomes of patients with community- acquired and hospital-acquired COVID-19 in the United Kingdom: An observational study. Respir. Med. 2021; 178:106314Shiwani HA, Bilal M, Shahzad MU et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550150 66. [Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients]. Rev. Esp. Quimioter. 2021; Ortonobes Roig S, Soler-Blanco N, Torrente Jiménez I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522213 67. Novel Coronavirus Disease (COVID-19) in Italian Patients: Gender Differences in Presentation and Severity. Saudi J Med Med Sci 2021; 9:59-62Baiardo Redaelli M, Landoni G, Di Napoli D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519345 68. Clinical Manifestations and Outcomes of Coronavirus Disease-19 in Heart Transplant Recipients: A Multicenter Case Series with a Systematic Review and Meta-Analysis. Transpl Int 2021; Granger C, Guedeney P, Arnaud C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539616

CNS (31 articles)

1. Regeneration Profiles of Olfactory Epithelium after SARS-CoV-2 Infection in Golden Syrian Hamsters. ACS Chem Neurosci 2021; Urata S, Maruyama J, Kishimoto-Urata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522795 2. Neurological Manifestations of COVID-19: Causality or Coincidence? Aging Dis 2021; 12:27-35Zhao F, Han Z, Wang R, Luo Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532124 3. Inflammatory cytokine patterns associated with neurological diseases in COVID-19. Ann. Neurol. 2021; Espíndola OM, Gomes YCP, Brandão CO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547819 4. Acute haemorrhagic leukoencephalitis (Hurst disease) in severe COVID- 19 infection. Brain Behav Immun Health 2021; 12:100208Haqiqi A, Samuels TL, Lamb FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521690 5. Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature. Brain Behav Immun Health 2021; 12:100210Pizzanelli C, Milano C, Canovetti S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521691 6. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front Med (Lausanne) 2020; 7:606824Komaroff AL, Bateman L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537329 7. Is Guillain-Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence. Front. Neurol. 2020; 11:566308Abdullahi A, Candan SA, Soysal Tomruk M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519663 8. Progress in Research on SARS-CoV-2 Infection Causing Neurological Diseases and Its Infection Mechanism. Front. Neurol. 2020; 11:592888Wang L, Ren Z, Ma L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519677 9. Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Geriatrics (Basel) 2021; 6Yu Y, Travaglio M, Popovic R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530357 10. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021; 18Fisicaro F, Di Napoli M, Liberto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546463 11. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery. Int J Mol Sci 2021; 22Qian L, Tcw J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530458 12. A Case of Guillain-Barré Syndrome Related to COVID-19 Infection. Int. J. Neurosci. 2021:1-6Türk Börü Ü, Köseoğlu Toksoy C, Bölük C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535007 13. Delayed onset of fatal encephalitis in a COVID-19 positive patient. Int. J. Neurosci. 2021:1-5Zanin L, Saraceno G, Renisi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535011 14. The neurological significance of COVID-19: Lesson learn from the pandemic. Interdiscip Neurosurg 2020; 22:100809Faried A, Dian S, Halim D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520665 15. Reversible Taste Loss in a COVID-19 Patient With Preexisting Chronic Smell Impairment. J Investig Med High Impact Case Rep 2021; 9:2324709621990765Klein H, Karni N, Israel S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535814 16. Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection. J Med Virol 2021; Ciotti M, Maurici M, Pieri M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527409 17. Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? J. Neuroimmune Pharmacol. 2021:1-6Chaves Filho AJM, Gonçalves F, Mottin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534108 18. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19. J. Neurol. 2021:1-4Hofstadt-van Oy U, Stankovic S, Kelbel C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537898 19. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021:1-5Hellmuth J, Barnett TA, Asken BM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528824 20. Subjective evaluation of smell and taste dysfunction in patients with mild COVID-19 in Spain. Med Clin (Engl Ed) 2021; 156:61-64Ninchritz-Becerra E, Soriano-Reixach MM, Mayo-Yánez M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521313 21. Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis. Mult. Scler. 2021:1352458520978354. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528295 22. Neuroinflammation and Brain Development: Possible Risk Factors in COVID- 19-Infected Children. Neuroimmunomodulation 2021:1-7da Silva Chagas L, Sandre PC, de Velasco PC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530091 23. Clinical features of neurological patients with coronavirus 2019: an observational study of one centre. Neurol. Neurochir. Pol. 2021; Zielińska-Turek J, Jasińska A, Kołakowska J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528832 24. Clinical activity changes in the neurology department of Wenzhou during the COVID-19 pandemic: an observational analysis. Neurol Sci 2021:1-7Cao YG, Li Y, Shen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523320 25. Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide. Neurol Sci 2021:1-4Yetkin MF, Yetkin NA, Akcakoyunlu M, Mirza M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534122 26. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry. Neurologia 2021; Abenza Abildúa MJ, Atienza S, Carvalho Monteiro G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549369 27. Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives. Neurotherapeutics 2021:1-8Bhise V, Dhib-Jalbut S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533012 28. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Where Will the Drugs Come From? Pharmacol. Res. 2021:105465Toogood PL, Clau DJ, Phadke S, Hoffman D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529750 29. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021; 9:e14726Østergaard L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523608 30. SARS-CoV-2 infection leading to ischemic and hemorrhagic brain lesions and acute respiratory distress syndrome. Radiol Case Rep 2021; 16:753- 759Thibodeau R, Jafroodifar A, Quraeshi S, Lisi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520045 31. Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune- Depleting Therapies. Vaccines (Basel) 2021; 9Sellner J, Rommer PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525459

Coagulation (28 articles)

1. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth 2021; 21:108Servante J, Swallow G, Thornton JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546624 2. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID- 19 Infection. Clin. Appl. Thromb. Hemost. 2021; 27:1076029620977702Magnani HN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539214 3. COVID-19 Infection and Acute Pulmonary Embolism in an Adolescent Female With Sickle Cell Disease. Cureus 2020; 12:e12348Kasinathan S, Mohammad Ashraf H, Minkowitz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520543 4. Venous Thromboembolism Has a Variable Time of Occurrence in the Course of COVID-19: A Case Series. Cureus 2020; 12:e12295Mene-Afejuku TO, Jeyashanmugaraja GP, Akinlonu AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520499 5. Isolated Radial Vein Thrombosis: Upper Extremity Deep Vein Thrombosis in a Patient With COVID-19 Infection. Cureus 2021; 13:e12856Ramalingam S, Arora H, Gunasekaran K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520558 6. The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review. Diagnostics (Basel) 2021; 11Hartmann J, Ergang A, Mason D, Dias JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530346 7. Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report. Eur Heart J Case Rep 2021; 5:ytaa563Fiorini NB, Garagoli F, Bustamante RC, Pizarro R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521514 8. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J Case Rep 2021; 5:ytaa388Scudiero F, Pitì A, Keim R, Parodi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542972 9. COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU. Exp Hematol Oncol 2021; 10:6Zheng R, Zhou J, Song B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522958 10. Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention. Front Cardiovasc Med 2020; 7:599334Liu H, Wang Z, Sun H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537347 11. Systematic Screening for Deep Vein Thrombosis in Critically Ill Inpatients With COVID-19: Impact on the Incidence of Venous Thromboembolism. Front Med (Lausanne) 2020; 7:624808Lapébie FX, Minville V, Ribes A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521028 12. Saddle thrombus in the region of the aortic bifurcation and critical limb ischaemia of the left leg associated with SARS-CoV-2 infection. Gefasschirurgie 2021; Meier J, Vallejos Köhnenkamp FA, Zierke K et al. 13. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung 2021; 50:357-360Salabei JK, Fishman TJ, Asnake ZT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524866 14. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review. Int Immunopharmacol 2021; 93:107397Tehrani HA, Darnahal M, Vaezi M, Haghighi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524803 15. Diagnosis and treatment of disseminated intravascular coagulation in COVID- 19 patients: a scoping review. Int. J. Hematol. 2021; Mori H, Ohkawara H, Togawa R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550533 16. Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19. Int. J. Med. Sci. 2021; 18:1207-1215Ding R, Yang Z, Huang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526982 17. The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective. Int J Mol Sci 2021; 22Kwaan HC, Lindholm PF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525440 18. Cerebral venous sinus thrombosis in patients with COVID-19 infection. Interdiscip Neurosurg 2021; 24:101091Abouhashem S, Eldawoody H, Taha MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520667 19. Acute pulmonary embolism following acute type A aortic dissection in a patient with COVID-19. J. Card. Surg. 2021; Volvovitch D, Ram E, Cohen H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533105 20. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth 2021; De Cobelli F, Palumbo D, Ciceri F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518461 21. Intensified thromboprophylaxis in COVID-19 critically ill patients: is it enough? J Infect 2021; de Montmollin E, Faille D, Andrieu V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549626 22. COVID-19 patients often show high-titer non-platelet-activating anti- PF4/heparin IgG antibodies. J Thromb Haemost 2021; Brodard J, Kremer Hovinga JA, Fontana P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550713 23. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. J Thromb Haemost 2021; Li JY, Wang HF, Yin P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534149 24. The Incidence, Prognosis and Laboratory Indicators of Venous Thromboembolism in Hospitalized Patients with COVID-19: A Systematic Review and Meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; Liu Y, Cai J, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529719 25. Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 2021; 156:112-117Gonzalez-Fajardo JA, Ansuategui M, Romero C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521296 26. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost 2021; 5:132-141von Meijenfeldt FA, Havervall S, Adelmeijer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537537 27. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res 2020; 199:143-148. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535120 28. Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: A multicenter case-control study. Thromb Res 2021; 200:87-90Smit JM, Lopez Matta JE, Vink R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549899

Complications (94 articles)

1. COVID-19 PRESENTING WITH DIABETIC KETOACIDOSIS: A CASE SERIES. AACE Clin Case Rep 2020; Gorthi RS, Kamel G, Dhindsa S, Nayak RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521253 2. Graves' Thyrotoxicosis Following SARS-CoV-2 Infection. AACE Clin Case Rep 2020; Harris A, Al Mushref M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521256 3. EUGLYCEMIC DIABETIC KETOACIDOSIS WITH COVID-19 INFECTION IN PATIENTS WITH TYPE 2 DIABETES TAKING SGLT2 INHIBITORS. AACE Clin Case Rep 2020; Vitale RJ, Valtis YK, McDonnell ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521255 4. Hematological manifestations and complications of COVID-19. Adv Clin Exp Med 2021; 30:101-107Erdinc B, Sahni S, Gotlieb V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529513 5. Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: A meta-analysis. Am J Emerg Med 2021; 43:88-96Cardona S, Downing J, Alfalasi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550104 6. Non-invasive positive pressure ventilation versus endotracheal intubation in treatment of COVID-19 patients requiring ventilatory support. Am J Emerg Med 2021; 43:103-108Daniel P, Mecklenburg M, Massiah C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550100 7. COVID-19-Associated Suspected Myocarditis as the Etiology for Recurrent and Protracted Fever in an Otherwise Healthy Adult. Am. J. Med. Sci. 2020; Volis I, Livneh I, Hussein K, Raz-Pasteur A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546881 8. Total gastric necrosis following acute pancreatitis in a patient with COVID -19: Case report and literature review. Ann Med Surg (Lond) 2021; 62:362-364Bouali M, Ouchane M, Elbakouri A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520227 9. Emergency high ligation in a suspected COVID-19 pediatric patient with incarcerated inguinal hernia: A case report. Ann Med Surg (Lond) 2021; 62:261- 264Gunadi, Makkadafi M, Fauzi AR et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520222 10. A rare manifestation of indolent systemic mastocytosis and its management during the coronavirus disease 2019 pandemic; educational lessons from Syria. Ann Med Surg (Lond) 2021; 62:293-297Slaibi A, Alshehabi Z, Soltany A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520224 11. The features comparison between patients in the ICU and general wards and between patients with different outcomes: a 2020 COVID-19 study. Ann Palliat Med 2021; 10:672-680Chen Y, Geng Y, Xu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545796 12. Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy. BMJ Case Rep. 2021; 14Tambawala ZY, Hakim ZT, Hamza LK, Al Rayes M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541967 13. Pandemic ICU triage challenge and medical ethics. BMJ Support Palliat Care 2021; Netters S, Dekker N, van de Wetering K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541855 14. Acute haemorrhagic leukoencephalitis (Hurst disease) in severe COVID- 19 infection. Brain Behav Immun Health 2021; 12:100208Haqiqi A, Samuels TL, Lamb FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521690 15. Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report. Braz J Anesthesiol 2020; Eroglu A, Kartal S, Saral OB. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518836 16. When cardiomyopathy, cancer, and COVID-19 collide: A case report. Breast J 2021; Symonds L, Natarajan P, Cheng RK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527538 17. Diseasome and comorbidities complexities of SARS-CoV-2 infection with common malignant diseases. Brief. Bioinform. 2021; Satu MS, Khan MI, Rahman MR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539530 18. A case series of concomitant burn and COVID-19. Burns Open 2021; 5:34- 38Hesamirostami M, Nazarian R, Asghari H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521415 19. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID- 19 Infection. Clin. Appl. Thromb. Hemost. 2021; 27:1076029620977702Magnani HN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539214 20. COVID-19 Patient with Severe Comorbidity in Multimodal Acute Care Setting with Non-Invasive Medical Ventilation: A Clinical Outcome Report. Clin Pract 2021; 11:81-91Romeyke T, Noehammer E, Stummer H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546107 21. A Rare Case of Varicella-Zoster Virus Reactivation Following Recovery From COVID-19. Cureus 2021; 13:e12423Desai HD, Sharma K, Patoliya JV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542871 22. COVID-19 Infection and Acute Pulmonary Embolism in an Adolescent Female With Sickle Cell Disease. Cureus 2020; 12:e12348Kasinathan S, Mohammad Ashraf H, Minkowitz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520543 23. Venous Thromboembolism Has a Variable Time of Occurrence in the Course of COVID-19: A Case Series. Cureus 2020; 12:e12295Mene-Afejuku TO, Jeyashanmugaraja GP, Akinlonu AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520499 24. Isolated Radial Vein Thrombosis: Upper Extremity Deep Vein Thrombosis in a Patient With COVID-19 Infection. Cureus 2021; 13:e12856Ramalingam S, Arora H, Gunasekaran K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520558 25. COVID-2019 Associated with Acquired Monocular Blindness. Curr Eye Res 2021:1-4Liu L, Cai D, Huang X, Shen Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530768 26. Neurosyphilis and the Jarisch-Herxheimer Reaction: A Therapy Concern with HIV Disease. Dermatol Ther 2021:e14839Kapila R, Schwartz RA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527658 27. Successful treatment of a bullous vasculitis with intravenous immunoglobulins in A Covid-19 Patient. Dermatol Ther 2021:e14853Zavattaro E, Cammarata E, Tarantino V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547851 28. Non autoimmune type 1B diabetes after mild COVID-19: Report of three cases. Diabetes Metab Res Rev 2021; Seow CJ, Wei Choon Koh A, Lian JX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534177 29. Novel Case Report: A Previously Reported, but Pathophysiologically Unexplained, Association Between Collagenous Colitis and Protein-Losing Enteropathy May Be Explained by an Undetected Link with Collagenous Duodenitis. Dig. Dis. Sci. 2021:1-8Gill I, Shaheen AA, Edhi AI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537921 30. Modified Negative Pressure Enclosure During Tracheostomy in Patients With COVID-19. Ear Nose Throat J 2021:145561321991319Levy DA, Boey HP, Leff PD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530740 31. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States. EClinicalMedicine 2021; 31:100688Wang Q, Davis PB, Xu R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521611 32. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis 2021; 27Salmanton-García J, Sprute R, Stemler J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539721 33. COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue. Emerg Microbes Infect 2021:1-30Xi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522893 34. Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report. Eur Heart J Case Rep 2021; 5:ytaa475Colombier S, Mahendiran T, Niclauss L, Kirsch M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542974 35. Acute pulmonary embolism in a patient with mild COVID-19 symptoms: a case report. Eur Heart J Case Rep 2021; 5:ytaa563Fiorini NB, Garagoli F, Bustamante RC, Pizarro R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521514 36. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J Case Rep 2021; 5:ytaa388Scudiero F, Pitì A, Keim R, Parodi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542972 37. COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU. Exp Hematol Oncol 2021; 10:6Zheng R, Zhou J, Song B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522958 38. PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia. Exp. Lung Res. 2021:1-12Beute J, Boermans P, Benraad B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544007 39. Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention. Front Cardiovasc Med 2020; 7:599334Liu H, Wang Z, Sun H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537347 40. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel. Front. Immunol. 2020; 11:614086Marcus N, Frizinsky S, Hagin D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519822 41. Tuberculosis mimicking Crohn's disease and respiratory infection with COVID- 19. Gastroenterol. Hepatol. 2021; Ferrero BE, Ruiz Pardo J, Albendea FJV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524468 42. Saddle thrombus in the region of the aortic bifurcation and critical limb ischaemia of the left leg associated with SARS-CoV-2 infection. Gefasschirurgie 2021; Meier J, Vallejos Köhnenkamp FA, Zierke K et al. 43. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30- day mortality: COVID PAN collaborative study. Gut 2021; Pandanaboyana S, Moir J, Leeds JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547182 44. A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives. Health Sci Rep 2021; 4:e237Ramani VK, Naik R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532600 45. Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic. Healthcare (Basel) 2021; 9Alamer AA, Almulhim AS, Alrashed AA, Abraham I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525596 46. Tracheostomy in Covid-19 Patients: Surgical Concerns and Considerations. Indian J Otolaryngol Head Neck Surg 2021:1-4Sebastian SK, Amar PS, Sharma R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532346 47. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle- aged adult population. Infect Dis Now 2021; Lapidus N, Paireau J, Levy-Bruhl D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521775 48. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review. Int Immunopharmacol 2021; 93:107397Tehrani HA, Darnahal M, Vaezi M, Haghighi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524803 49. Diagnosis and treatment of disseminated intravascular coagulation in COVID- 19 patients: a scoping review. Int. J. Hematol. 2021; Mori H, Ohkawara H, Togawa R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550533 50. Is liver involvement overestimated in COVID-19 patients? A meta-analysis. Int. J. Med. Sci. 2021; 18:1285-1296Li G, Yang Y, Gao D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526990 51. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis. Int. J. Med. Sci. 2021; 18:1143-1152Wu YH, Yeh IJ, Phan NN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526974 52. A Case of Guillain-Barré Syndrome Related to COVID-19 Infection. Int. J. Neurosci. 2021:1-6Türk Börü Ü, Köseoğlu Toksoy C, Bölük C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535007 53. Delayed onset of fatal encephalitis in a COVID-19 positive patient. Int. J. Neurosci. 2021:1-5Zanin L, Saraceno G, Renisi G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535011 54. Clinical characteristics and outcomes of people living with HIV hospitalized with COVID-19: a nationwide experience. Int. J. STD AIDS 2021:956462420973106Ceballos ME, Ross P, Lasso M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533294 55. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med 2021:1-14Shaefi S, Brenner SK, Gupta S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528595 56. Cerebral venous sinus thrombosis in patients with COVID-19 infection. Interdiscip Neurosurg 2021; 24:101091Abouhashem S, Eldawoody H, Taha MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520667 57. Seroconversion of SARS-CoV-2 infected patients on immunosuppression: a retrospective analysis. J Am Acad Dermatol 2021; Smith JS, Said JT, Elman SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549649 58. Signs, Symptoms, and Comorbidities Associated With Poor Outcomes Among Residents of a Skilled Nursing Facility With SARS-CoV-2 Infection-King County, Washington. J. Am. Med. Dir. Assoc. 2021; Tobolowsky FA, Bardossy AC, Currie DW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549565 59. Acute pulmonary embolism following acute type A aortic dissection in a patient with COVID-19. J. Card. Surg. 2021; Volvovitch D, Ram E, Cohen H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533105 60. Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J Clin Med 2021; 10Giacobbe DR, Battaglini D, Enrile EM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546093 61. Coronavirus disease 2019 and extra-pulmonary tuberculosis co-infection - A case report and review of literature. J Clin Tuberc Other Mycobact Dis 2021; 22:100213Gerstein S, Khatri A, Roth N, Wallach F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521333 62. Emergency Department Management of Severe Hypoxemic Respiratory Failure in Adults With COVID-19. J. Emerg. Med. 2020; Wilcox SR, Condella A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526308 63. COVID-19-associated liver injury: from bedside to bench. J. Gastroenterol. 2021:1-13Li D, Ding X, Xie M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527211 64. Altered blood cell traits underlie a major genetic locus of severe COVID-19. J Gerontol A Biol Sci Med Sci 2021; Zhou J, Sun Y, Huang W, Ye K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530099 65. Intensified thromboprophylaxis in COVID-19 critically ill patients: is it enough? J Infect 2021; de Montmollin E, Faille D, Andrieu V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549626 66. A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature. J Med Case Rep 2021; 15:41Dai Y, Liu S, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522942 67. COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist. J Nephrol 2021; Laboux T, Gibier JB, Pottier N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548053 68. Enteric fever and COVID-19 co-infection in a teenager returning from Pakistan. J Travel Med 2021; Ayoubzadeh SI, Isabel S, Coomes EA, Morris SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550371 69. Characteristics and Outcomes of COVID-19 in Patients with ANCA associated vasculitis. Kidney Int Rep 2020; Kant S, Raman G, Damera P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521401 70. Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection. Liver Int 2021; Butt AA, Yan P, Chotani RA, Shaikh OS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534931 71. Pneumococcal superinfection in COVID-19 patients: A series of 5 cases. Med Clin (Engl Ed) 2020; 155:502-505Cucchiari D, Pericàs JM, Riera J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521301 72. Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 2021; 156:112-117Gonzalez-Fajardo JA, Ansuategui M, Romero C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521296 73. Alternative CPAP methods for the treatment of secondary serious respiratory failure due to pneumonia by COVID-19. Med Clin (Engl Ed) 2021; 156:55- 60Mateos-Rodríguez A, Ortega-Anselmi J, Candel-González FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521312 74. Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide. Neurol Sci 2021:1-4Yetkin MF, Yetkin NA, Akcakoyunlu M, Mirza M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534122 75. Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives. Neurotherapeutics 2021:1-8Bhise V, Dhib-Jalbut S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533012 76. Pneumocystis and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Case Report and Review of an Emerging Diagnostic Dilemma. Open Forum Infect Dis 2021; 8:ofaa633Rubiano C, Tompkins K, Sellers SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537365 77. Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients. Physiol Rep 2021; 9:e14715Giraud R, Legouis D, Assouline B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527751 78. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021; 9:e14726Østergaard L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523608 79. Aging of the lungs and immune system as hellmark in the pathogenesis of idiopathic pulmonary fibrosis and COVID-19. Pneumologe 2021; Stieglitz S, Frohnhofen H. 80. A skeleton in the closet: The implications of COVID-19 on XDR strain of typhoid in Pakistan. Public Health Pract (Oxf) 2021; 2:100084Ahmad S, Tsagkaris C, Aborode AT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521736 81. Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology 2021; Migliori GB, Visca D, van den Boom M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547028 82. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology 2021; Visca D, Ong CWM, Tiberi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547029 83. Bowel necrosis associated with COVID-19 pneumonia: A report of two cases. Radiol Case Rep 2021; 16:819-823Mir MZ, Mashhadi A, Jahantigh M, Seyedi SJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520046 84. SARS-CoV-2 infection leading to ischemic and hemorrhagic brain lesions and acute respiratory distress syndrome. Radiol Case Rep 2021; 16:753- 759Thibodeau R, Jafroodifar A, Quraeshi S, Lisi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520045 85. A fatal outcome from SARS-CoV-2 infection: One case report of a young man with multiple organ damage. Radiol Infect Dis 2020; 7:208-212Zeng Y, Zhou X, Gang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521222 86. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost 2021; 5:132-141von Meijenfeldt FA, Havervall S, Adelmeijer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537537 87. Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: a consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group). Rev. Endocr. Metab. Disord. 2021; Fernandez Martinez A, Barajas Galindo D, Ruiz Sanchez J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547563 88. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case- based review. Rheumatol. Int. 2021:1-11Gracia-Ramos AE, Saavedra-Salinas M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543338 89. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res 2020; 199:143-148. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535120 90. Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: A multicenter case-control study. Thromb Res 2021; 200:87-90Smit JM, Lopez Matta JE, Vink R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549899 91. Clinical Manifestations and Outcomes of Coronavirus Disease-19 in Heart Transplant Recipients: A Multicenter Case Series with a Systematic Review and Meta-Analysis. Transpl Int 2021; Granger C, Guedeney P, Arnaud C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539616 92. Cancer, COVID-19, and the need for critique. Wellcome Open Res 2020; 5:280Greco C, Arteaga I, Fabian-Therond C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521331 93. Severity of COVID-19 in hospitalized patients with and without atopic disease. World Allergy Organ J 2021; 14:100508Timberlake DT, Narayanan D, Ogbogu PU et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520082 94. Risk factors associated with acute respiratory distress syndrome in COVID-19 patients outside Wuhan: A double-center retrospective cohort study of 197 cases in Hunan, China. World J Clin Cases 2021; 9:344-356Hu XS, Hu CH, Zhong P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=3352110

Cured – Recovered (15 articles)

1. Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age Ageing 2021. http://www.ncbi.nlm.nih.gov/pubmed/? term=33543243 2. Do Patients with Covid-19 Benefit from Rehabilitation? Functional outcomes of the first 100 patients in a Covid-19 rehabilitation unit. Arch. Phys. Med. Rehabil. 2021; Piquet V, Luczak C, Seiler F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548208 3. A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding? BMJ Case Rep. 2021; 14Tuan J, Spichler-Moffarah A, Ogbuagu O. http://www.ncbi.nlm.nih.gov/pubmed/? term=33542020 4. Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors? Front. Physiol. 2020; 11:614590Motiejunaite J, Balagny P, Arnoult F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536937 5. Assessment of the Impact of a Daily Rehabilitation Program on Anxiety and Depression Symptoms and the Quality of Life of People with Mental Disorders during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Smolarczyk-Kosowska J, Szczegielniak A, Legutko M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546511 6. The characteristics of 527 discharged COVID-19 patients undergoing long- term follow-up in China. Int J Infect Dis 2021; Zhang J, Xu J, Zhou S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540129 7. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res 2021; Khoshkam Z, Aftabi Y, Stenvinkel P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520309 8. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J. Am. Soc. Echocardiogr. 2021; Moody WE, Liu B, Mahmoud-Elsayed HM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33539950 9. Discharge Clinical Characteristics and Post-Discharge Events in Patients with Severe COVID-19: A Descriptive Case Series. J Gen Intern Med 2021:1-6Saab FG, Chiang JN, Brook R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532963 10. Targets and assay types for COVID-19 diagnosis. J. Immunoassay Immunochem. 2020; 41:946-959Bostan M, Ataman M, Bostan IS, Bleotu C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539260 11. Clinical Features of Patients who had two COVID-19 Episodes: A European Multicenter Case-series. J Intern Med 2021; Lechien JR, Chiesa-Estomba CM, Radulesco T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527495 12. Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves. J Med Virol 2021; Elshazli RM, Kline A, Elgaml A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527440 13. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021:1-5Hellmuth J, Barnett TA, Asken BM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528824 14. How did socio-demographic status and personal attributes influence compliance to COVID-19 preventive behaviours during the early outbreak in Japan? Lessons for pandemic management. Pers. Individ. Dif. 2021; 175:110692Uddin S, Imam T, Khushi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526954 15. Aging of the lungs and immune system as hellmark in the pathogenesis of idiopathic pulmonary fibrosis and COVID-19. Pneumologe 2021; Stieglitz S, Frohnhofen H.

Cardiovascular disease (75 articles)

1. The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population. Aging (Albany NY) 2021; 13Nimgaonkar I, Valeri L, Susser E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550276 2. COVID-19-Associated Suspected Myocarditis as the Etiology for Recurrent and Protracted Fever in an Otherwise Healthy Adult. Am. J. Med. Sci. 2020; Volis I, Livneh I, Hussein K, Raz-Pasteur A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546881 3. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19. Am J Prev Cardiol 2021; 5:100150Al Rifai M, Khalid U, Misra A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521756 4. Acute pericarditis revealing COVID-19 infection: Case report. Ann Med Surg (Lond) 2021; 62:225-227Faraj R, Belkhayat C, Bouchlarhem A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520219 5. Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity. Antioxidants (Basel) 2021; 10Cho KH, Kim JR, Lee IC, Kwon HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535459 6. Adult cardiac surgery during COVID-19 lockdown: Impact on activity and outcomes in a high-volume centre. Arch Cardiovasc Dis 2021; Nader J, Anselmi A, Tomasi J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541832 7. Beneficial Effect of Statins in COVID-19-Related Outcomes: A National Population-Based Cohort Study. Arterioscler. Thromb. Vasc. Biol. 2021:Atvbaha120315551Lee HY, Ahn J, Park J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535790 8. Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment. Atherosclerosis 2021; 320:53- 60Vuorio A, Raal F, Kaste M, Kovanen PT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33540179 9. When cardiomyopathy, cancer, and COVID-19 collide: A case report. Breast J 2021; Symonds L, Natarajan P, Cheng RK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527538 10. Initial single center ST-segment elevation myocardial infarction experience in New York before and during the COVID-19 pandemic. Cardiovasc. Revasc. Med. 2021; Medranda GA, Brahmbhatt K, Alawneh B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526393 11. Virtual support for remote proctoring in TAVR during COVID-19. Catheter. Cardiovasc. Interv. 2021; Arslan F, Gerckens U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527578 12. Outcomes of in-hospital cardiac arrest in COVID-19 patients: A proportional prevalence meta-analysis. Catheter. Cardiovasc. Interv. 2021; Mir T, Sattar Y, Ahmad J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543564 13. Decline and Recurrence of Stroke Consultations during the COVID-19 Pandemic Lockdown Parallels Population Activity Levels. Cerebrovasc. Dis. 2021:1-9Schlachetzki F, Wilfling S, Hubert ND et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540410 14. Takayasu's Arteritis in Pregnancy: Challenges During the Ongoing Coronavirus Disease 2019 Pandemic for Optimal Maternal and Neonatal Outcomes. Cureus 2020; 12:e12386Singh S, Pati A, Mohakud S, Behera DR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532151 15. ECG Images dataset of Cardiac and COVID-19 Patients. Data Brief 2021; 34:106762Khan AH, Hussain M, Malik MK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521183 16. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19. Diagnostics (Basel) 2021; 11Miftode RS, Petriș AO, Onofrei Aursulesei V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530550 17. Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis. Egypt Heart J 2021; 73:13Laurentius A, Mendel B, Prakoso R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544293 18. Cardiac arrest in COVID-19: characteristics and outcomes of in- and out-of- hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation. Eur Heart J 2021; Sultanian P, Lundgren P, Strömsöe A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543259 19. Cardiac arrest and COVID-19: inflammation, angiotensin-converting enzyme 2, and the destabilization of non-significant coronary artery disease-a case report. Eur Heart J Case Rep 2021; 5:ytaa475Colombier S, Mahendiran T, Niclauss L, Kirsch M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542974 20. Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases. Eur Heart J Case Rep 2021; 5:ytaa488Guillet H, Gallet R, Pham V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542975 21. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J Case Rep 2021; 5:ytaa388Scudiero F, Pitì A, Keim R, Parodi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542972 22. Gene Expression Profiling Reveals the Shared and Distinct Transcriptional Signatures in Human Lung Epithelial Cells Infected With SARS-CoV-2, MERS- CoV, or SARS-CoV: Potential Implications in Cardiovascular Complications of COVID-19. Front Cardiovasc Med 2020; 7:623012Jha PK, Vijay A, Halu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521069 23. Biventricular Longitudinal Strain Predict Mortality in COVID-19 Patients. Front Cardiovasc Med 2020; 7:632434Xie Y, Wang L, Li M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537350 24. Systematic Screening for Deep Vein Thrombosis in Critically Ill Inpatients With COVID-19: Impact on the Incidence of Venous Thromboembolism. Front Med (Lausanne) 2020; 7:624808Lapébie FX, Minville V, Ribes A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521028 25. Acute Stroke Care in the With-COVID-19 Era: Experience at a Comprehensive Stroke Center in Japan. Front. Neurol. 2020; 11:611504Koge J, Shiozawa M, Toyoda K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536996 26. Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain. Front Pediatr 2020; 8:617039Fernández-Cooke E, Grasa CD, Domínguez-Rodríguez S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537269 27. Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond. Front. Pharmacol. 2020; 11:579548Vuorio A, Kovanen PT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542685 28. Saddle thrombus in the region of the aortic bifurcation and critical limb ischaemia of the left leg associated with SARS-CoV-2 infection. Gefasschirurgie 2021; Meier J, Vallejos Köhnenkamp FA, Zierke K et al. 29. Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic. Healthcare (Basel) 2021; 9Alamer AA, Almulhim AS, Alrashed AA, Abraham I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525596 30. COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether? Heart 2021; Danchin N, Marijon E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526507 31. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. Heart Lung 2021; 50:329-333Turgay Yıldırım Ö, Kaya Ş. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524862 32. Air pollution and cardiovascular diseases. Herz 2021; Münzel T, Hahad O, Daiber A, Lelieveld J. 33. COVID-19 and cardiovascular disease: a review of current knowledge. Horm. Mol. Biol. Clin. Investig. 2021; Pal A, Ahirwar AK, Sakarde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544511 34. Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT- logs study. Int J Cardiol 2021; Maille B, Wilkin M, Millon M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524462 35. Remote Monitoring for Heart Failure Management during COVID-19. Int J Cardiol Heart Vasc 2021; 32:100724Bertagnin E, Greco A, Bottaro G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532544 36. Remote monitoring for heart failure management during COVID-19 pandemic. Int J Cardiol Heart Vasc 2021; 32:100724Bertagnin E, Greco A, Bottaro G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532544 37. Left ventricular global longitudinal strain in identifying subclinical myocardial dysfunction among patients hospitalized with COVID-19. Int J Cardiol Heart Vasc 2021; 32:100719Shmueli H, Shah M, Ebinger JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521240 38. Identifying the Stroke Mimics. Int. J. Gen. Med. 2021; 14:285-288Mishra AK, Vanjare HA, George AA, Sahu KK. http://www.ncbi.nlm.nih.gov/pubmed/? term=33542647 39. Cerebral venous sinus thrombosis in patients with COVID-19 infection. Interdiscip Neurosurg 2021; 24:101091Abouhashem S, Eldawoody H, Taha MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520667 40. Stroke in patients infected by the novel coronavirus and its causal mechanisms: A narrative review. J Am Coll Emerg Physicians Open 2021; 2:e12332de Oliveira RMF, de Souza Aguiar PHC, de Paula R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521783 41. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J. Am. Soc. Echocardiogr. 2021; Moody WE, Liu B, Mahmoud-Elsayed HM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33539950 42. Acute pulmonary embolism following acute type A aortic dissection in a patient with COVID-19. J. Card. Surg. 2021; Volvovitch D, Ram E, Cohen H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533105 43. Acute right ventricular failure in COVID-19 infection: A case series. J Cardiol Cases 2021; García-Cruz E, Manzur-Sandoval D, Baeza-Herrera LA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520022 44. Remote monitoring temporal trends during COVID-19 pneumonia in patients with implanted defibrillators. J Cardiol Cases 2021; Mascioli G, Lucca E, Annunziata L, Giacopelli D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520021 45. Pulmonary Vascular Thrombosis in COVID-19 Pneumonia. J Cardiothorac Vasc Anesth 2021; De Cobelli F, Palumbo D, Ciceri F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518461 46. Disaster hypertension and cardiovascular events in disaster and COVID-19 pandemic. J. Clin. Hypertens. (Greenwich) 2021; Narita K, Hoshide S, Tsoi K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527663 47. The State of Atrial Fibrillation in 2020. J Innov Card Rhythm Manag 2021; 12:4350-4353Doshi RN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520349 48. Micra™ Leadless Intracardiac Pacemaker Implantation: A Safer Option During the Coronavirus Disease 2019 Pandemic. J Innov Card Rhythm Manag 2021; 12:4368-4370Kazmi M, Rashid S, Markovic N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520352 49. Arrhythmias in the Age of Coronavirus Disease 2019. J Innov Card Rhythm Manag 2021; 12:4345-4348Niazi I, Khan M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520348 50. Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data. J. Neurol. 2021; Beyrouti R, Best JG, Chandratheva A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547527 51. Potential mechanisms of cerebrovascular diseases in COVID-19 patients. J. Neurovirol. 2021:1-17Lou M, Yuan D, Liao S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534131 52. Unusual Cardiac Presentation of COVID-19 with Significant Sinus Pauses. J Saudi Heart Assoc 2020; 32:450-453Chachar TS, Slais SK, Almadani A, Hamad AK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537189 53. Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US. J. Stroke Cerebrovasc. Dis. 2021; 30:105639Friedlich D, Newman T, Bricker S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540335 54. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study. J Thromb Haemost 2021; Li JY, Wang HF, Yin P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534149 55. The Incidence, Prognosis and Laboratory Indicators of Venous Thromboembolism in Hospitalized Patients with COVID-19: A Systematic Review and Meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; Liu Y, Cai J, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529719 56. Atrial Flutter in Patient With Critical COVID-19: Beneficial Effects of Rhythm Control on Respiratory Distress. JACC Case Rep 2021; 3:162-164Bertini M, Vitali F, Malagù M, Rapezzi C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521679 57. Balancing Service and Safety: Cardiovascular Medicine Divisional Response to the COVID-19 Pandemic. JACC Case Rep 2020; 2:1368-1375Khan AN, Desai K, Zviman A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521678 58. Papillary Muscle Rupture Due to Delayed STEMI Presentation in a Patient Self- Isolating for Presumed COVID-19. JACC Case Rep 2020; 2:1633-1636Kunkel KJ, Anwaruddin S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521677 59. Personalized Monitoring Model for Electrocardiogram Signals: Diagnostic Accuracy Study. JMIR Biomed Eng 2020; 5:e24388Kotorov R, Chi L, Shen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529270 60. Investigation of cardiac alterations after COVID-19 with MRI. Kardiologe 2021; von Knobelsdorff F. 61. Risk of severe COVID-19 in hypertensive patients treated with renin- angiotensin-aldosterone system inhibitors. Med Clin (Engl Ed) 2020; 155:488- 490Golpe R, Pérez-de-Llano LA, Dacal D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521300 62. Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 2021; 156:112-117Gonzalez-Fajardo JA, Ansuategui M, Romero C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521296 63. SARS-CoV-2 associated polyradiculitis and myocarditis may favour Takotsubo syndrome. Med. Hypotheses 2021; 148:110509Finsterer J, Stöllberger C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540143 64. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2020; Du Y, Zhou N, Zha W, Lv Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549450 65. A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19. Obes Med 2021; 22:100323Naeini MB, Sahebi M, Nikbakht F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521379 66. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies. Pediatr. Cardiol. 2021; Gerber N, Flynn PA, Holzer RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547936 67. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021; 9:e14726Østergaard L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523608 68. [CME: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. Praxis (Bern 1994) 2021; 110:60-64Wuerzner G, Waeber B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530777 69. SARS-CoV-2 infection leading to ischemic and hemorrhagic brain lesions and acute respiratory distress syndrome. Radiol Case Rep 2021; 16:753- 759Thibodeau R, Jafroodifar A, Quraeshi S, Lisi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520045 70. Out-of-Hospital Cardiac Arrest in London during the COVID-19 pandemic. Resusc Plus 2021; 5:100066Fothergill RT, Smith AL, Wrigley F, Perkins GD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521706 71. The use of personal protection equipment does not impair the quality of cardiopulmonary resuscitation: A prospective triple-cross over randomised controlled non-inferiority trial. Resuscitation 2021; Kienbacher CL, Grafeneder J, Tscherny K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524489 72. Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients. Transl Med Commun 2021; 6:3Peymani P, Dehesh T, Aligolighasemabadi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521322 73. Clinical Manifestations and Outcomes of Coronavirus Disease-19 in Heart Transplant Recipients: A Multicenter Case Series with a Systematic Review and Meta-Analysis. Transpl Int 2021; Granger C, Guedeney P, Arnaud C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539616 74. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:115Aflaki M, Flannery A, Ferreira JP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546734 75. How Safe Are Children With Covid-19 From Cardiac Risks? Pediatric Risk Assessment, insights from Echocardiography and Electrocardiography. Turk J Med Sci 2021; Şaylan Çevİk B, Arici Ş, ErgenÇ Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517608 76. Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease. Vasc Biol 2021; 3:R1-r14Monteonofrio L, Florio MC, AlGhatrif M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537555

Diagnosis (21 articles)

1. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 2021; 11:94Ratre YK, Kahar N, Bhaskar L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520580 2. Continuation of telemedicine in otolaryngology post-COVID-19: Applications by subspecialty. Am. J. Otolaryngol. 2021; 42:102928Samarrai R, Riccardi AC, Tessema B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545447 3. Automated medical diagnosis of COVID-19 through EfficientNet convolutional neural network. Appl Soft Comput 2020; 96:106691Marques G, Agarwal D, de la Torre Díez I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519327 4. Comparison of deep learning approaches to predict COVID-19 infection. Chaos Solitons Fractals 2020; 140:110120Alakus TB, Turkoglu I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519109 5. Admission COVID-19 clinical risk assessment for guiding patient placement and diagnostic testing strategy. Clin Med (Lond) 2021; Jones NK, Ramsay I, Moore E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541910 6. An overview of COVID-19 for diagnostic pathologists: clinicopathological correlation and diagnostic techniques. Diagn. Histopathol. (Oxf.) 2020; 26:529- 536Ghosh A, Colling R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519973 7. COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue. Emerg Microbes Infect 2021:1-30Xi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522893 8. [Course of Revision of the Diagnosis and Treatment Protocol for COVID-19 and the Forensic Contribution]. Fa Yi Xue Za Zhi 2020; 36:841-847Zhang L, Kong LJ, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550733 9. Comparison of pre-analytical characteristics for molecular and serological diagnostics of COVID-19. GMS Hyg Infect Control 2021; 16:Doc03Wendt R, Nickel O, Kalbitz S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520604 10. COVID-19 classification by CCSHNet with deep fusion using transfer learning and discriminant correlation analysis. Inf Fusion 2021; 68:131-148Wang SH, Nayak DR, Guttery DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519321 11. A simple model for fitting mild, severe, and known cases during an epidemic with an application to the current SARS-CoV-2 pandemic. Infect Dis Model 2021; 6:313-323Betti MI, Heffernan JM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521406 12. A commentary on "Diagnosis and treatment of coronavirus disease 2019 (COVID-19) Laboratory, PCR, and chest CT imaging findings". Int J Surg 2021; 86:64-65Shuang Wu MM, Xiaofei Li MM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535086 13. The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World. J Allergy Clin Immunol Pract 2021; Greenhawt M, Abrams EM, Oppenheimer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529722 14. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J. Am. Soc. Echocardiogr. 2021; Moody WE, Liu B, Mahmoud-Elsayed HM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33539950 15. Loss of Smell and Taste Can Accurately Predict COVID-19 Infection: A Machine-Learning Approach. J Clin Med 2021; 10Callejon-Leblic MA, Moreno- Luna R, Del Cuvillo A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546319 16. "Diagnostic Features Of Sars-Covid-2 Positive Patients: A Rapid Review And Meta-Analysis". J. Clin. Nurs. 2021; Anderson G, Casasanta D, Cocchieri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527510 17. Current diagnostic and therapeutic strategies for COVID-19. J Pharm Anal 2021; Chen BB, Liu ML, Huang CZ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520327 18. An alternate prospect in detecting presymptomatic and asymptomatic COVID- 19 carriers through odor differentiation by HeroRATs. J. Vet. Behav. 2021; 42:26-29Adekanmbi AJ, Olude MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519319 19. Convolutional neural network use chest radiography images for identification of COVID-19. Mater Today Proc 2020; Murali D, Bhuvaneswari E, Parvathi S, Sanjeev Kumar AN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520674 20. Clinical characteristics of confirmed and clinically diagnosed patients with 2019 novel coronavirus pneumonia: a single-center, retrospective, case- control study. Med Clin (Engl Ed) 2020; 155:327-334Ke C, Yu C, Yue D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521303 21. Use of Failure Mode and Effect Analysis to Reduce Admission of Asymptomatic COVID-19 Patients to the Adult Emergency Department: An Institutional Experience. Risk Manag. Healthc. Policy 2021; 14:273-282Teklewold B, Anteneh D, Kebede D, Gezahegn W. http://www.ncbi.nlm.nih.gov/pubmed/? term=33536800 DM-MS-Obesity (12 articles)

1. COVID-19 PRESENTING WITH DIABETIC KETOACIDOSIS: A CASE SERIES. AACE Clin Case Rep 2020; Gorthi RS, Kamel G, Dhindsa S, Nayak RP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521253 2. EUGLYCEMIC DIABETIC KETOACIDOSIS WITH COVID-19 INFECTION IN PATIENTS WITH TYPE 2 DIABETES TAKING SGLT2 INHIBITORS. AACE Clin Case Rep 2020; Vitale RJ, Valtis YK, McDonnell ME et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521255 3. Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy. Acta Diabetol 2021:1-4Marigliano M, Maffeis C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532867 4. Metabolic Healthy Obesity, Vitamin D Status, and Risk of COVID-19. Aging Dis 2021; 12:61-71Li S, Cao Z, Yang H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532128 5. Perioperative Nurse Educators: Rapid Response to the COVID-19 Pandemic. AORN J. 2021; 113:180-189Peneza D, White-Edwards KY, Bricker C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534158 6. DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End? Arch. Immunol. Ther. Exp. (Warsz.) 2021; 69:1Krejner-Bienias A, Grzela K, Grzela T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527308 7. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study. BMC Infect. Dis. 2021; 21:147Cai H, Yang L, Lu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546633 8. The relationship between obesity, hemoglobin A1c and the severity of COVID- 19 at an urban tertiary care center in New York City: a retrospective cohort study. BMJ Open 2021; 11:e044526Randhawa G, Syed KA, Singh K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518528 9. Substance use, mental health and weight-related behaviours during the COVID-19 pandemic in people with obesity. Clin Obes 2021:e12440Almandoz JP, Xie L, Schellinger JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539652 10. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders. Clin Sci (Lond) 2021; 135:535-554Cao X, Song LN, Yang JK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533405 11. COVID-19 and Diabetic Ketoacidosis: A Single Center Experience. Cureus 2021; 13:e13000Singh B, Kaur P, Patel P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542884 12. Non autoimmune type 1B diabetes after mild COVID-19: Report of three cases. Diabetes Metab Res Rev 2021; Seow CJ, Wei Choon Koh A, Lian JX et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534177 13. Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation. Diabetes Metab. Syndr. Obes. 2021; 14:409-415Mehanna O, El Askary A, Ali E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542640 14. The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia. Diabetes Res Clin Pract 2021:108682Alharthi SK, Alyusuf EY, Alguwaihes AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539868 15. Updated overview on the interplay between obesity and COVID-19. Diagnosis (Berl) 2021; 8:5-16Onorato D, Carpenè G, Lippi G, Pucci M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544485 16. Is liver involvement overestimated in COVID-19 patients? A meta-analysis. Int. J. Med. Sci. 2021; 18:1285-1296Li G, Yang Y, Gao D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526990 17. Glycemic control in type 1 diabetes children and teenagers around lockdown for COVID-19: a continuous glucose monitoring based observational study. J Diabetes Investig 2021; Wu X, Luo S, Zheng X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539665 18. COVID-19 and emergencies in patients with diabetes: two case reports. J Med Case Rep 2021; 15:57Dey RK, Hilmy AI, Imad HA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531061 19. Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein. J Med Virol 2021; Koh H, Moh AMC, Yeoh E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527464 20. Obesity as a risk factor for hospitalization in COronaVirus Disease-19 (COVID- 19) patients: Analysis of the Tuscany regional database. Nutr. Metab. Cardiovasc. Dis. 2020; Bellini B, Cresci B, Cosentino C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549434 21. Obesity as a risk factor for unfavourable outcomes in critically ill patients affected by Covid 19. Nutr. Metab. Cardiovasc. Dis. 2020; Rossi AP, Gottin L, Donadello K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549439 22. Childhood Obesity and COVID-19 Lockdown: Remarks on Eating Habits of Patients Enrolled in a Food-Education Program. Nutrients 2021; 13Nicodemo M, Spreghini MR, Manco M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530570 23. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19. Obes Med 2020:100317AbdelMassih A, Yacoub E, Husseiny RJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521378

Education and training and science (63 articles)

1. Training non-intensivist doctors to work with COVID-19 patients in intensive care units. Acta Anaesthesiol. Scand. 2021; Engberg M, Bonde J, Sigurdsson ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529356 2. Medical students' perception of the reliability, usefulness and feasibility of unproctored online formative assessment tests. Adv. Physiol. Educ. 2021; 45:84-88Snekalatha S, Marzuk SM, Meshram SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529145 3. Remote E-exams during Covid-19 pandemic: A cross-sectional study of students' preferences and academic dishonesty in faculties of medical sciences. Ann Med Surg (Lond) 2021; 62:326-333Elsalem L, Al-Azzam N, Jum'ah AA, Obeidat N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520225 4. Analysis of the impact of the pandemic on surgical residency programs during the first wave in Argentina: A cross - sectional study. Ann Med Surg (Lond) 2021; 62:455-459Palacios Huatuco RM, Liaño JE, Moreno LB, Ponce Beti MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532065 5. Comparison between camcorder, frontal head and temporal mounted action- cam in digestive surgery: Documentation and educational alternative during COVID-19 pandemic. Ann Med Surg (Lond) 2021; 62:347-352Yuda Handaya A, Fauzi AR, Andrew J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520226 6. A Curriculum for Perioperative Nurse Deployment During a Pandemic. AORN J. 2021; 113:138-145Hemingway MW, Silvestri S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534151 7. A health worker knowledge, attitudes and practices survey of SARS-CoV-2 infection prevention and control in South Africa. BMC Infect. Dis. 2021; 21:138Moodley SV, Zungu M, Malotle M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526033 8. A cross-sectional survey of knowledge, attitude and practice (KAP) towards COVID-19 pandemic among the Syrian residents. BMC Public Health 2021; 21:296Al Ahdab S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546652 9. Knowledge, attitudes, and practices (KAP) toward COVID-19: a cross-sectional study in South Korea. BMC Public Health 2021; 21:295Lee M, Kang BA, You M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546644 10. Knowledge, attitude and practice of the Sudanese people towards COVID-19: an online survey. BMC Public Health 2021; 21:274Mohamed AAO, Elhassan EAM, Mohamed AO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535995 11. Knowledge-attitude-practice and psychological status of college students during the early stage of COVID-19 outbreak in China: a cross-sectional study. BMJ Open 2021; 11:e045034Jia Y, Qi Y, Bai L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550266 12. THRIVE: five years on and into the COVID-19 era. Br J Anaesth 2021; Sud A, Patel A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546843 13. Assessment of general awareness among Pakistani students regarding COVID-19 outbreak. Child Youth Serv Rev 2021; 121:105830Hussain T, Gilani US, Khan S, Raza SMM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518864 14. Knowledge, attitudes and mental health of university students during the COVID-19 pandemic in China. Child Youth Serv Rev 2020; 119:105494Jiang R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518860 15. An ethics framework for consolidating and prioritizing COVID-19 clinical trials. Clin. Trials 2021:1740774520988669Meyer MN, Gelinas L, Bierer BE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530721 16. Implementation of a digital semester for ophthalmology during the COVID-19 pandemic. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; Müller A, Wagner FM, Matlach J et al. 17. International publication activity during the COVID-19 pandemic. Der Pathologe 2021; Strobl S, Roth W. 18. Digital teaching with, during and after COVID-19. Der Radiologe 2021; 61:64- 66Molwitz I, Othman A, Brendlin A et al. 19. Preschool Education in Turkey During the Covid-19 Pandemic: A Phenomenological Study. Early Child Educ J 2021:1-17Yıldırım B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519174 20. Social Determinants of Health and Implementation Research: Lessons from the COVID-19 Pandemic. Ethn. Dis. 2021; 31:5-8Riley WT, Mensah GA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519150 21. Shared learning in and beyond the COVID-19 pandemic. Eur J Cardiothorac Surg 2021; Ravishankar R, Adreak NA, Vervoort D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523212 22. Brazilian dental students and COVID-19: a survey on knowledge and perceptions. Eur. J. Dent. Educ. 2021; Brito Aragao MG, Fernandes Gomes FI, de Melo L, Corona SAM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547843 23. A systematic bias assessment of top-cited full-length original clinical investigations related to COVID-19. Eur J Intern Med 2021; Elgendy IY, Nimri N, Barakat AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541829 24. EBCOG position statement - Simulation-based training for obstetrics and gynaecology during the COVID-19 pandemic. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; Zimmerman E, Martins NN, Verheijen RHM, Mahmood T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518409 25. The National Institutes of Health COVID-19 NeuroDatabank and NeuroBiobank: A National Resource for Learning, Discovery, and Progress. Front. Neurol. 2020; 11:615061Troxel AB, Frontera JA, Mendoza-Puccini C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519693 26. Progress in Research on SARS-CoV-2 Infection Causing Neurological Diseases and Its Infection Mechanism. Front. Neurol. 2020; 11:592888Wang L, Ren Z, Ma L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519677 27. SARS-CoV-2 Infections in Italian Schools: Preliminary Findings After 1 Month of School Opening During the Second Wave of the Pandemic. Front Pediatr 2020; 8:615894Buonsenso D, De Rose C, Moroni R, Valentini P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520898 28. Social Support and Loneliness Among Chinese Caregivers of Children With Chronic Kidney Disease During the COVID-19 Pandemic: A Propensity Score Matching Analysis. Front Pediatr 2020; 8:570535Shi L, Zhang H, Yang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520883 29. Impact of COVID-19 Pandemic on University Students' Physical Activity Levels: An Early Systematic Review. Front. Psychol. 2020; 11:624567López- Valenciano A, Suárez-Iglesias D, Sanchez-Lastra MA, Ayán C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519653 30. The Influence of Coronavirus Diseases 2019 (COVID-19) Pandemic and the Quarantine Practices on University Students' Beliefs About the Online Learning Experience in Jordan. Front Public Health 2020; 8:595874Almomani EY, Qablan AM, Atrooz FY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520916 31. How Does Public Knowledge, Attitudes, and Behaviors Correlate in Relation to COVID-19? A Community-Based Cross-Sectional Study in Nepal. Front Public Health 2020; 8:589372Devkota HR, Sijali TR, Bogati R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520911 32. Communication and Cooperation Between the Medical Academy, Medical Association, and Local Government: Health Counseling Program After Recovery From Coronavirus Disease 2019 (COVID-19) in Daegu. Front Public Health 2020; 8:563757Kim YA, Lee GH, Lee KM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520907 33. Study on the Knowledge, Attitude, and Practice (KAP) of Nursing Staff and Influencing Factors on COVID-19. Front Public Health 2020; 8:560606Wen X, Wang F, Li X, Gu H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537272 34. Impact of COVID-19 on longitudinal ophthalmology authorship gender trends. Graefes Arch Clin Exp Ophthalmol 2021:1-12Nguyen AX, Trinh XV, Kurian J, Wu AY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537883 35. [Electronic learning for otorhinolaryngology students using the content management system ILIAS]. HNO 2021:1-8van Bonn SM, Grajek JS, Großmann W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537879 36. In the emerging evidence base on coronavirus disease 2019 and loss of smell, how many preprint papers are subsequently published? Int Forum Allergy Rhinol 2021; Walsh ME, Hopkins C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33539666 37. Engagement in Health Risk Behaviours before and during the COVID-19 Pandemic in German University Students: Results of a Cross-Sectional Study. Int J Environ Res Public Health 2021; 18Busse H, Buck C, Stock C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546344 38. Blurring the Boundaries: Reflections From Early Career Faculty During the COVID-19 Era. Intellect Dev Disabil 2021; 59:1-6Rodriguez G, Monteleone R, Munandar VD, Bumble JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543272 39. Rising to the challenge: medical students as Doctors' Assistants; an evaluation of a new clinical role. J Adv Med Educ Prof 2021; 9:26-33Lavender DM, Dekker AP, Tambe AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521138 40. COVID-19: a Review of the Literature Regarding African American Patient Outcomes. J Afr Am Stud (New Brunsw) 2021:1-10Mangum VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519320 41. Obtaining EHR-derived datasets for COVID-19 research within a short time: a flexible methodology based on Detailed Clinical Models. J. Biomed. Inform. 2021:103697Pedrera Jiménez M, García Barrio N, Cruz Rojo J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548541 42. Bibliometric analysis of global scientific research on COVID-19. J Biosaf Biosecur 2021; 3:4-9Wang P, Tian D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521590 43. Scientometric analyzing the output of researchers and organizations on COVID-19 for better conducting the scientific efforts: with a glance to endocrinology. J Diabetes Metab Disord 2021:1-12Atlasi R, Noroozi Chakoli A, Ramezani A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532371 44. COVID-19 among Chinese high school graduates: Psychological distress, growth, meaning in life and resilience. J Health Psychol 2021:1359105321990819Yu Y, Yu Y, Hu J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541149 45. Ethics of research at the intersection of COVID-19 and black lives matter: a call to action. J. Med. Ethics 2021; Crooks N, Donenberg G, Matthews A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547181 46. The emergence of virtual education during the COVID-19 pandemic: The past, present, and future of the plastic surgery education. J. Plast. Reconstr. Aesthet. Surg. 2021; Cho MJ, Hong JP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541826 47. Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US. J. Stroke Cerebrovasc. Dis. 2021; 30:105639Friedlich D, Newman T, Bricker S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540335 48. COVID-19: Knowledge of Mode of Spread and Preventive Practices among College Adolescents in Nigeria. J. Trop. Pediatr. 2021; Aronu AE, Chinawa AT, Ossai EN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544871 49. Knowledge, attitude, practices, and behavior regarding COVID-19 among serving personnel of a large military garrison: a quick online cross- sectional survey. Med J Armed Forces India 2020; Grewal VS, Sharma PA, Rani R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519047 50. Adapting Education at the Medical College of Georgia at Augusta University in Response to the COVID-19 Pandemic: the Pandemic Medicine Elective. Med Sci Educ 2021:1-8Elengickal JA, Delgado AM, Jain SP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527043 51. Remote Medical Education: Adapting Kern's Curriculum Design to Tele- teaching. Med Sci Educ 2021:1-8Said JT, Schwartz AW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520396 52. First-Year Medical Student Experiences Adjusting to the Immediate Aftermath of COVID-19. Med Sci Educ 2021:1-8Slivkoff MD, Johnson C, Tackett S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520395 53. Changes in Medical Education during the COVID-19 Pandemic. Mediterr J Rheumatol 2020; 31:376-377Benlidayi IC. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521566 54. PSO-Blockchain-based image steganography: towards a new method to secure updating and sharing COVID-19 data in decentralised hospitals intelligence architecture. Multimed Tools Appl 2021:1-25Mohsin AH, Zaidan AA, Zaidan BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519293 55. Encephalopathy and encephalitis during acute SARS-CoV-2 infection. Spanish Society of Neurology COVID-19 Registry. Neurologia 2021; Abenza Abildúa MJ, Atienza S, Carvalho Monteiro G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549369 56. Clinical placement experience of nursing students during the COVID-19 pandemic: A cross-sectional study. Nurse Educ. Today 2021; 99:104746Ulenaers D, Grosemans J, Schrooten W, Bergs J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33545565 57. Challenges with medical education in Nigeria in the COVID-19 era. Pan Afr. Med. J. 2020; 37:223Oladipo AT, Fashola OT, Agboola EI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520062 58. How Threat Perceptions Relate to Learning and Conspiracy Beliefs About COVID-19: Evidence From a Panel Study. Pers. Individ. Dif. 2021:110672Heiss R, Gell S, Röthlingshofer E, Zoller C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518866 59. A Systematic Review of Systematic Reviews on the COVID-19 Pandemic. SN Compr Clin Med 2021:1-18Hatmi ZN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521564 60. Threat or opportunity? A case study of digital-enabled redesign of entrepreneurship education in the COVID-19 emergency. Technol Forecast Soc Change 2021; 166:120565Secundo G, Mele G, Vecchio PD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518821 61. [Not Available]. Vacunas 2021; Gatta A, Ghidinelli F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519331 62. Thirty-three vascular residency programs among 13 countries joining forces to improve surgical education in times of COVID-19: A survey-based assessment. Vascular 2021:1708538121991268Fabiani MA, Gonzalez-Urquijo M, Cassagne G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541247 63. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19. Wellcome Open Res 2020; 5:179Augusto JB, Menacho K, Andiapen M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537459

Elderly (11 articles)

1. Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age Ageing 2021. http://www.ncbi.nlm.nih.gov/pubmed/? term=33543243 2. Age in the Time of COVID-19: An Ethical Analysis. Aging Dis 2021; 12:7- 13Hostiuc S, Negoi I, Maria-Isailă O et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532122 3. Successful Treatment of Elderly Male With COVID-19 Infection With Severe Acute Respiratory Distress Syndrome Using Multimodal Therapy, Including Immune Modulation Therapy. Cureus 2020; 12:e12402Jitsuiki K, Katayama I, Iida T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532160 4. COVID-19 Amplifiers on Health Inequity Among the Older Populations. Front Public Health 2020; 8:609695Lee S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520919 5. Clinical Features, Inpatient Trajectories and Frailty in Older Inpatients with COVID-19: A Retrospective Observational Study. Geriatrics (Basel) 2021; 6Osuafor CN, Davidson C, Mackett AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535520 6. COVID-19 and geriatric population: from pathophysiology to clinical perspectives. Horm. Mol. Biol. Clin. Investig. 2021; Bansod S, Ahirwar AK, Sakarde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544506 7. Age-associated Ligand-receptor Interactions Imputed from Nasopharyngeal Transcriptomes of COVID-19 Patients. Immunol. Invest. 2021:1-8Batchu S, Yu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533266 8. The COVID-19 Pandemic, Biogerontology and the Ageing of Humanity. J Gerontol A Biol Sci Med Sci 2021; Farrelly C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528503 9. Delirium in older patients with COVID-19: prevalence, risk factors and clinical relevance. J Gerontol A Biol Sci Med Sci 2021; Mendes A, Herrmann FR, Périvier S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539505 10. The Aging Bowel Dysfunction and Elderly Vulnerability towards COVID-19 Infection. Life (Basel) 2021; 11Lerner A, McCarty MF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525368 11. Care for Older People with Dementia During COVID-19 Pandemic. SN Compr Clin Med 2021:1-7Emmerton D, Abdelhafiz AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527095

Epidemiology (149 articles)

1. The age pattern of the male-to-female ratio in mortality from COVID-19 mirrors that of cardiovascular disease in the general population. Aging (Albany NY) 2021; 13Nimgaonkar I, Valeri L, Susser E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550276 2. COVID-19 deaths by occupation, Massachusetts, March 1-July 31, 2020. Am. J. Ind. Med. 2021; Hawkins D, Davis L, Kriebel D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522627 3. Racial residential segregation and economic disparity jointly exacerbate COVID-19 fatality in large American cities. Ann. N. Y. Acad. Sci. 2021; Yu Q, Salvador CE, Melani I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521931 4. Real-time measurement of the uncertain epidemiological appearances of COVID-19 infections. Appl Soft Comput 2021; 101:107039Gupta M, Jain R, Taneja S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519324 5. Overview of the characteristics of and responses to the three waves of COVID- 19 in Japan during 2020-2021. Biosci Trends 2021; Karako K, Song P, Chen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518668 6. The role of clinical simulation in preparing for a pandemic. BJA Educ 2021; Shelton C, Huda T, Lee A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520288 7. A cross-sectional study of the epidemic situation on COVID-19 in Gansu Province, China - a big data analysis of the national health information platform. BMC Infect. Dis. 2021; 21:146Yan X, Wang J, Yao J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546618 8. The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med 2021; 19:40Liu Y, Morgenstern C, Kelly J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541353 9. Rapid review of COVID-19 epidemic estimation studies for Iran. BMC Public Health 2021; 21:257Pourmalek F, Rezaei Hemami M, Janani L, Moradi-Lakeh M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522928 10. Seroprevalence of SARS-CoV-2 in the West Bank region of Palestine: a cross- sectional seroepidemiological study. BMJ Open 2021; 11:e044552Qutob N, Awartani F, Salah Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542045 11. The three frontlines against COVID-19: Brain, Behavior, and Immunity. Brain Behav Immun 2021; Wang SC, Su KP, Pariante CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548496 12. The current situation of COVID-19 in India. Brain Behav Immun Health 2021; 11:100200Jabaris SS, V A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521689 13. Mathematical modeling of the spread of COVID-19 among different age groups in Morocco: Optimal control approach for intervention strategies. Chaos Solitons Fractals 2020; 141:110437Kada D, Kouidere A, Balatif O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519111 14. A close look at 2019 novel coronavirus (COVID 19) infections in Turkey using time series analysis & efficiency analysis. Chaos Solitons Fractals 2021; 143:110583Kınacı H, Ünsal MG, Kasap R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519117 15. Optimal control approach of a mathematical modeling with multiple delays of the negative impact of delays in applying preventive precautions against the spread of the COVID-19 pandemic with a case study of Brazil and cost- effectiveness. Chaos Solitons Fractals 2021; 142:110438Kouidere A, Kada D, Balatif O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519112 16. A novel grey model based on traditional Richards model and its application in COVID-19. Chaos Solitons Fractals 2021; 142:110480Luo X, Duan H, Xu K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519114 17. Assessing the role of quarantine and isolation as control strategies for COVID- 19 outbreak: A case study. Chaos Solitons Fractals 2021; 144:110655Memon Z, Qureshi S, Memon BR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519123 18. A SIR-type model describing the successive waves of COVID-19. Chaos Solitons Fractals 2021; 144:110682Muñoz-Fernández GA, Seoane JM, Seoane- Sepúlveda JB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519124 19. Projections and fractional dynamics of COVID-19 with optimal control strategies. Chaos Solitons Fractals 2021:110689Nabi KN, Kumar P, Erturk VS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531738 20. Effective epidemic model for COVID-19 using accumulated deaths. Chaos Solitons Fractals 2021; 144:110667Nakamura G, Grammaticos B, Deroulers C, Badoual M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519102 21. Fractional model of COVID-19 applied to Galicia, Spain and Portugal. Chaos Solitons Fractals 2021; 144:110652Ndaïrou F, Area I, Nieto JJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519122 22. Short-term forecasts of the COVID-19 pandemic: a study case of Cameroon. Chaos Solitons Fractals 2020; 140:110106Nkwayep CH, Bowong S, Tewa JJ, Kurths J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519106 23. A mathematical model for COVID-19 transmission by using the Caputo fractional derivative. Chaos Solitons Fractals 2020; 140:110107Tuan NH, Mohammadi H, Rezapour S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519107 24. Dynamic analysis of a delayed COVID-19 epidemic with home quarantine in temporal-spatial heterogeneous via global exponential attractor method. Chaos Solitons Fractals 2021; 143:110546Zhu CC, Zhu J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519115 25. A comprehensive spatial-temporal infection model. Chem. Eng. Sci. 2021; 233:116347Ramaswamy H, Oberai AA, Yortsos YC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518773 26. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA. Clin. Biochem. 2021; Thomas SN, Altawallbeh G, Zaun C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539808 27. Spatial mapping of COVID-19 for Indian states using Principal Component Analysis. Clin Epidemiol Glob Health 2021; 10:100690Joshua V, Sylvia Grace J, Godwin Emmanuel J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521388 28. The impact of temperature, population size and median age on COVID-19 (SARS-CoV-2) outbreak. Clin Epidemiol Glob Health 2021; 9:231-236Lulbadda KT, Kobbekaduwa D, Guruge ML. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521391 29. National Early Warning Score 2 (NEWS2) to identify inpatient COVID-19 deterioration: a retrospective analysis. Clin Med (Lond) 2021; Baker KF, Hanrath AT, van der Loeff IS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547065 30. Contact tracing for SARS-CoV-2: what can be learned from other conditions? Clin Med (Lond) 2021; Brown J, Ring K, White J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541911 31. The UK physician workforce: one-third at increased risk of death from COVID- 19. Clin Med (Lond) 2021; Verma AM, Goddard AF, O'Donoghue D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541909 32. Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19. Comput Methods Appl Mech Eng 2020; 372:113410Peirlinck M, Linka K, Sahli Costabal F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518823 33. Organizing a Mass Gathering Amidst a Rising COVID-19 Public Health Crisis: Lessons Learned From a Chinese Public Health Forum in Vancouver, BC. Cureus 2020; 12:e12365Limbachia J, Owens H, Matean M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527047 34. Application of one-, three-, and seven-day forecasts during early onset on the COVID-19 epidemic dataset using moving average, autoregressive, autoregressive moving average, autoregressive integrated moving average, and naïve forecasting methods. Data Brief 2021; 35:106759Lynch CJ, Gore R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521186 35. Covid-19 risk data during lockdown-like policy in Indonesia. Data Brief 2021; 35:106801Syuhada K, Wibisono A, Hakim A, Addini F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532521 36. Descriptive epidemiology of SARS-CoV-2 infection in Karnataka state, South India: Transmission dynamics of symptomatic vs. asymptomatic infections. EClinicalMedicine 2021:100717Kumar N, Shahul Hameed SK, Babu GR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521608 37. SARS-CoV-2 Seropositivity among US Marine Recruits Attending Basic Training, United States, Spring-Fall 2020. Emerg Infect Dis 2021; 27Letizia AG, Ge Y, Goforth CW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529569 38. Natural Host-Environmental Media-Human: A New Potential Pathway of COVID-19 Outbreak. Engineering (Beijing) 2020; 6:1085-1098Li M, Yang Y, Lu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520330 39. On the usefulness of the bioclimatic correlative models of SARS-CoV-2. Environ. Res. 2021:110818Gutiérrez-Hernández O, García LV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548299 40. Meteorological factors, COVID-19 cases, and deaths in top 10 most affected countries: an econometric investigation. Environ. Sci. Pollut. Res. Int. 2021; Sharma GD, Bansal S, Yadav A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547610 41. A model for COVID-19 with isolation, quarantine and testing as control measures. Epidemics 2021; 34:100437Aronna MS, Guglielmi R, Moschen LM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540378 42. Community Informatics for Sustainable Management of Pandemics in Developing Countries: A Case Study of COVID-19 in Nigeria. Ethics Med Public Health 2021:100632Eze PU, Ezenkwu CP, Etteh CC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532534 43. Social Determinants of Health and Implementation Research: Lessons from the COVID-19 Pandemic. Ethn. Dis. 2021; 31:5-8Riley WT, Mensah GA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519150 44. Evidence of early circulation of SARS-CoV-2 in France: findings from the population-based "CONSTANCES" cohort. Eur. J. Epidemiol. 2021; Carrat F, Figoni J, Henny J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548003 45. Proposed Design of a Real-Time COVID-19 Pandemic Contact Tracing Using Mobile Phone. Eur Sci J 2020; 16:1-7Nwawudu E, Ikwu A, Ikwu U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519994 46. Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread, Denmark, June to November 2020. Euro Surveill 2021; 26Larsen HD, Fonager J, Lomholt FK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541485 47. The enforcement of statewide mask wearing mandates to prevent COVID-19 in the US: an overview. F1000Res 2020; 9:1100Jacobs P, Ohinmaa AP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520192 48. COVID-19-Related Fatalities and Intensive-Care-Unit Admissions by Age Groups in Europe: A Meta-Analysis. Front Med (Lausanne) 2020; 7:560685Cohen JF, Korevaar DA, Matczak S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521004 49. COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med (Lausanne) 2020; 7:627278Polverino F, Kheradmand F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537336 50. Isolation, Solitude and Social Distancing for People Who Use Drugs: An Ethnographic Perspective. Front Psychiatry 2020; 11:623032Roe L, Proudfoot J, Tay Wee Teck J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519561 51. Mathematical Modeling Predicts That Strict Social Distancing Measures Would Be Needed to Shorten the Duration of Waves of COVID-19 Infections in Vietnam. Front Public Health 2020; 8:559693Bouchnita A, Chekroun A, Jebrane A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520905 52. Correlation Between Local Air Temperature and the COVID-19 Pandemic in Hubei, China. Front Public Health 2020; 8:604870Hu CY, Xiao LS, Zhu HB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537279 53. Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown. Front Public Health 2020; 8:594117Kapsner LA, Kampf MO, Seuchter SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520914 54. Controlling COVID-19 Pandemic: A Mass Screening Experience in Saudi Arabia. Front Public Health 2020; 8:606385Khan AA, Alahdal HM, Alotaibi RM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537280 55. Clusters in the Spread of the COVID-19 Pandemic: Evidence From the G20 Countries. Front Public Health 2020; 8:628789Meng T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537284 56. [Insight on how to assess and improve the response to the COVID-19 pandemic]. Gac. Sanit. 2020; Martín-Moreno JM, Arenas A, Bengoa R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518411 57. Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic. Healthcare (Basel) 2021; 9Alamer AA, Almulhim AS, Alrashed AA, Abraham I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525596 58. Turn to the Internet First? Using Online Medical Behavioral Data to Forecast COVID-19 Epidemic Trend. Inf. Process. Manag. 2021; 58:102486Huang W, Cao B, Yang G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519039 59. A simple model for fitting mild, severe, and known cases during an epidemic with an application to the current SARS-CoV-2 pandemic. Infect Dis Model 2021; 6:313-323Betti MI, Heffernan JM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521406 60. Mathematical modeling of COVID-19 infection dynamics in Ghana: Impact evaluation of integrated government and individual level interventions. Infect Dis Model 2021; 6:381-397Dwomoh D, Iddi S, Adu B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521403 61. SARS-COV-2 outbreak and control in Kenya - Mathematical model analysis. Infect Dis Model 2021; 6:370-380Mbogo RW, Orwa TO. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527092 62. Forecasting the number of confirmed new cases of COVID-19 in Italy for the period from 19 May to 2 June 2020. Infect Dis Model 2021; 6:362-369Triacca M, Triacca U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521404 63. COVID-19: The Forgotten Cases of Hidden Exiles. Infect Dis Now 2021; Bihan CL, Faucherre V, Moing VL et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521773 64. Risk factors for outbreaks of COVID-19 in care homes following hospital discharge: A national cohort analysis. Influenza Other Respir Viruses 2021; Emmerson C, Adamson JP, Turner D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547872 65. Clinical Characteristics and Reproduction Number of Coronavirus Disease (COVID-19) Cases in Markazi Province in Iran. Int J Community Based Nurs Midwifery 2021; 9:18-29Moradzadeh R, Zamanian M, Amini S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521146 66. Engagement in Health Risk Behaviours before and during the COVID-19 Pandemic in German University Students: Results of a Cross-Sectional Study. Int J Environ Res Public Health 2021; 18Busse H, Buck C, Stock C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546344 67. Young Adults View Smartphone Tracking Technologies for COVID-19 as Acceptable: The Case of Taiwan. Int J Environ Res Public Health 2021; 18Garrett PM, Wang Y, White JP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540628 68. Adherence to COVID-19 Preventive Measures in Mozambique: Two Consecutive Online Surveys. Int J Environ Res Public Health 2021; 18Júnior A, Dula J, Mahumane S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530538 69. COVID-19 Response in Thailand and Its Implications on Future Preparedness. Int J Environ Res Public Health 2021; 18Marome W, Shaw R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530526 70. Estimating Unreported COVID-19 Cases with a Time-Varying SIR Regression Model. Int J Environ Res Public Health 2021; 18Peng Z, Ao S, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530563 71. Dynamical characteristics of Covid-19 epidemic: Estimation from Colombia's case. Int J Infect Dis 2021; Diaz H, España G, Castañeda N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529705 72. A Qualitative Exploration of Predominantly White Non-Hispanic Tennessee WIC Participants' Food Retail and WIC Clinic Experiences During COVID-19. J. Acad. Nutr. Diet. 2021; McElrone M, Zimmer MC, Anderson Steeves ET. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547032 73. Combined measures to control the COVID-19 pandemic in Wuhan, Hubei, China: A narrative review. J Biosaf Biosecur 2020; 2:51-57Hasnain M, Pasha MF, Ghani I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521592 74. Initial experiences regarding COVID19 mortality in Punjab-A mixed method analysis. J Family Med Prim Care 2020; 9:5689-5694Chaudhary A, Bansal P, Gupta VK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532415 75. UVB radiation alone may not explain sunlight inactivation of SARS-CoV-2. J Infect Dis 2021; Luzzatto-Fegiz P, Temprano-Coleto F, Peaudecerf FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544845 76. Modelling COVID-19 transmission in the United States through interstate and foreign travels and evaluating impact of governmental public health interventions. J Math Anal Appl 2020:124896Shah NH, Sheoran N, Jayswal E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518800 77. Learning versus habit formation: Optimal timing of lockdown for disease containment. J Math Econ 2021:102452Bandyopadhyay S, Chatterjee K, Das K, Roy J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519024 78. Reply to: Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol 2021; Rossotti R, Molteni SN, Faccini M, Puoti M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527415 79. Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study. J Med Virol 2021; Xie W, Chen Z, Wang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538342 80. Human mobility restrictions and the spread of the Novel Coronavirus (2019- nCoV) in China. J Public Econ 2020; 191:104272Fang H, Wang L, Yang Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518827 81. Mitigating SARS-CoV-2 Transmission in Hispanic and Latino Communities- Prince William Health District, Virginia, June 2020. J Racial Ethn Health Disparities 2021:1-9Davlantes E, Tippins A, Espinosa C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543447 82. Are stay-at-home orders more difficult to follow for low-income groups? J Transp Geogr 2020; 89:102894Lou J, Shen X, Niemeier D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519126 83. Mobility and the effective reproduction rate of COVID-19. J Transp Health 2021; 20:101016Noland RB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542894 84. COVID-19: Knowledge of Mode of Spread and Preventive Practices among College Adolescents in Nigeria. J. Trop. Pediatr. 2021; Aronu AE, Chinawa AT, Ossai EN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544871 85. Foresight in the time of COVID-19. Lancet Reg Health West Pac 2021; 6:100049Gariboldi MI, Lin V, Bland J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521742 86. Experience in responding to COVID-19 outbreaks from Vietnam. Lancet Reg Health West Pac 2021; 7:100077Nguyen TA, Nguyen BTC, Duong DT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532745 87. A new model for epidemic prediction: COVID-19 in kingdom saudi arabia case study. Mater Today Proc 2021; Mohamed IA, Aissa AB, Hussein LF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520671 88. The Impact of Various Policy Factors Implemented for Controlling the Spread of COVID-19. Mater Today Proc 2021; Senthil Prakash PN, Hariharan B, Kaliraj S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532246 89. Deterministic and stochastic models for the epidemic dynamics of COVID-19 in Wuhan, China. Math Biosci Eng 2021; 18:950-967Olabode D, Culp J, Fisher A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525127 90. A mathematical model for the impacts of face mask, hospitalization and quarantine on the dynamics of COVID-19 in India: deterministic vs. stochastic. Math Biosci Eng 2020; 18:182-213Srivastav AK, Tiwari PK, Srivastava PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525087 91. Modeling and analysis of COVID-19 based on a time delay dynamic model. Math Biosci Eng 2020; 18:154-165Yang C, Yang Y, Li Z, Zhang L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525085 92. The Use and Misuse of Mathematical Modeling for Infectious Disease Policymaking: Lessons for the COVID-19 Pandemic. Med. Decis. Making 2021:272989x21990391James LP, Salomon JA, Buckee CO, Menzies NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535889 93. Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020. Med. J. Aust. 2021; Gidding HF, Machalek DA, Hendry AJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538019 94. Machine learning techniques to detect and forecast the daily total COVID-19 infected and deaths cases under different lockdown types. Microsc. Res. Tech. 2021; Saba T, Abunadi I, Shahzad MN, Khan AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522669 95. Statistical data analysis of risk factor associated with mortality rate by COVID- 19 pandemic in India. Model Earth Syst Environ 2021:1-11Halder B, Bandyopadhyay J, Banik P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527084 96. Climate effects on the COVID-19 outbreak: a comparative analysis between the UAE and Switzerland. Model Earth Syst Environ 2021:1-14Mansouri Daneshvar MR, Ebrahimi M, Sadeghi A, Mahmoudzadeh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521243 97. Use of masks by children to prevent infection with SARS-CoV-2: Consensus statement of the German Society for Pediatric Infectious Diseases (DGPI), the Professional Association of Pediatricians (BVKJ), the German Society for Pediatric and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Society for Social Pediatrics and Adolescent Medicine (DGSPJ), the Southern German Society for Pediatric and Adolescent Medicine (SGKJ) and the German Society for Pediatric and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP). Monatsschr. Kinderheilkd. 2021; 169:52-56Huppertz HI, Berner R, Schepker R et al. 98. Prevalence of SARS-CoV-2 in children from a cohort of 2192 patients. Monatsschr. Kinderheilkd. 2021; 169:46-51Meyer M, Rübsteck E, Lehmann C et al. 99. Seroprevalence of SARS-CoV-2 Antibodies in Children and Adults in St. Louis, Missouri, USA. mSphere 2021; 6Smith BK, Janowski AB, Danis JE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536325 100. Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis. Mult. Scler. 2021:1352458520978354. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528295 101. SARS-CoV-2/COVID-19—epidemiology and prevention. Nephrologe 2021; 16:3- 9Salzberger B, Buder F, Lampl B et al. 102. A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy. Open Forum Infect Dis 2021; 8:ofaa592Nicolás D, Camós-Carreras A, Spencer F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537362 103. The epidemiological characteristics of COVID-19 in Libya during the ongoing- armed conflict. Pan Afr. Med. J. 2020; 37:219Daw MA, El-Bouzedi AH, Ahmed MO, Alejenef AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520058 104. COVID-19 mimics endemic tropical diseases at an early stage: a report of two symptomatic COVID-19 patients treated in a polymerase chain reaction void zone in Cameroon. Pan Afr. Med. J. 2020; 37:212Kom FM, Baane MP, Mbody M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520051 105. Epidemiology, management and risk of SARS-CoV-2 transmission in a cohort of newborns born to mothers diagnosed with COVID-19 infection. An Pediatr (Engl Ed) 2021; Solís-García G, Gutiérrez-Vélez A, Pescador Chamorro I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521167 106. Urban exodus and the dynamics of COVID-19 pandemics. Physica A 2021; 569:125780Weisbuch G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519051 107. How effective were physical distancing interventions in the COVID-19 pandemic up to now? Pneumologie 2021; 75:10. 108. Mechanistic transmission modeling of COVID-19 on the Diamond Princess cruise ship demonstrates the importance of aerosol transmission. Proc Natl Acad Sci U S A 2021; 118Azimi P, Keshavarz Z, Cedeno Laurent JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536312 109. Social distancing decreases an individual's likelihood of contracting COVID- 19. Proc Natl Acad Sci U S A 2021; 118Fazio RH, Ruisch BC, Moore CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542156 110. Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland. Proc Natl Acad Sci U S A 2021; 118Perry BL, Aronson B, Pescosolido BA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547252 111. Using machine learning to estimate the effect of racial segregation on COVID- 19 mortality in the United States. Proc Natl Acad Sci U S A 2021; 118Torrats- Espinosa G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531345 112. COVID-19 in Bangladesh: A Deeper Outlook into The Forecast with Prediction of Upcoming Per Day Cases Using Time Series. Procedia Comput Sci 2020; 178:291-300Mohammad Masum AK, Khushbu SA, Keya M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520018 113. COVID-19 dynamic model: balanced identification of general biological and country specific features. Procedia Comput Sci 2020; 178:301-310Sokolov AV, Sokolova LA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520019 114. The promise of curriculum in the post-Covid world: Eclecticism, deliberation, and a return to the practical and the prophetic. Prospects (Paris) 2021:1- 13Burns JP, Cruz C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518815 115. Understanding the Slow COVID-19 Trajectory of Cambodia. Public Health Pract (Oxf) 2021; 2:100073Nit B, Samy AL, Tan SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521738 116. Population perspective comparing COVID-19 to all and common causes of death during the first wave of the pandemic in seven European countries. Public Health Pract (Oxf) 2021; 2:100077Olabi B, Bagaria J, Bhopal SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521739 117. Mathematical Modelling and Analysis of COVID-19 Epidemic and Predicting its Future Situation in Ethiopia. Results Phys 2021; 22:103853Abay A, Berhe HW, Atsbaha HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532177 118. Modeling and analysis of the dynamics of novel coronavirus (COVID-19) with Caputo fractional derivative. Results Phys 2021; 20:103669Ali A, Alshammari FS, Islam S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520621 119. Mathematical model to assess the imposition of lockdown during COVID-19 pandemic. Results Phys 2021; 20:103716Baba IA, Yusuf A, Nisar KS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520624 120. Analysis of the outbreak of the novel coronavirus COVID-19 dynamic model with control mechanisms. Results Phys 2020; 19:103586Bozkurt F, Yousef A, Abdeljawad T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527069 121. Optimal control and sensitivity analysis for transmission dynamics of Coronavirus. Results Phys 2020; 19:103642Deressa CT, Mussa YO, Duressa GF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520619 122. Mathematical modelling and analysis of COVID-19 epidemic and predicting its future situation in Ethiopia. Results Phys 2021; 22:103853Gebremeskel AA, Berhe HW, Atsbaha HA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532177 123. Identification of dominant risk factor involved in spread of COVID-19 using hesitant fuzzy MCDM methodology. Results Phys 2021; 21:103811Ghorui N, Ghosh A, Mondal SP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520630 124. COVID-19 Vaccine: A neutrosophic MCDM approach for determining the priority groups. Results Phys 2021; 20:103654Hezam IM, Nayeem MK, Foul A, Alrasheedi AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520620 125. Numerical study of fractional order COVID-19 pandemic transmission model in context of ABO blood group. Results Phys 2021; 22:103852Higazy M, Allehiany FM, Mahmoud EE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520615 126. A study on the spread of COVID 19 outbreak by using mathematical modeling. Results Phys 2020; 19:103605Mishra J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520617 127. Modeling Ivory Coast COVID-19 cases: Identification of a high-performance model for utilization. Results Phys 2021; 20:103763Nwosu UI, Obite CP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520627 128. Mathematical modeling for the outbreak of the coronavirus (COVID-19) under fractional nonlocal operator. Results Phys 2020; 19:103610Redhwan SS, Abdo MS, Shah K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520618 129. A lattice gas model for infection spreading: Application to the COVID-19 pandemic in the Mexico City Metropolitan Area. Results Phys 2021; 20:103758Salcido A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520626 130. Characteristics of First Cases of Coronavirus Disease 2019 and the Effort to Prevent the Early Spread of COVID-19 in Saudi Arabia. Risk Manag. Healthc. Policy 2021; 14:315-321Natto ZS, Alshaeri HK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531849 131. Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts. Scand. J. Prim. Health Care 2021:1- 5Norheim AJ, Borud EK, Lind A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544016 132. Early warning of COVID-19 via wastewater-based epidemiology: potential and bottlenecks. Sci Total Environ 2021; 767:145124Zhu Y, Oishi W, Maruo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548842 133. The Bayesian Susceptible-Exposed-Infected-Recovered model for the outbreak of COVID-19 on the Diamond Princess Cruise Ship. Stoch. Environ. Res. Risk Assess. 2021:1-15Lai CC, Hsu CY, Jen HH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519302 134. Exploring geographical distribution of transportation research themes related to COVID-19 using text network approach. Sustain Cities Soc 2021; 67:102729Kutela B, Novat N, Langa N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520611 135. Spatial statistical analysis of pre-existing mortalities of 20 diseases with COVID-19 mortalities in the continental United States. Sustain Cities Soc 2021; 67:102738Mollalo A, Rivera KM, Vahabi N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532175 136. COVID-19 cases prediction by using hybrid machine learning and beetle antennae search approach. Sustain Cities Soc 2021; 66:102669Zivkovic M, Bacanin N, Venkatachalam K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520607 137. Using input-output analysis to model the impact of pandemic mitigation and suppression measures on the workforce. Sustain Prod Consum 2020; 23:249- 255Santos J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521216 138. A Novel Large Scale Integrated Telemonitoring Program for COVID-19. Telemed J E Health 2021; Shaw JG, Sankineni S, Olaleye CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544043 139. Basic sanitation: a new indicator for the spread of COVID-19? Trans. R. Soc. Trop. Med. Hyg. 2021; Silva RR, Ribeiro CJN, Moura TR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547895 140. A multi-regional, hierarchical-tier mathematical model of the spread and control of COVID-19 epidemics from epicenter to adjacent regions. Transbound Emerg Dis 2021; Zheng Q, Wang X, Bao C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539678 141. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada. Transfusion 2021; Saeed S, Drews SJ, Pambrun C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527398 142. Modeling epidemic spreading through public transit using time-varying encounter network. Transp Res Part C Emerg Technol 2021; 122:102893Mo B, Feng K, Shen Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519128 143. Full-length title: Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: an investigational study. Travel Med Infect Dis 2021:101980Colson P, Levasseur A, Gautret P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535105 144. Remote data collection during COVID-19 restrictions: an example from a refugee and asylum-seeker participant group in the UK. Trials 2021; 22:117Walker L, Bailey D, Churchill R, Peckham E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546716 145. Random forest regression analysis on combined role of meteorological indicators in disease dissemination in an Indian city: A case study of New Delhi. Urban Clim 2021; 36:100780Hariharan R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520641 146. Facing the Threat of COVID-19 in Pakistan: A Nation's Dilemma. Value Health Reg Issues 2021; 24:90-95Habib M, Abbas M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524901 147. Novel insights into impacts of the COVID-19 pandemic on aquatic environment of Beijing-Hangzhou Grand Canal in southern Jiangsu region. Water Res 2021; 193:116873Shen J, Liu C, Lv Q et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550167 148. Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks. Wellcome Open Res 2020; 5:239Endo A, Leclerc QJ, Knight GM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33154980 149. The first 8 weeks of the Austrian SARS-CoV-2 epidemic. Wien. Klin. Wochenschr. 2021:1-13Nagel A, Łaszewska A, Haidinger G, Simon J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523297

Gastro-enterology (28 articles)

1. Total gastric necrosis following acute pancreatitis in a patient with COVID -19: Case report and literature review. Ann Med Surg (Lond) 2021; 62:362-364Bouali M, Ouchane M, Elbakouri A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520227 2. Novel Case Report: A Previously Reported, but Pathophysiologically Unexplained, Association Between Collagenous Colitis and Protein-Losing Enteropathy May Be Explained by an Undetected Link with Collagenous Duodenitis. Dig. Dis. Sci. 2021:1-8Gill I, Shaheen AA, Edhi AI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537921 3. SARS-CoV-2 prevalence in saliva and gastric and intestinal fluid in patients undergoing gastrointestinal endoscopy in COVID-19 endemic areas: prospective cross-sectional study in Japan. Dig Endosc 2021; Miyake S, Ashikari K, Kato S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548095 4. Where have all the other coeliacs gone in 2020? Road for a 2021 catch-up with missed diagnoses. Dig. Liver Dis. 2021; Valitutti F, Troncone R, Pisano P, Ciacci C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541798 5. Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology. Drug Deliv 2021; 28:325-342Liu F, Li Y, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33517789 6. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States. EClinicalMedicine 2021; 31:100688Wang Q, Davis PB, Xu R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521611 7. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity. Engineering (Beijing) 2020; 6:1178-1184Tang L, Gu S, Gong Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520333 8. Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic. Front Med (Lausanne) 2020; 7:584888Fan H, Cai J, Tian A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521010 9. Susceptibility Factors of Stomach for SARS-CoV-2 and Treatment Implication of Mucosal Protective Agent in COVID-19. Front Med (Lausanne) 2020; 7:597967Zhang M, Feng C, Zhang X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521016 10. SARS-CoV-2 entry molecules' expression and COVID-19 in inflammatory bowel disease: is the gut critical? Gastroenterology 2021; Nowak JK, Kalla R, Satsangi J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549534 11. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19. Genes Dis 2020; Zhang J, Garrett S, Sun J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521210 12. SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30- day mortality: COVID PAN collaborative study. Gut 2021; Pandanaboyana S, Moir J, Leeds JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547182 13. COVID-19 and endoscopic services: the impact of delays in therapeutic colonoscopies on patients. Gut 2021; Samani S, Mir N, Naumann DN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541864 14. Virus discharge and initial gastrointestinal involvement are inversely associated with circulating lymphocyte count in COVID-19. Int. J. Med. Sci. 2021; 18:1137-1142Chen W, Zheng KI, Liu S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526973 15. Is liver involvement overestimated in COVID-19 patients? A meta-analysis. Int. J. Med. Sci. 2021; 18:1285-1296Li G, Yang Y, Gao D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526990 16. Management of inflammatory bowel disease in the COVID-19 era. Intest Res 2021; Kim KO, Jang BI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525860 17. Novel coronavirus (COVID-19) and its potential G.I. manifestation: A review. J Family Med Prim Care 2020; 9:5474-5479Deep A, Verma K, Swaroop S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532381 18. COVID-19-associated liver injury: from bedside to bench. J. Gastroenterol. 2021:1-13Li D, Ding X, Xie M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527211 19. Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves. J Med Virol 2021; Elshazli RM, Kline A, Elgaml A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527440 20. COVID-19 presenting as intussusception in infants: A case report with literature review. J Pediatr Surg Case Rep 2021; 66:101779Athamnah MN, Masade S, Hamdallah H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520650 21. The Aging Bowel Dysfunction and Elderly Vulnerability towards COVID-19 Infection. Life (Basel) 2021; 11Lerner A, McCarty MF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525368 22. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res 2021; Higuera-de la Tijera F, Servín-Caamaño A, Reyes-Herrera D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520337 23. Letter to the Editor: Microbiota in the Respiratory System-A Possible Explanation to Age and Sex Variability in Susceptibility to SARS-CoV-2. Microbiol Insights 2021; 14:1178636120988604Shah V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519207 24. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? Nutrition 2020; 85:111115Balmant BD, Torrinhas RS, Rocha IM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545540 25. Bowel necrosis associated with COVID-19 pneumonia: A report of two cases. Radiol Case Rep 2021; 16:819-823Mir MZ, Mashhadi A, Jahantigh M, Seyedi SJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520046 26. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19. Sci China Life Sci 2021:1-15Luo J, Liang S, Jin F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521857 27. Triage of General Gastrointestinal Endoscopic Procedures During the COVID- 19 Pandemic: Results from a National Delphi Consensus Panel. Tech Innov Gastrointest Endosc 2020; Feuerstein A, Bilal M, Berzin TM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521705 28. STAY (GI) HEALTHY: COVID-19 and Gastrointestinal manifestations. Tech Innov Gastrointest Endosc 2021; Vespa E, Pugliese N, Colapietro F, Aghemo A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521703

Guidelines (12 articles)

1. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update: S2k-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Medical Association of German Allergologists (AeDA), the Society of Pediatric Allergology and Environmental Medicine (GPA), the German Academy of Allergology and Environmental Medicine (DAAU), the German Professional Association of Pediatricians (BVKJ), the Society for Neonatology and Pediatric Intensive Care (GNPI), the German Society of Dermatology (DDG), the Austrian Society for Allergology and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Anaesthesiology and Intensive Care Medicine (DGAI), the German Society of Pharmacology (DGP), the German Respiratory Society (DGP), the patient organization German Allergy and Asthma Association (DAAB), the German Working Group of Anaphylaxis Training and Education (AGATE). Allergo J Int 2021:1-25Ring J, Beyer K, Biedermann T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527068 2. Guidelines and best practice recommendations on reproductive health services provision amid COVID-19 pandemic: scoping review. BMC Public Health 2021; 21:276Tolu LB, Feyissa GT, Jeldu WG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536001 3. Perspectives on Repurposed Drugs Based on Globally Accepted Therapeutic Guidelines to Combat SARS-CoV-2 Infection. Drug Healthc Patient Saf 2021; 13:11-18Rosalia R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536792 4. EBCOG position statement - Simulation-based training for obstetrics and gynaecology during the COVID-19 pandemic. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; Zimmerman E, Martins NN, Verheijen RHM, Mahmood T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518409 5. STIKO vaccination recommendations: Vaccination of immunodeficient patients and vaccination against COVID-19. Hautarzt 2021; 72:92-99Bogdan C. 6. Health-care guidelines and policies during the COVID-19 pandemic in Mexico: A case of health-inequalities. Health Policy Open 2021; 2:100025Bautista- González E, Werner-Sunderland J, Pérez-Duarte Mendiola P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521627 7. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung 2021; 50:357-360Salabei JK, Fishman TJ, Asnake ZT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524866 8. Association between periodontitis and severity of COVID-19 infection: a case- control study. J. Clin. Periodontol. 2021; Marouf N, Cai W, Said KN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527378 9. Development of rapid advice guideline and standard and continuous updating guideline: experiences and practice. Mil Med Res 2021; 8:10Jin YH, Yao XM, Zeng XT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531069 10. Use of masks by children to prevent infection with SARS-CoV-2: Consensus statement of the German Society for Pediatric Infectious Diseases (DGPI), the Professional Association of Pediatricians (BVKJ), the German Society for Pediatric and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Society for Social Pediatrics and Adolescent Medicine (DGSPJ), the Southern German Society for Pediatric and Adolescent Medicine (SGKJ) and the German Society for Pediatric and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP). Monatsschr. Kinderheilkd. 2021; 169:52-56Huppertz HI, Berner R, Schepker R et al. 11. The need for exercise sciences and an integrated response to COVID-19: A position statement from the international HL-PIVOT network. Prog Cardiovasc Dis 2021; Faghy MA, Arena R, Stoner L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549590 12. Management of hyponatraemia and hypernatraemia during the Covid-19 pandemic: a consensus statement of the Spanish Society for Endocrinology (Acqua Neuroendocrinology Group). Rev. Endocr. Metab. Disord. 2021; Fernandez Martinez A, Barajas Galindo D, Ruiz Sanchez J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547563

Imaging (26 articles)

1. Various radiological findings in patients with COVID-19: A case series. Ann Med Surg (Lond) 2021; 62:269-273Riawati T, Indrarto W, Fauzi AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520223 2. Dynamic changes in chest CT findings of patients with coronavirus disease 2019 (COVID-19) in different disease stages: a multicenter study. Ann Palliat Med 2021; 10:572-583Huang Y, Li Z, Guo H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545787 3. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta- analysis. Ann Palliat Med 2021; Xie J, Wang Q, Xu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548996 4. Impacts of COVID-19 on energy demand and consumption: Challenges, lessons and emerging opportunities. Appl Energy 2021; 285:116441Jiang P, Fan YV, Klemeš JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519038 5. An investigation of depression, anxiety, and stress and its relating factors during COVID-19 pandemic in Iran. BMC Public Health 2021; 21:275Khademian F, Delavari S, Koohjani Z, Khademian Z. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535992 6. Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? Cells 2021; 10Elgohary S, Elkhodiry AA, Amin NS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540625 7. TLCoV- An automated Covid-19 screening model using Transfer Learning from chest X-ray images. Chaos Solitons Fractals 2021; 144:110713Das AK, Kalam S, Kumar C, Sinha D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526961 8. A novel Covid-19 and Pneumonia Classification Method based on F-transform. Chemometr Intell Lab Syst 2021; 210:104256Tuncer T, Ozyurt F, Dogan S, Subasi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531722 9. Improving CT accuracy in the diagnosis of COVID-19 in a hospital setting. Clin Imaging 2021; 76:1-5Erxleben C, Adams LC, Albrecht J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545516 10. COVID-19 vaccine is here: practical considerations for clinical imaging applications. Clin Imaging 2021; 76:38-41Katal S, Pouraryan A, Gholamrezanezhad A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548891 11. Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19. Clin Imaging 2021; 75:119-124Satici C, Cengel F, Gurkan O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545439 12. Diagnosis of COVID-19 using CT scan images and deep learning techniques. Emerg Radiol 2021:1-9Shah V, Keniya R, Shridharani A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523309 13. Machine learning applied on chest x-ray can aid in the diagnosis of COVID-19: a first experience from Lombardy, Italy. Eur Radiol Exp 2021; 5:7Castiglioni I, Ippolito D, Interlenghi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527198 14. COVID-19 classification by CCSHNet with deep fusion using transfer learning and discriminant correlation analysis. Inf Fusion 2021; 68:131-148Wang SH, Nayak DR, Guttery DS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519321 15. COVID-19 Detection System Using Chest CT Images and Multiple Kernels- Extreme Learning Machine Based on Deep Neural Network. Ing Rech Biomed 2021; Turkoglu M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527035 16. Mimickers of novel coronavirus disease 2019 (COVID-19) on chest CT: spectrum of CT and clinical features. Insights Imaging 2021; 12:12Elmokadem AH, Batouty NM, Bayoumi D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533965 17. Six artificial intelligence paradigms for tissue characterisation and classification of non-COVID-19 pneumonia against COVID-19 pneumonia in computed tomography lungs. Int. J. Comput. Assist. Radiol. Surg. 2021:1-12Saba L, Agarwal M, Patrick A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532975 18. COVINet: a convolutional neural network approach for predicting COVID-19 from chest X-ray images. J Ambient Intell Humaniz Comput 2021:1-13Umer M, Ashraf I, Ullah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527000 19. Point-of-Care Lung Ultrasound for COVID-19: Findings and Prognostic Implications From 105 Consecutive Patients. J. Intensive Care Med. 2021; 36:334-342Yasukawa K, Minami T, Boulware DR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535883 20. Quantitative Assessment of Chest CT Patterns in COVID-19 and Bacterial Pneumonia Patients: a Deep Learning Perspective. J Korean Med Sci 2021; 36:e46Kang M, Hong KS, Chikontwe P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527788 21. Fast and Accurate Detection of COVID-19 Along With 14 Other Chest Pathologies Using a Multi-Level Classification: Algorithm Development and Validation Study. J Med Internet Res 2021; 23:e23693Albahli S, Yar G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529154 22. FSS-2019-nCov: A deep learning architecture for semi-supervised few-shot segmentation of COVID-19 infection. Knowl Based Syst 2021; 212:106647Abdel- Basset M, Chang V, Hawash H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519100 23. Convolutional neural network use chest radiography images for identification of COVID-19. Mater Today Proc 2020; Murali D, Bhuvaneswari E, Parvathi S, Sanjeev Kumar AN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520674 24. Momentum contrastive learning for few-shot COVID-19 diagnosis from chest CT images. Pattern Recognit 2021; 113:107826Chen X, Yao L, Zhou T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518813 25. Multi-task Contrastive Learning for Automatic CT and X-ray Diagnosis of COVID-19. Pattern Recognit 2021:107848Li J, Zhao G, Tao Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518812 26. Low-dose chest CT presentation and dynamic changes in patients with novel coronavirus disease 2019. Radiol Infect Dis 2020; 7:186-194Zhao Y, Wang Y, Duan W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521221

Immune response (39 articles)

1. COVID-19 Antibody Tests and Their Limitations. ACS Sens 2021; Liu G, Rusling JF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544999 2. Inflammatory cytokine patterns associated with neurological diseases in COVID-19. Ann. Neurol. 2021; Espíndola OM, Gomes YCP, Brandão CO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547819 3. The interplay between neutrophils, complement, and microthrombi in COVID- 19. Best Pract. Res. Clin. Rheumatol. 2021:101661Zuo Y, Kanthi Y, Knight JS, Kim AHJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526325 4. Cross-reactivity of SARS-CoV structural protein antibodies against SARS- CoV-2. Cell Rep. 2021:108737Bates TA, Weinstein JB, Farley S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545052 5. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med 2021; 2:100166Chevrier S, Zurbuchen Y, Cervia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521697 6. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Cytokine 2021; 140:155439Sami R, Fathi F, Eskandari N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524886 7. Sustained cellular immunity in adults recovered from mild COVID-19. Cytometry A 2021; Rank A, Löhr P, Hoffmann R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522107 8. Surveillance of COVID-19-Associated Multisystem Inflammatory Syndrome in Children, South Korea. Emerg Infect Dis 2021; 27Choe YJ, Choi EH, Choi JW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539720 9. COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue. Emerg Microbes Infect 2021:1-30Xi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522893 10. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill 2021; 26Jeffery-Smith A, Iyanger N, Williams SV et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541486 11. Evolutionarily Conserved Long Non-coding RNA Regulates Gene Expression in Cytokine Storm During COVID-19. Front Bioeng Biotechnol 2020; 8:582953Morenikeji OB, Bernard K, Strutton E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520952 12. Potential False-Positive and False-Negative Results for COVID-19 IgG/IgM Antibody Testing After Heat-Inactivation. Front Med (Lausanne) 2020; 7:589080Lin J, Dai W, Li W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537325 13. COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects. Front Med (Lausanne) 2020; 7:627278Polverino F, Kheradmand F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537336 14. Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies. Genes Dis 2020; Li S, Wang W, Li T et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521209 15. Predictive immunogenetic markers in COVID-19. Hum. Immunol. 2021; Leite MM, Gonzalez-Galarza FF, Silva B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546902 16. What do we know about the antibody responses to SARS-CoV-2? Immunobiology 2021; 226:152054Lagunas-Rangel FA, Chávez-Valencia V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524881 17. Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction. Int Dairy J 2021:105002Oshiro S, Tada T, Mizutani N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526960 18. IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection. Int J Environ Res Public Health 2021; 18De Donno A, Lobreglio G, Panico A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535692 19. Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 infection induces dysregulation of immunity: in silico gene expression analysis. Int. J. Med. Sci. 2021; 18:1143-1152Wu YH, Yeh IJ, Phan NN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526974 20. Seroconversion of SARS-CoV-2 infected patients on immunosuppression: a retrospective analysis. J Am Acad Dermatol 2021; Smith JS, Said JT, Elman SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549649 21. Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status. J Autoimmun 2021; 118:102596Zhou Y, Zhang J, Wang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540371 22. Post Convalescent SARS-CoV-2 IgG and Neutralizing Antibodies Are Elevated in Individuals with Poor Metabolic Health. J. Clin. Endocrinol. Metab. 2021; Racine-Brzostek SE, Yang HS, Jack GA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524125 23. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. J. Clin. Invest. 2021; 131Bolouri H, Speake C, Skibinski D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529167 24. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother 2021; Kutsuna S, Asai Y, Matsunaga A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531292 25. Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Infect Dis 2021; 223:197- 205Crawford KHD, Dingens AS, Eguia R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535236 26. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19. J Infect Dis 2021; Janssen NAF, Grondman I, de Nooijer AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524124 27. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms. J Inflamm Res 2021; 14:175-189Khan MA, Khan ZA, Charles M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519225 28. SARS-CoV-2-specific humoral and cellular immunity in two renal transplant and two haemodialysis patients treated with convalescent plasma. J Med Virol 2021; Lindemann M, Krawczyk A, Dolff S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527424 29. SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma. J Med Virol 2021; Lindemann M, Krawczyk A, Dolff S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527424 30. Diagnostic Performance of SARS-CoV-2 IgM/IgG Rapid Test Kits for the Detection of the Novel Coronavirus in Ethiopia. J Multidiscip Healthc 2021; 14:171-180Sisay A, Tesfaye A, Desale A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536760 31. Characteristics of COVID-19 infection and antibody formation in a Tertiary Immunology department. J Transl Autoimmun 2021:100084Guchelaar NAD, van Laar JAM, Hermans MAW et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532723 32. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021; 36:101051Bonam SR, Kotla NG, Bohara RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519949 33. To stress or not to stress: Brain-behavior-immune interaction may weaken or promote the immune response to SARS-CoV-2. Neurobiol Stress 2021:100296Peters EMJ, Schedlowski M, Watzl C, Gimsa U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527083 34. Neuroinflammation and Brain Development: Possible Risk Factors in COVID- 19-Infected Children. Neuroimmunomodulation 2021:1-7da Silva Chagas L, Sandre PC, de Velasco PC et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530091 35. Evaluation of Antibody Response in Symptomatic and Asymptomatic COVID- 19 Patients and Diagnostic Assessment of New IgM/IgG ELISA Kits. Pathogens 2021; 10Al-Jighefee HT, Yassine HM, Nasrallah GK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546341 36. Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications. An Pediatr (Engl Ed) 2020; 93:60.e61-60.e67García-Salido A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521168 37. Coronary Artery Dilation in an Asymptomatic Pediatric Patient with COVID19 Antibodies. Pediatr. Cardiol. 2021; Gerber N, Flynn PA, Holzer RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547936 38. The seroprevalence of SARS-CoV-2 IgG antibodies among asymptomatic blood donors in Saudi Arabia. Saudi J. Biol. Sci. 2020; Mahallawi WH, Al-Zalabani AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519277 39. Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19. Saudi Pharm J 2021; Hyder Pottoo F, Abu-Izneid T, Mohammad Ibrahim A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519271

Management miscellaneous diseases (106 articles)

1. Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era. Actas Urol. Esp. 2020; García-Rojo E, Manfredi C, Santos-Pérez-de-la-Blanca R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546905 2. The effects of the COVID-19 lockdown and alcohol restriction on trauma- related emergency department cases in a South African regional hospital. Afr J Emerg Med 2021; Manyoni MJ, Abader MI. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520631 3. Managing food allergy immunotherapy in children during the COVID-19 pandemic. Allergol. Immunopathol. (Madr.) 2021; 49:150-152Barni S, Giovannini M, Sarti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528943 4. Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities. Am. J. Health Syst. Pharm. 2021; Kubin CJ, Loo AS, Cheng J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543233 5. Reflections on the COVID-19 pandemic and Pharmacy Forecast 2021. Am. J. Health Syst. Pharm. 2021; Shea SB. http://www.ncbi.nlm.nih.gov/pubmed/? term=33543232 6. COVID-19 survivorship: How otolaryngologist-head and neck surgeons can restore quality of life after critical illness. Am. J. Otolaryngol. 2021; 42:102917Pandian V, Brodsky MB, Brigham EP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545448 7. Job stress in paediatric ICU staff caring for adult COVID-19 patients: An observational study during the first COVID-19 wave. Anaesth Crit Care Pain Med 2021:100810Poncelet G, Le Bourgeois F, Nicolas-Robin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540126 8. The impact of COVID-19 outbreak on otolaryngology practice, jordanian experience: A qualitative study. Ann Med Surg (Lond) 2021; 62:435-439Al Omari A, Kanaan Y, Nuseir A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542825 9. The impact of COVID-19 on surgical practice in Jordan during the second outbreak: A survey. Ann Med Surg (Lond) 2021; 62:402-405Ennab RM, Ibdah RK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532069 10. Algorithm of traumatic brain injury management at Indonesia in the COVID 19 pandemic ERA. Retrospective cohort study. Ann Med Surg (Lond) 2021; 62:98- 103Rosyidi RM, Wisnu Wardhana DP, Apriawan T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520203 11. COVID-19 impact on vascular surgery practice: experience from an Italian university regional hub center for vascular pathology. Ann. Vasc. Surg. 2021; Boschetti GA, Gregorio SD, Vera JMM et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549797 12. Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore. Antimicrob Resist Infect Control 2021; 10:28Ng TM, Tan SH, Heng ST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536077 13. Effects of COVID-19 lockdown measures on emergency plastic and reconstructive surgery presentations. ANZ J Surg 2021; Cordova LZ, Savage N, Ram R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538101 14. COVID-19 in the Perioperative Setting: Applying a Hierarchy of Controls to Prevent Transmission. AORN J. 2021; 113:147-164Alvino RT, Caughell CM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534156 15. Community Hospital Perioperative Services Department Responds to the COVID-19 Pandemic. AORN J. 2021; 113:165-178Messinger M, McNeill MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534154 16. Disability and the COVID-19 Pandemic: A Survey of Individuals with Traumatic Brain Injury. Arch. Phys. Med. Rehabil. 2021; Morrow EL, Patel NN, Duff MC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529614 17. Total Joint Arthroplasty during the COVID-19 Pandemic: A Scoping Review with Implications for Future Practice. Arthroplast Today 2021; Chen AZ, Shen TS, Bovonratwet P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521188 18. Arthroplasty During COVID-19: Surveillance of AAHKS Members in the First Year of the Pandemic. Arthroplast Today 2021; 7:209-215Stambough JB, Deen JT, Walton SL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521187 19. The protective effect of rheumatic disease agents in COVID-19. Best Pract. Res. Clin. Rheumatol. 2021:101659Valenzuela-Almada MO, Putman MS, Duarte-García A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526326 20. COVID-19 pandemic management and the rheumatology patient. Best Pract. Res. Clin. Rheumatol. 2021:101663Varley CD, Ku JH, Winthrop KL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536145 21. Care homes, their communities, and resilience in the face of the COVID-19 pandemic: interim findings from a qualitative study. BMC Geriatr. 2021; 21:102Marshall F, Gordon A, Gladman JRF, Bishop S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546612 22. Consequences of COVID-19 crisis for persons with HIV: the impact of social determinants of health. BMC Public Health 2021; 21:299Waterfield KC, Shah GH, Etheredge GD, Ikhile O. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546659 23. Perioperative challenges in managing a patient with COVID-19 undergoing debridement for massive scalp myiasis. BMJ Case Rep. 2021; 14Lo SY, Teah MK, Ho YZ, Yeap TB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547110 24. Change in urban and non-urban pattern of ED use during the COVID-19 pandemic in 28 Michigan hospitals: an observational study. BMJ Open 2021; 11:e043024Keyes D, Hardin B, Sweeney B, Shedden K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550257 25. Looking ahead to 2021. Bone Jt Open 2021; 2:1-2Haddad FS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537669 26. St Andrew's COVID-19 surgery safety (StACS) study: The Burns Centre experience. Burns 2021; Smith ACD, Miranda BH, Strong B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549394 27. Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis. Cancer Med 2021; Li P, Li L, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547886 28. Managing the Journey of Patients under Chemotherapy in a Pandemic Era: A Nursing Perspective. Chemotherapy 2021:1-4Gualandi R, De Benedictis A, De Marinis MG, Tartaglini D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540409 29. COVID-19: how has a global pandemic changed manual therapy technique education in chiropractic programs around the world? Chiropr. Man. Therap. 2021; 29:7de Luca K, McDonald M, Montgomery L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522933 30. Effect of the COVID-19 pandemic on antibiotic use in primary care. Clin Microbiol Infect 2021; Peñalva G, Benavente RS, Pérez-Moreno MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540117 31. Reduction in Ophthalmic Presentations to Australian Emergency Departments During the COVID-19 Period: Are We Seeing the Full Picture? Clin. Ophthalmol. 2021; 15:341-346Kam AW, Gunasekaran N, Chaudhry SG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542617 32. A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients with COVID-19. Clin. Ther. 2021; Chalkias A, Barreto EF, Laou E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549310 33. Minimal invasive surgery for left colectomy adapted to the COVID19 pandemic. Laparoscopic intracorporeal resection and anastomosis: "a don't touch the bowel technique". Colorectal Dis 2021; Serra-Aracil X, Mora-Lopez L, Gomez- Torres I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539644 34. Neurosyphilis and the Jarisch-Herxheimer Reaction: A Therapy Concern with HIV Disease. Dermatol Ther 2021:e14839Kapila R, Schwartz RA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527658 35. Where have all the other coeliacs gone in 2020? Road for a 2021 catch-up with missed diagnoses. Dig. Liver Dis. 2021; Valitutti F, Troncone R, Pisano P, Ciacci C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541798 36. "The doctor will see you now": Direct support professionals' perspectives on supporting adults with intellectual and developmental disabilities accessing health care during COVID-19. Disabil Health J 2021:101066Lunsky Y, Bobbette N, Selick A, Jiwa MI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531290 37. Separating the Physician and Patient: A Paradigm Shift for Routine Otolaryngology Examinations in COVID-19-Like Aerosol-Contaminated Environments. Ear Nose Throat J 2021:145561321992509Sayin I, Yazıcı ZM, Abakay MA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528271 38. Responses of people with epilepsy to the COVID-19 pandemic in the time of national lockdown. Epilepsy Behav. 2021; 116:107790Friedrich L, Sruk A, Bielen I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548913 39. Hip fracture care and mortality among patients treated in dedicated COVID-19 and non-COVID-19 circuits. Eur. Geriatr. Med. 2021; Ojeda-Thies C, Cuarental- García J, García-Gómez E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550563 40. Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection. Front Med (Lausanne) 2020; 7:571214La Rosa GRM, Libra M, De Pasquale R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521007 41. Cognitive Telerehabilitation for Older Adults With Neurodegenerative Diseases in the COVID-19 Era: A Perspective Study. Front. Neurol. 2020; 11:623933Bernini S, Stasolla F, Panzarasa S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519704 42. Patients Living With Breast Cancer During the Coronavirus Pandemic: The Role of Family Resilience, Coping Flexibility, and Locus of Control on Affective Responses. Front. Psychol. 2020; 11:567230Brivio E, Guiddi P, Scotto L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519580 43. Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit. Future Oncol 2021; Quaglino P, Fava P, Brizio M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533662 44. Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure. Graefes Arch Clin Exp Ophthalmol 2021:1- 8Korobelnik JF, Loewenstein A, Eldem B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528647 45. Migraine treatment and COVID-19 vaccines: no cause for concern. Headache 2021; Gelfand AA, Poland G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543775 46. Impact of the novel coronavirus disease and lockdown on the packed red blood cells inventory management: An experience from a tertiary care oncology center in Western India. Hematol Transfus Cell Ther 2021; Gupta AM, Ojha S, Nagaraju P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521581 47. COVID-19 Management in Clinical Dental Care Part II: Personal Protective Equipment for the Dental Care Professional. Int. Dent. J. 2021; Melo P, Afonso A, Monteiro L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531145 48. Otorhinolaryngology in the COVID-19 era: there significant differences between hospital-based and private practices? Int J Clin Pract 2021:e14054Guha A, Plzak J, Schalek P, Chovanec M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523523 49. Drug-related violence: Will COVID-19 drive better data for safer and more secure EU? Int. J. Drug Policy 2021; 93:103143Groshkova T, Liem M, Cunningham A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550030 50. A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID- 19. Int. J. Drug Policy 2021:103127Zolopa C, Hoj S, Bruneau J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549464 51. The Impact of COVID-19 on the Performance of Primary Health Care Service Providers in a Capitation Payment System: A Case Study from Poland. Int J Environ Res Public Health 2021; 18Korneta P, Kludacz-Alessandri M, Walczak R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546467 52. Awake craniotomy in a Covid-19 positive patient: The challenges and outcome. Interdiscip Neurosurg 2021; 24:101064Okunlola AI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520666 53. Management of inflammatory bowel disease in the COVID-19 era. Intest Res 2021; Kim KO, Jang BI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525860 54. Quantifying the impact of COVID-19 on chronic pain services in the Republic of Ireland. Ir. J. Med. Sci. 2021:1-5Mullins CF, Harmon D, O'Connor T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544332 55. The Initial Impact of COVID-19 on Total Hip and Knee Arthroplasty. J. Arthroplasty 2021; Barnes CL, Zhang X, Stronach BM, Haas DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549421 56. Continuing cancer care in a religious facility: A feasible alternative in the COVID-19 Pandemic Era? J Cancer Policy 2021; 27:100269Montoya JE, Item LM, Ganggay SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520649 57. Hospital transmission rates of the SARS-CoV 2 disease amongst orthopaedic in-patients in a secondary care centre: A quantitative review. J Clin Orthop Trauma 2021; 16:43-48Holmes N, Virani S, Relwani J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519136 58. Impact of COVID-19 on small biopsy diagnostic procedures and cancer resection surgeries in the North-West of Ireland. J. Clin. Pathol. 2021; O'Connor E, O'Dowd G, Phelan S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542109 59. LncRNAs: Promising new targets in pulmonary fibrosis. J. Gene Med. 2021:e3318Zhang S, Chen H, Yue D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533071 60. Impact of the COVID-19 Outbreak on Trends in Emergency Department Utilization in Children: a Multicenter Retrospective Observational Study in Seoul Metropolitan Area, Korea. J Korean Med Sci 2021; 36:e44Choi DH, Jung JY, Suh D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527786 61. The impact of the COVID-19 pandemic on medical assistance in dying in Canada and the relationship of public health laws to private understandings of the legal order. J Law Biosci 2020; 7:lsaa087Tremblay-Huet S, McMorrow T, Wiebe E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537150 62. COVID-19 Pandemic and Its Impact on Pediatric Dentistry in Austria: Knowledge, Perception and Attitude Among Pediatric Dentists in a Cross- Sectional Survey. J Multidiscip Healthc 2021; 14:161-169Bekes K, Ritschl V, Stamm T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531814 63. Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19. J. Neurol. 2021:1-4Hofstadt-van Oy U, Stankovic S, Kelbel C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537898 64. Impact of COVID-19 Pandemic on Neurosurgical Practice in a Tertiary Care Center in India. J. Neurosci. Rural Pract. 2021; 12:24-32Singh R, Sahu A, Singh K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531756 65. Assesment of SARS-CoV-2 infection-in dentists and supporting staff at a university dental hospital in Argentina. J Oral Biol Craniofac Res 2021; 11:169- 173Sebastian P, Jorge P, Ariel G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520644 66. Managing low-risk febrile neutropenia in children in the time of COVID-19: What matters to parents and clinicians. J. Paediatr. Child Health 2021; Haeusler GM, De Abreu Lourenco R, Bakos C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533525 67. Paediatric appendicitis during the COVID-19 pandemic. J. Paediatr. Child Health 2021; Sheath C, Abdelrahman M, MacCormick A, Chan D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527572 68. Challenges faced by mothers caring for children with leukaemia during COVID-19 pandemic: A qualitative study. J. Pediatr. Nurs. 2021; Atout M, Tarawneh FS, Al-Kharabsheh A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526289 69. Day case laparoscopic cholecystectomy: Identifying patients for a 'COVID- Cold' isolated day-case unit during the pandemic. J Perioper Pract 2021:1750458920977418Hinchcliffe Z, Mohamed I, Lala A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544661 70. Anesthetic challenges while performing emergency laparotomy in a patient having COVID-19 infection. J. Postgrad. Med. 2021; Karna ST, Kumari S, Singh P, Waindeskar V. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533746 71. Cancer surgery during the COVID-19 pandemic: The experience of a comprehensive cancer center performing preoperative screening by RT-PCR and chest CT scan. J. Surg. Oncol. 2021; Guerlain J, Haroun F, Voicu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524172 72. The COVID-19 pandemic and follow-up for shoulder surgery: The impact of a shift toward telemedicine on validated patient-reported outcomes. J Telemed Telecare 2021:1357633x21990997Sabbagh R, Shah N, Jenkins S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525951 73. Impact of COVID-19 on the Society for Vascular Surgery Vascular Quality Initiative Arterial Procedure Registry. J. Vasc. Surg. 2021; Natarajan JP, Mahenthiran AK, Bertges DJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33548419 74. Appendicitis during the COVID-19 lockdown: results of a multicenter analysis in Germany. Langenbecks Arch. Surg. 2021; Willms AG, Oldhafer KJ, Conze S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550453 75. Structure of hospital care for COVID-19 patients up to July 2020 in Germany. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2021; Hentschker C, Mostert C, Klauber J et al. 76. Retrospective study in clinical governance and financing system impacts of the COVID-19 pandemic in the hand surgery and microsurgery HUB center. Musculoskelet. Surg. 2021:1-6Leti Acciaro A, Montanari S, Venturelli M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528801 77. Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress. Neurogastroenterol. Motil. 2021:e14092Oliviero G, Ruggiero L, D'Antonio E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550640 78. Clinical activity changes in the neurology department of Wenzhou during the COVID-19 pandemic: an observational analysis. Neurol Sci 2021:1-7Cao YG, Li Y, Shen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523320 79. Factors Related to Weight Gain in Subjects with Sleeve Gastrectomy During Lockdown by the COVID-19 Pandemic. Obes. Surg. 2021:1-6de Luis D, Izaola O, Primo D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527253 80. Feasibility and predictive performance of a triage system for cancer patients during the COVID-19 pandemic. Oncologist 2021; Fasola G, Pelizzari G, Zara D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539583 81. The effect of the COVID-19 pandemic on working practices of UK primary care optometrists. Ophthalmic Physiol. Opt. 2021; Nagra M, Allen PM, Norgett Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533077 82. The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research. Orphanet J. Rare Dis. 2021; 16:61Radtke HB, Klein-Tasman BP, Merker VL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522938 83. [Impact of the COVID‒19 pandemic on ophthalmic outpatient care at the Ophthalmology Department of the New St. John’s Hospital, Budapest]. Orv. Hetil. 2021; 162:203-211Széles R, Szentmáry N, Burka G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550272 84. The Impact of COVID-19 on Otolaryngology Community Practice in Massachusetts. Otolaryngol Head Neck Surg 2021:194599820983732Fan T, Workman AD, Miller LE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525964 85. The Early Impact of COVID-19 on Chronic Pain: A Cross-Sectional Investigation of a Large Online Sample of Individuals with Chronic Pain in the United States, April to May, 2020. Pain Med. 2021; Mun CJ, Campbell CM, McGill LS, Aaron RV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537764 86. Paediatric dental care during and post-COVID-19 era: changes and challenges ahead. Pediatr Dent J 2021; Luo W, Lee GH, Nalabothu P, Kumar H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531735 87. Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection. Probiotics Antimicrob Proteins 2021:1-19Patra S, Saxena S, Sahu N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537958 88. Prison health during the COVID-19 era in Africa. Public Health Pract (Oxf) 2021; 2:100083Nweze VN, Anosike UG, Ogunwusi JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521740 89. Sexually Transmitted Diseases during the COVID-19 pandemic: a focus on syphilis and gonorrhoea in Cuba. Public Health Pract (Oxf) 2020:100072Rodríguez I, Hernández Y. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521735 90. COVID-19 and Public Interest in Ophthalmic Services and Conditions. R I Med J (2013) 2021; 104:61-64Lin JC, Jiang L, Scott IU, Greenberg PB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517603 91. Delayed Diagnosis of a Testicular Mass During COVID-19 Pandemic in Lombardy: A Case Report. Res Rep Urol 2021; 13:41-44Cieri M, Contieri R, De Carlo C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537246 92. Impact of COVID-19 pandemic on epilepsy practice in India: A tripartite survey. Seizure 2021; 86:60-67Rathore C, Baheti N, Bansal AR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550135 93. Prevalence of and risk factors associated with sleep disturbances among HPCD exposed to COVID-19 in China. Sleep Med. 2021; 80:16-22Yang G, Li C, Zhu X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540240 94. Care for Older People with Dementia During COVID-19 Pandemic. SN Compr Clin Med 2021:1-7Emmerton D, Abdelhafiz AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527095 95. Being in touch: narrative assessment of patients receiving online integrative oncology treatments during COVID-19. Support. Care Cancer 2021:1-7Ben-Arye E, Keshet Y, Gressel O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538895 96. Global concerns of dental and oral health workers during COVID-19 outbreak: a scope study on the concerns and the coping strategies. Syst Rev 2021; 10:45Bastani P, Mohammadpour M, Ghanbarzadegan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526078 97. Triage of General Gastrointestinal Endoscopic Procedures During the COVID- 19 Pandemic: Results from a National Delphi Consensus Panel. Tech Innov Gastrointest Endosc 2020; Feuerstein A, Bilal M, Berzin TM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521705 98. Optimize the management of urological tube-related emergencies during the coronavirus disease 2019 (COVID-19) pandemic. Transl Androl Urol 2021; 10:466-474Luan Y, Zhang Y, Cui K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532334 99. Impact of the COVID-19 pandemic on blood supply and demand in the WHO African Region. Vox Sang 2021; Loua A, Kasilo OMJ, Nikiema JB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529421 100. Cancer, COVID-19, and the need for critique. Wellcome Open Res 2020; 5:280Greco C, Arteaga I, Fabian-Therond C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521331 101. Continuity of cancer care in the era of COVID-19 pandemic: Role of social media in low- and middle-income countries. World J Clin Cases 2021; 9:291- 295Yadav SK, Yadav N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521097 102. Thirty-day mortality of patients with hip fracture during COVID-19 pandemic and pre-pandemic periods: A systematic review and meta-analysis. World J Orthop 2021; 12:35-50Tripathy SK, Varghese P, Panigrahi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520680 103. Hello, can you hear me? Orthopaedic clinic telephone consultations in the COVID-19 era- a patient and clinician perspective. World J Orthop 2021; 12:24- 34Vusirikala A, Ensor D, Asokan AK et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520679 104. Innovations in otorhinolaryngology in the age of COVID-19: a systematic literature review. World J Otorhinolaryngol Head Neck Surg 2021; McCarty EB, Soldatova L, Brant JA, Newman JG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520334 105. COVID-19 and changes in neurosurgical workload in the United Kingdom. World Neurosurg 2021; ElGhamry AN, Jayakumar N, Youssef M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540092 106. Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases—relative all clear through consistent testing. Z. Rheumatol. 2021; Andreica I, Guminski B, Sokolar J et al.

Management (61 articles)

1. Supporting Caregivers During COVID-19: Transforming Compassionate Care From a Way of Doing to Being. AANA J. 2021; 89:1-6Pelt MV, Morris T, Lilly AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543706 2. Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: A meta-analysis. Am J Emerg Med 2021; 43:88-96Cardona S, Downing J, Alfalasi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550104 3. Non-invasive positive pressure ventilation versus endotracheal intubation in treatment of COVID-19 patients requiring ventilatory support. Am J Emerg Med 2021; 43:103-108Daniel P, Mecklenburg M, Massiah C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550100 4. Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic. Am J Respir Crit Care Med 2021; 203:287-295White DB, Lo B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522881 5. Interprofessional primary care during COVID-19: a survey of the provider perspective. BMC Fam. Pract. 2021; 22:31Donnelly C, Ashcroft R, Bobbette N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535973 6. Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study. BMC Med. Genomics 2021; 14:38Li S, Hua X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536004 7. Dilemma of countering happy hypoxaemia COVID-19 patients. BMJ Case Rep. 2021; 14Kobayashi K, Takaoka H, Hirano T, Inoue T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541978 8. Successful management of severe acute respiratory distress syndrome due to COVID-19 with extracorporeal membrane oxygenation during mid-trimester of pregnancy. BMJ Case Rep. 2021; 14Tambawala ZY, Hakim ZT, Hamza LK, Al Rayes M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541967 9. Pandemic ICU triage challenge and medical ethics. BMJ Support Palliat Care 2021; Netters S, Dekker N, van de Wetering K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541855 10. Elastomeric pumps for symptom control medication in patients dying with COVID-19. BMJ Support Palliat Care 2021; Selway P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526421 11. Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge: A Prospective Cohort and Nested Case- Control Study. Chin J Integr Med 2021:1-7Li L, Gou CY, Li XM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534076 12. Asia's largest urban slum-Dharavi: A global model for management of COVID- 19. Cities 2021; 111:103097Kaushal J, Mahajan P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519012 13. Rationale for the Role of Heparin and Related GAG Antithrombotics in COVID- 19 Infection. Clin. Appl. Thromb. Hemost. 2021; 27:1076029620977702Magnani HN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539214 14. The effects of COVID-19 on sickness of medical staff across departments: A single centre experience. Clin Med (Lond) 2021; Khorasanee R, Grundy T, Isted A, Breeze R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547066 15. COVID-19 Patient with Severe Comorbidity in Multimodal Acute Care Setting with Non-Invasive Medical Ventilation: A Clinical Outcome Report. Clin Pract 2021; 11:81-91Romeyke T, Noehammer E, Stummer H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546107 16. Successful treatment of a bullous vasculitis with intravenous immunoglobulins in A Covid-19 Patient. Dermatol Ther 2021:e14853Zavattaro E, Cammarata E, Tarantino V et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547851 17. Modified Negative Pressure Enclosure During Tracheostomy in Patients With COVID-19. Ear Nose Throat J 2021:145561321991319Levy DA, Boey HP, Leff PD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530740 18. [Between care for others and self-care: intensive care nursing in times of the COVID-19 pandemic]. Ethik Med 2021:1-20Kuhn E, Seidlein AH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526958 19. Acute pulmonary embolism in COVID-19 patient: a case report of free-floating right heart thrombus successfully treated with fibrinolysis. Eur Heart J Case Rep 2021; 5:ytaa388Scudiero F, Pitì A, Keim R, Parodi G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542972 20. PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia. Exp. Lung Res. 2021:1-12Beute J, Boermans P, Benraad B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544007 21. The public perception of food and non-food related risks of infection and trust in the risk communication during COVID-19 crisis: A study on selected countries from the Arab region. Food Control 2021; 121:107617Faour-Klingbeil D, Osaili TM, Al-Nabulsi AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519101 22. Thrombosis and Coagulopathy in COVID-19: Current Understanding and Implications for Antithrombotic Treatment in Patients Treated With Percutaneous Coronary Intervention. Front Cardiovasc Med 2020; 7:599334Liu H, Wang Z, Sun H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537347 23. Allocation of the "Already" Limited Medical Resources Amid the COVID-19 Pandemic, an Iterative Ethical Encounter Including Suggested Solutions From a Real Life Encounter. Front Med (Lausanne) 2020; 7:616277Alhalaseh YN, Elshabrawy HA, Erashdi M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521023 24. Reduced Rate of Inpatient Hospital Admissions in 18 German University Hospitals During the COVID-19 Lockdown. Front Public Health 2020; 8:594117Kapsner LA, Kampf MO, Seuchter SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520914 25. Community Based Management of COVID-19 as a Way Forward for Pandemic Response. Front Public Health 2020; 8:589772Panigrahi SK, Majumdar S, Galhotra A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520913 26. Lifestyle factors in the prevention of COVID-19. Glob Health J 2020; 4:146- 152Lange KW, Nakamura Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520339 27. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation. Heart Lung 2021; 50:357-360Salabei JK, Fishman TJ, Asnake ZT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524866 28. Rapid response and learning for later: establishing high quality information networks and evaluation frameworks for the National Ambulance Service response to COVID-19 - the ENCORE COVID Project Protocol. HRB Open Res 2020; 3:68Masterson S, Heffernan E, Keegan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537553 29. Tracheostomy in Covid-19 Patients: Surgical Concerns and Considerations. Indian J Otolaryngol Head Neck Surg 2021:1-4Sebastian SK, Amar PS, Sharma R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532346 30. Evolving Treatment Patterns for Hospitalized COVID-19 Patients in the United States in April 2020-July 2020. Int. J. Gen. Med. 2021; 14:267-271Fan X, Johnson BH, Johnston SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531828 31. Diagnosis and treatment of disseminated intravascular coagulation in COVID- 19 patients: a scoping review. Int. J. Hematol. 2021; Mori H, Ohkawara H, Togawa R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550533 32. Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19. Intensive Care Med 2021:1-14Shaefi S, Brenner SK, Gupta S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528595 33. An Open Clinical Evaluation Of Selected Siddha Regimen In Expediting The Management Of Covid-19 -A Randomized Controlled Study. J. Ayurveda Integr. Med. 2021; Chitra SM, Mallika P, Anbu N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519133 34. SARS-CoV-2 and self-medication in Cameroon: a mathematical model. J. Biol. Dyn. 2021; 15:137-150Kong JD, Tchuendom RF, Adeleye SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538240 35. Combined measures to control the COVID-19 pandemic in Wuhan, Hubei, China: A narrative review. J Biosaf Biosecur 2020; 2:51-57Hasnain M, Pasha MF, Ghani I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521592 36. Emergency Department Management of Severe Hypoxemic Respiratory Failure in Adults With COVID-19. J. Emerg. Med. 2020; Wilcox SR, Condella A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526308 37. Preparing for a COVID-19 pandemic: Redefining roles of multidisciplinary team in a large tertiary hospital in Rajasthan. J Family Med Prim Care 2020; 9:5439-5444Elhence A, Sureka B, Garg MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532376 38. Role of self-care in COVID-19 pandemic for people living with comorbidities of diabetes and hypertension. J Family Med Prim Care 2020; 9:5495-5501Gupta SK, Lakshmi PVM, Kaur M, Rastogi A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532385 39. Intensified thromboprophylaxis in COVID-19 critically ill patients: is it enough? J Infect 2021; de Montmollin E, Faille D, Andrieu V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549626 40. Pathophysiological Mechanisms and Management of Patients with Long-time Anosmia related to COVID-19. J Intern Med 2021; Lechien JR, Chiesa-Estomba CM, Hans S, Saussez S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527593 41. A Virtual Ward Model of Care for Patients With COVID-19: Retrospective Single-Center Clinical Study. J Med Internet Res 2021; 23:e25518Ferry OR, Moloney EC, Spratt OT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529157 42. Palliative Care in Toronto during the COVID-19 pandemic. J Pain Symptom Manage 2021; Wentlandt K, Cook R, Morgan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549737 43. Vitamin C supplementation is necessary for patients with coronavirus disease: An ultra-high-performance liquid chromatography-tandem mass spectrometry finding. J. Pharm. Biomed. Anal. 2021; 196:113927Xing Y, Zhao B, Yin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549875 44. Managing patients in the COVID-19 pandemic: A Virtual Multidisciplinary Approach. Mayo Clin Proc Innov Qual Outcomes 2020; Ganesh R, Salonen BR, Bhuiyan MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521583 45. Alternative CPAP methods for the treatment of secondary serious respiratory failure due to pneumonia by COVID-19. Med Clin (Engl Ed) 2021; 156:55- 60Mateos-Rodríguez A, Ortega-Anselmi J, Candel-González FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521312 46. Could diet and exercise reduce risk of COVID-19 syndemic? Med. Hypotheses 2021; 148:110502Chesnut WM, MacDonald S, Wambier CG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529978 47. [Nutrition and the COVID-19 pandemic]. Medicine (Madr) 2020; 13:1311- 1321Álvarez J, Lallena S, Bernal M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519030 48. Preventive home therapy for symptomatic patients affected by COVID-19 and followed by teleconsultations. Multidiscip Respir Med 2021; 16:748D'Amato G, Acanfora L, Delli Paoli L, D'Amato M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532070 49. A fuzzy rule-based efficient hospital bed management approach for coronavirus disease-19 infected patients. Neural Comput Appl 2021:1-22Jena KK, Bhoi SK, Prasad M, Puthal D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526959 50. COVID-19 experience in mainland China: Nursing lessons for the United States of America. Nurs. Forum 2021; Anders RL, Lam SC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538005 51. Nutrition and the Covid-19 pandemic: Three factors with high impact on community health. Nutr. Metab. Cardiovasc. Dis. 2020; Iaccarino Idelson P, Rendina D, Strazzullo P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549427 52. Responses to the Pandemic COVID-19 in Primary Health Care in Oman: Muscat Experience. Oman Med. J. 2021; 36:e216Al Ghafri T, Al Ajmi F, Al Balushi L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537154 53. Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation. Pharmaceutics 2021; 13Joyce M, McGrath JA, Mac Giolla Eain M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540764 54. Timing of VV-ECMO therapy implementation influences prognosis of COVID-19 patients. Physiol Rep 2021; 9:e14715Giraud R, Legouis D, Assouline B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527751 55. The intersection of climate change with the era of COVID-19. Public Health Nurs. 2021; Zang SM, Benjenk I, Breakey S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521994 56. Potential bangle (Zingiber montanum J.König) rhizome extract as a supplement to prevent and reduce symptoms of Covid-19. Saudi J. Biol. Sci. 2021; Musdja MY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519275 57. Forecasting of medical equipment demand and outbreak spreading based on deep long short-term memory network: the COVID-19 pandemic in Turkey. Signal Image Video Process 2021:1-9Koç E, Türkoğlu M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520001 58. Impact of COVID-19 on doctors and healthcare providers during the pandemic in Sudan. Trans. R. Soc. Trop. Med. Hyg. 2021; El-Sadig SM, Fahal LA, Abdelrahim ZB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547896 59. Food policy, nutrition and nutraceuticals in the prevention and management of COVID-19: Advice for healthcare professionals. Trends Food Sci Technol 2020; 105:186-199Ayseli YI, Aytekin N, Buyukkayhan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519086 60. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19. Wellcome Open Res 2020; 5:179Augusto JB, Menacho K, Andiapen M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537459 61. Success in combating a pandemic: Role of fast policy responses. World Dev Perspect 2021; 21:100285Tung LT. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521402

Mental – public health (166 articles)

1. Psychological impact and social support in pregnant women during lockdown due to SARS-CoV2 pandemic: A cohort study. Acta Obstet Gynecol Scand 2021; Brik M, Sandonis MA, Fernández S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533051 2. Childhood Adversity and Perceived Distress from the COVID-19 Pandemic. Advers Resil Sci 2021:1-4Shreffler KM, Joachims CN, Tiemeyer S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527096 3. High Prevalence of Elder Abuse During the COVID-19 Pandemic: Risk and Resilience Factors. Am J Geriatr Psychiatry 2021; Chang ES, Levy BR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518464 4. Trauma, Resilience, Anxiety Disorders, and PTSD. Am. J. Psychiatry 2021; 178:103-105Kalin NH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517749 5. Anxiety Levels Among Physician Mothers During the COVID-19 Pandemic. Am. J. Psychiatry 2021; 178:203-204Linos E, Halley MC, Sarkar U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517747 6. Clozapine Intoxication in COVID-19. Am. J. Psychiatry 2021; 178:123-127Tio N, Schulte PFJ, Martens HJM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517757 7. Job stress in paediatric ICU staff caring for adult COVID-19 patients: An observational study during the first COVID-19 wave. Anaesth Crit Care Pain Med 2021:100810Poncelet G, Le Bourgeois F, Nicolas-Robin A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540126 8. Mental Health outcome and Professional quality of Life among Healthcare Worker during COVID-19 pandemic: A (FRONTLINE-COVID) survey. Ann. Med. Psychol. (Paris) 2021; Nathiya D, Suman S, Singh P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518767 9. Effect of the COVID-19 pandemic first wave and public policy on elective and emergency surgery provision in Southern Queensland. ANZ J Surg 2021; Fowler S, Zahir SF, Manning W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522697 10. Role of psychiatric hospitals during a pandemic: introducing the Munich Psychiatric COVID-19 Pandemic Contingency Plan. BJPsych Open 2021; 7:e41Adorjan K, Pogarell O, Streb D et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33517940 11. Clinical characteristics, management and health related quality of life in young to middle age adults with COVID-19. BMC Infect. Dis. 2021; 21:134Temperoni C, Grieco S, Pasquini Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522907 12. COVID-19 pandemic and violence: rising risks and decreasing urgent care- seeking for sexual assault and domestic violence survivors. BMC Med 2021; 19:20Muldoon KA, Denize KM, Talarico R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541357 13. An investigation of depression, anxiety, and stress and its relating factors during COVID-19 pandemic in Iran. BMC Public Health 2021; 21:275Khademian F, Delavari S, Koohjani Z, Khademian Z. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535992 14. Knowledge-attitude-practice and psychological status of college students during the early stage of COVID-19 outbreak in China: a cross-sectional study. BMJ Open 2021; 11:e045034Jia Y, Qi Y, Bai L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550266 15. COVID-19 impacts the expression of molecular markers associated with neuropsychiatric disorders. Brain Behav Immun Health 2021; 11:100196Quincozes-Santos A, Rosa RL, Tureta EF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521688 16. The Role of Uncertainty in the Experiences of Nurses During the Covid-19 Pandemic: A Phenomenological Study. Can. J. Nurs. Res. 2021:844562121992202Nelson H, Hubbard Murdoch N, Norman K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541124 17. "We Are at Risk Too": The Disparate Mental Health Impacts of the Pandemic on Younger Generations: Nous Sommes Aussi à Risque: Les Effets Disparates de la Pandémie Sur la Santé Mentale des Générations Plus Jeunes. Can. J. Psychiatry. 2021:706743721989162El-Gabalawy R, Sommer JL. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522837 18. In the Patients' Best Interest: Visitors Policy and Inpatient Psychiatry Wards in the COVID-19 Era. Can. J. Psychiatry. 2021:706743721990798Maraj A, Ferrari M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525901 19. An Emotion Care Model using Multimodal Textual Analysis on COVID-19. Chaos Solitons Fractals 2021; 144:110708Gupta V, Jain N, Katariya P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519125 20. Child maltreatment in the time of COVID-19: Changes in the Florida foster care system surrounding the COVID-19 safer-at-home order. Child Abuse Negl. 2021:104945Musser ED, Riopelle C, Latham R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546917 21. Viral time capsule: a global photo-elicitation study of child and adolescent mental health professionals during COVID-19. Child Adolesc Psychiatry Ment Health 2021; 15:5Herrington OD, Clayton A, Benoit L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531051 22. Knowledge, attitudes and mental health of university students during the COVID-19 pandemic in China. Child Youth Serv Rev 2020; 119:105494Jiang R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518860 23. Psychological impact of covid-19 crises on students through the lens of Stimulus-Organism-Response (SOR) model. Child Youth Serv Rev 2021; 120:105783Pandita S, Mishra HG, Chib S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518862 24. Mental health outcomes during the COVID-19 and perceptions towards the pandemic: Findings from a cross sectional study among Bangladeshi students. Child Youth Serv Rev 2020; 119:105658Sayeed A, Kundu S, Banna MHA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518861 25. Exploring the triggering factors for mental stress of university students amid COVID-19 in Bangladesh: A perception-based study. Child Youth Serv Rev 2021; 120:105789Shafiq S, Nipa SN, Sultana S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518863 26. The Impact of COVID-19 on the Adaptive Functioning, Behavioral Problems, and Repetitive Behaviors of Italian Children with Autism Spectrum Disorder: An Observational Study. Children (Basel) 2021; 8Siracusano M, Segatori E, Riccioni A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540683 27. COVID-19 Pandemic and Mental Health of Vulnerable Two Groups: Developmental Trauma of the Child-Adolescents and Work Disaster of Health Care Workers. Chonnam Med. J. 2021; 57:7-12Nam SH, Yang JC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537214 28. Public perception and preparedness for the pandemic COVID 19: A Health Belief Model approach. Clin Epidemiol Glob Health 2021; 9:41-46Jose R, Narendran M, Bindu A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521389 29. Impact of COVID-19 on the mental health of radiologists. Clin Imaging 2021; 76:60Triana G, Forero PA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549921 30. Substance use, mental health and weight-related behaviours during the COVID-19 pandemic in people with obesity. Clin Obes 2021:e12440Almandoz JP, Xie L, Schellinger JN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539652 31. Difficulties with emotion regulation and drinking during the COVID-19 pandemic among undergraduates: the serial mediation of COVID-related distress and drinking to cope with the pandemic. Cogn. Behav. Ther. 2021:1- 15Buckner JD, Lewis EM, Abarno CN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522892 32. Examining the longitudinal effects and potential mechanisms of hope on COVID-19 stress, anxiety, and well-being. Cogn. Behav. Ther. 2021:1- 12Gallagher MW, Smith LJ, Richardson AL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544032 33. The association between sleep quality, depression, anxiety and stress levels, and temporomandibular joint disorders among Turkish dental students during the COVID-19 pandemic. Cranio 2021:1-6Gaş S, Ekşi Özsoy H, Cesur Aydın K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543679 34. A Three-Step, Single Session Therapy Intervention for COVID-Related Anxiety in a Pediatric Emergency Department. Cureus 2020; 12:e12371Lee DP, Simpson SA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527052 35. Encountering Covid-19 and perceived stress and the role of a health climate among medical workers. Curr. Psychol. 2021:1-14Abbas S, Al-Abrrow H, Abdullah HO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519147 36. The impact of epidemic information on the public's worries and attitude toward epidemic prevention measures during the COVID-19 outbreak. Curr. Psychol. 2021:1-9Liao HP, Wang JL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33531791 37. Data on media use and mental health during the outbreak of COVID-19 in China. Data Brief 2021; 35:106765Xue D, Liu T, Chen X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537381 38. The association between witnessing patient death and mental health outcomes in frontline COVID-19 healthcare workers. Depress. Anxiety 2021; Mosheva M, Gross R, Hertz-Palmor N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544405 39. Psychological stress during the COVID-19 pandemic: consequences for psychiatric patients and therapeutic implications. Der Nervenarzt 2021; Winkler JG, Jalilzadeh Masah D, Moran JK et al. 40. "The doctor will see you now": Direct support professionals' perspectives on supporting adults with intellectual and developmental disabilities accessing health care during COVID-19. Disabil Health J 2021:101066Lunsky Y, Bobbette N, Selick A, Jiwa MI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531290 41. The effects of COVID-19 restrictions on physical activity and mental health of children and young adults with physical and/or intellectual disabilities. Disabil Health J 2021:101064Theis N, Campbell N, De Leeuw J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549499 42. Local measures enable COVID-19 containment with fewer restrictions due to cooperative effects. EClinicalMedicine 2021:100718Bittihn P, Hupe L, Isensee J, Golestanian R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521609 43. [Psychological impact of the COVID-19 pandemic: Comparison between residents of metropolitan France and of Reunion Island]. Encephale 2021; Laconi S, Ramaye D, Kalaitzaki A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541714 44. Peripandemic psychiatric emergencies: impact of the COVID-19 pandemic on patients according to diagnostic subgroup. Eur. Arch. Psychiatry Clin. Neurosci. 2021:1-12Seifert J, Meissner C, Birkenstock A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544227 45. Postpartum depression during COVID-19. Eur J Midwifery 2020; 4:19Almasidou ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537621 46. Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress. Eur J Psychiatry 2020; Lippi G, Henry BM, Sanchis-Gomar F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518879 47. Time for lessons from the first wave of SARS-CoV-2 epidemic. A case report of a patient with acute psychosis and COVID-19 and later virus reactivation. Eur J Psychiatry 2020; Saje M, Prebil K, Kores Plesnicar B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518880 48. COVID-19 quarantine: Two-way interaction between physical activity and mental health. Eur. J. Transl. Myol. 2020; 30:9509Khosravi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520149 49. Coronavirus syndrome: COVID-19 psychotrauma. Eur. J. Transl. Myol. 2020; 30:9302Soloveva NV, Makarova EV, Kichuk IV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520144 50. The public perception of food and non-food related risks of infection and trust in the risk communication during COVID-19 crisis: A study on selected countries from the Arab region. Food Control 2021; 121:107617Faour-Klingbeil D, Osaili TM, Al-Nabulsi AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519101 51. COVID-19 Lockdown and Self-Perceived Changes of Food Choice, Waste, Impulse Buying and Their Determinants in Italy: QuarantEat, a Cross-Sectional Study. Foods 2021; 10Scacchi A, Catozzi D, Boietti E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540825 52. The Impact of COVID-19 Quarantine on Patients With Dementia and Family Caregivers: A Nation-Wide Survey. Front. Aging Neurosci. 2020; 12:625781Rainero I, Bruni AC, Marra C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33536898 53. Digging Signatures in 13-Month-Old 3xTg-AD Mice for Alzheimer's Disease and Its Disruption by Isolation Despite Social Life Since They Were Born. Front. Behav. Neurosci. 2020; 14:611384Gimenez-Llort L, Alveal-Mellado D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536883 54. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front Med (Lausanne) 2020; 7:606824Komaroff AL, Bateman L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537329 55. Social Support and Loneliness Among Chinese Caregivers of Children With Chronic Kidney Disease During the COVID-19 Pandemic: A Propensity Score Matching Analysis. Front Pediatr 2020; 8:570535Shi L, Zhang H, Yang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520883 56. Mental Health Outcomes Amongst Health Care Workers During COVID 19 Pandemic in Saudi Arabia. Front Psychiatry 2020; 11:619540Al Ammari M, Sultana K, Thomas A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519559 57. Global Imperative of Suicidal Ideation in 10 Countries Amid the COVID-19 Pandemic. Front Psychiatry 2020; 11:588781Cheung T, Lam SC, Lee PH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519545 58. The Mental Well-Being of Frontline Physicians Working in Civil Wars Under Coronavirus Disease 2019 Pandemic Conditions. Front Psychiatry 2020; 11:598720Elhadi M, Msherghi A, Elgzairi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542695 59. Polish Experiences of Safety Measures Involving Forensic Psychiatric Inpatients Implemented During the SARS-CoV-2 Pandemic. Front Psychiatry 2020; 11:576703Heitzman J, Gosek P. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519542 60. A Key Factor for Psychosomatic Burden of Frontline Medical Staff: Occupational Pressure During the COVID-19 Pandemic in China. Front Psychiatry 2020; 11:590101Yi J, Kang L, Li J, Gu J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536948 61. COVID-19 Pandemic as the Beginning of a Golden Era for Telepsychiatry in Poland's Healthcare System. Front Psychiatry 2020; 11:555559Zadka Ł, Olajossy M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519538 62. Post-traumatic Growth Dimensions Differently Mediate the Relationship Between National Identity and Interpersonal Trust Among Young Adults: A Study on COVID-19 Crisis in Italy. Front. Psychol. 2020; 11:576610Ellena AM, Aresi G, Marta E, Pozzi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519591 63. COVID-19: A Boon or a Bane for Creativity? Front. Psychol. 2020; 11:601150Mercier M, Vinchon F, Pichot N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536973 64. The Psychological Impacts of COVID-19 Home Confinement and Physical Activity: A Structural Equation Model Analysis. Front. Psychol. 2020; 11:614770Sang X, Menhas R, Saqib ZA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519638 65. Risk Perception and Protective Behaviors During the Rise of the COVID-19 Outbreak in Italy. Front. Psychol. 2020; 11:577331Savadori L, Lauriola M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519593 66. The Relationship Between Creativity and Intrusive Rumination Among Chinese Teenagers During the COVID-19 Pandemic: Emotional Resilience as a Moderator. Front. Psychol. 2020; 11:601104Wang Q, Zhao X, Yuan Y, Shi B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519607 67. How Does Public Knowledge, Attitudes, and Behaviors Correlate in Relation to COVID-19? A Community-Based Cross-Sectional Study in Nepal. Front Public Health 2020; 8:589372Devkota HR, Sijali TR, Bogati R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520911 68. Communication and Cooperation Between the Medical Academy, Medical Association, and Local Government: Health Counseling Program After Recovery From Coronavirus Disease 2019 (COVID-19) in Daegu. Front Public Health 2020; 8:563757Kim YA, Lee GH, Lee KM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520907 69. Community Based Management of COVID-19 as a Way Forward for Pandemic Response. Front Public Health 2020; 8:589772Panigrahi SK, Majumdar S, Galhotra A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520913 70. [Insight on how to assess and improve the response to the COVID-19 pandemic]. Gac. Sanit. 2020; Martín-Moreno JM, Arenas A, Bengoa R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518411 71. Health-care guidelines and policies during the COVID-19 pandemic in Mexico: A case of health-inequalities. Health Policy Open 2021; 2:100025Bautista- González E, Werner-Sunderland J, Pérez-Duarte Mendiola P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521627 72. The impact of Covid-19 pandemic on community-oriented mental health services: The experience of Friuli Venezia Giulia region, Italy. Health Policy Technol 2020; Castelpietra G, Colli C, Tossut D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520636 73. Europe's Covid-19 outliers: German, Austrian and Swiss policy responses during the early stages of the 2020 pandemic. Health Policy Technol 2020; 9:405- 418Desson Z, Lambertz L, Peters JW et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520639 74. An analysis of the policy responses to the COVID-19 pandemic in France, Belgium, and Canada. Health Policy Technol 2020; 9:430-446Desson Z, Weller E, McMeekin P, Ammi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520640 75. Public Trust and Policy Compliance during the COVID-19 Pandemic: The Role of Professional Trust. Healthcare (Basel) 2021; 9Saechang O, Yu J, Li Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540762 76. Application of the Weathering Framework: Intersection of Racism, Stigma, and COVID-19 as a Stressful Life Event among African Americans. Healthcare (Basel) 2021; 9Wakeel F, Njoku A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33540498 77. COVID-19 and Alcohol Misuse: A Case Report. Infect Disord Drug Targets 2021; Asadollahi-Amin A, Nowroozi A, Hasibi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538677 78. Coping strategies in obsessive-compulsive patients during Covid-19 lockdown. Int. J. Clin. Health Psychol. 2021; 21:100223Rosa-Alcázar Á, García- Hernández MD, Parada-Navas JL et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519939 79. Impact of the COVID-19 Pandemic on Psychiatric Admissions to a Large Swiss Emergency Department: An Observational Study. Int J Environ Res Public Health 2021; 18Ambrosetti J, Macheret L, Folliet A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525740 80. Impact of the COVID-19 Pandemic on the Mental Health of Healthcare Workers. Int J Environ Res Public Health 2021; 18Chatzittofis A, Karanikola M, Michailidou K, Constantinidou A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546513 81. Change of Use in Community Services among Disabled Older Adults during COVID-19 in Japan. Int J Environ Res Public Health 2021; 18Ito T, Hirata-Mogi S, Watanabe T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525441 82. Adherence to COVID-19 Preventive Measures in Mozambique: Two Consecutive Online Surveys. Int J Environ Res Public Health 2021; 18Júnior A, Dula J, Mahumane S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530538 83. Effects of the COVID-19 Pandemic on the Budgetary Mechanism Established to Cover Public Health Expenditure. A Case Study of Romania. Int J Environ Res Public Health 2021; 18Onofrei M, Cigu E, Gavriluta Vatamanu AF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525330 84. Assessment of the Impact of a Daily Rehabilitation Program on Anxiety and Depression Symptoms and the Quality of Life of People with Mental Disorders during the COVID-19 Pandemic. Int J Environ Res Public Health 2021; 18Smolarczyk-Kosowska J, Szczegielniak A, Legutko M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546511 85. Mental Health and Psychological Impact on Students with or without Hearing Loss during the Recurrence of the COVID-19 Pandemic in China. Int J Environ Res Public Health 2021; 18Yang Y, Xiao Y, Liu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546488 86. Strategic assessment of mental health and suicide amid COVID-19 pandemic in Bangladesh. Int. J. Health Plann. Manage. 2021; Ahmed F, Sifat RI. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539580 87. Impact on physical and mental health among medical personnel in Wuhan during COVID-19 outbreak: a cluster analysis. Int. J. Med. Sci. 2021; 18:1185- 1188Gao J, Li J, Han X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526979 88. Exploring Factors Associated with Alcohol and/or Substance Use During the COVID-19 Pandemic. Int J Ment Health Addict 2021:1-10MacMillan T, Corrigan MJ, Coffey K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519318 89. Development and psychometric assessment of the public health emergency risk perception scale: Under the outbreak of COVID-19. Int J Nurs Sci 2021; 8:87-94Shen Z, Zhong Z, Xie J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520340 90. A pilot randomized controlled trial of a group intervention via Zoom to relieve loneliness and depressive symptoms among older persons during the COVID- 19 outbreak. Internet Interv 2021; 24:100368Shapira S, Yeshua-Katz D, Cohn- Schwartz E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527072 91. PSYCHOMETRIC PROPERTIES OF THE SPANISH VERSION OF THE FEAR OF COVID-19 SCALE IN PARAGUAYAN POPULATION. Ir. J. Psychol. Med. 2021:1- 17Barrios I, Ríos-González C, O'Higgins M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526156 92. Overview of Tertiary Addictions Services response to Opioid dependence during the COVID-19 Pandemic. Ir. J. Psychol. Med. 2021:1-14Hennigan K, Corrigan E, Killeen N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536093 93. Stress and associated factors among French university students under the COVID-19 lockdown: The results of the PIMS-CoV 19 study. J. Affect. Disord. 2021; 283:108-114Bourion-Bédès S, Tarquinio C, Batt M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540333 94. Relationship between physical and mental health comorbidities and COVID-19 positivity, hospitalization, and mortality. J. Affect. Disord. 2021; 283:94- 100Egede J, Campbell JA, Walker RJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530015 95. Risk and protective factors for college students' psychological health during the COVID-19 pandemic. J. Am. Coll. Health 2021:1-5Haliwa I, Spalding R, Smith K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522442 96. Responding to the pressing yet unrecognized needs of student-parents amid the COVID-19 pandemic. J. Am. Coll. Health 2021:1-5Lin HC, Zeanah PL, Olivier DF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544047 97. Responses to COVID-19: The role of governance, healthcare infrastructure, and learning from past pandemics. J Bus Res 2021; 122:597-607Sharma A, Borah SB, Moses AC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518844 98. Prospective impact of COVID-19 on mental health functioning in adolescents with and without ADHD: protective role of emotion regulation abilities. J. Child Psychol. Psychiatry 2021; Breaux R, Dvorsky MR, Marsh NP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543486 99. Anxiety, sleep disorders and self-efficacy among nurses during COVID-19 pandemic: A cross-sectional study. J. Clin. Nurs. 2021; Simonetti V, Durante A, Ambrosca R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534934 100. Psychological inflexibility and mental health symptoms during the COVID-19 lockdown in Spain: A longitudinal study. J Contextual Behav Sci 2021; 19:42- 49Hernández-López M, Cepeda-Benito A, Díaz-Pavón P, Rodríguez-Valverde M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520642 101. A case of psychogenic visual disturbance improved by staying at home after the declaration of a state of emergency in relation to the coronavirus disease. J Family Med Prim Care 2020; 9:5763-5765Makino S, Shioya M, Yoshida Y, Takahashi E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532428 102. Measuring the impact of COVID-19 on mental health as a preliminary procedure in primary care provision: A cross-sectional study using COVID-19 anxiety scale. J Family Med Prim Care 2020; 9:5554-5558Meesala N, Harsha G, Kandikatla P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532394 103. Public health response to COVID-19 in selected countries - Hits and misses. J Family Med Prim Care 2020; 9:5580-5587Rath RS, Lohiya A, Ahamed F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532398 104. Worry during the initial height of the COVID-19 crisis in an Italian sample. J. Gen. Psychol. 2021:1-33Sebri V, Cincidda C, Savioni L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522456 105. Delirium in older patients with COVID-19: prevalence, risk factors and clinical relevance. J Gerontol A Biol Sci Med Sci 2021; Mendes A, Herrmann FR, Périvier S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539505 106. A longitudinal study of the influence of concerns about contagion on negative affect during the COVID-19 lockdown in adults: The moderating effect of gender and resilience. J Health Psychol 2021:1359105321990794Megías-Robles A, Gutiérrez-Cobo MJ, Cabello R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541155 107. COVID-19 among Chinese high school graduates: Psychological distress, growth, meaning in life and resilience. J Health Psychol 2021:1359105321990819Yu Y, Yu Y, Hu J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541149 108. Living Through COVID-19: Social Distancing, Computer-Mediated Communication, and Well-Being in Sexual Minority and Heterosexual Adults. J. Homosex. 2021:1-19Baumel K, Hamlett M, Wheeler B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523776 109. Associations Between Physical Distancing and Mental Health, Sexual Health and Technology Use Among Gay, Bisexual and Other Men Who Have Sex With Men During the COVID-19 Pandemic. J. Homosex. 2021:1-17Holloway IW, Garner AB, Tan D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528316 110. The immediate psychological response of the general population in Saudi Arabia during COVID-19 pandemic: A cross-sectional study. J Infect Public Health 2021; 14:1-8Joseph R, Lucca JM, Alshayban D, Alshehry YA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548660 111. Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors. J Intern Med 2021; Méndez R, Balanzá-Martínez V, Luperdi SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533521 112. COVID-19 pandemic: demographic and clinical correlates of passive death wish and thoughts of self-harm among Canadians. J Ment Health 2021:1- 9Sapara A, Shalaby R, Osiogo F et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522340 113. Psychological Morbidity among People in Quarantine. J. Neurosci. Rural Pract. 2021; 12:67-70Kumar K, Mehra A, Jha S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531762 114. Prevalence of Depression and Anxiety during the COVID-19 Pandemic among the Residents of an Urban Slum in North India. J. Neurosci. Rural Pract. 2021; 12:153-158Rehman T, Singh T, Sharma S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531775 115. Impact of COVID-19 Pandemic on Neurosurgical Practice in a Tertiary Care Center in India. J. Neurosci. Rural Pract. 2021; 12:24-32Singh R, Sahu A, Singh K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531756 116. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J. Neurovirol. 2021:1- 6Simani L, Ramezani M, Darazam IA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528827 117. The impact of the coronavirus pandemic on specific symptom dimensions and severity in OCD: A comparison before and during COVID-19 in the context of stress responses. J Obsessive Compuls Relat Disord 2021; 29:100626Khosravani V, Aardema F, Samimi Ardestani SM, Sharifi Bastan F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520614 118. Challenges faced by mothers caring for children with leukaemia during COVID-19 pandemic: A qualitative study. J. Pediatr. Nurs. 2021; Atout M, Tarawneh FS, Al-Kharabsheh A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526289 119. Prosociality predicts health behaviors during the COVID-19 pandemic. J Public Econ 2021:104367Campos-Mercade P, Meier AN, Schneider FH, Wengström E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531719 120. Cyberbullying perpetration in the COVID-19 era: An application of general strain theory. J. Soc. Psychol. 2021:1-11Barlett CP, Rinker A, Roth B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543673 121. 'Online therapy' to reduce caregiver's distress and to stimulate post-severe acquired brain injury motor and cognitive recovery: A Sicilian hospital experience in the COVID era. J Telemed Telecare 2021:1357633x21990195De Luca R, Rifici C, Pollicino P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535914 122. Power of universal health coverage in the era of COVID-19: A nationwide observational study. Lancet Reg Health West Pac 2021; 7:100088Lee H, Lee JR, Jung H, Lee JY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521744 123. Interleukin 6 and depression in patients affected by Covid-19. Med Clin (Barc) 2020; Serrano García A, Montánchez Mateo J, Franch Pato CM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549331 124. [Update on COVID-19 and mental health]. Medicine (Madr) 2020; 13:1285- 1296Rodríguez-Quiroga A, Buiza C, Mon M, Quintero J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519028 125. Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress. Neurogastroenterol. Motil. 2021:e14092Oliviero G, Ruggiero L, D'Antonio E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550640 126. [Psychiatric consequences of Covid 19 pandemic in the pediatric population]. Neuropsychiatr. Enfance Adolesc. 2021; Gindt M, Fernandez A, Battista M, Askenazy F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518881 127. A qualitative exploration of the experiences of school nurses during COVID-19 pandemic as the frontline primary health care professionals. Nurs. Outlook 2020; Lee RLT, West S, Tang ACY et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541726 128. Brazilian Adaptation of the Coronavirus Anxiety Scale: A Psychometric Investigation of a Measure of Coronaphobia. Omega (Westport) 2021:30222821991325Padovan-Neto FE, Lee SA, Guimarães RP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530891 129. Social vulnerability and COVID-19: A call to action for paediatric clinicians. Paediatr. Child Health 2021; 26:1-3Prodanuk M, Wagner S, Orkin J, Noone D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537103 130. Measuring COVID-19-related Fear and Threat in Australian, Indian, and Nepali University Students. Pers. Individ. Dif. 2021:110693Collins FE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526955 131. Longitudinal study on affect, psychological well-being, depression, mental and physical health, prior to and during the COVID-19 pandemic in Spain. Pers. Individ. Dif. 2021; 172:110591Fernández-Abascal EG, Martín-Díaz MD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518870 132. Coping with COVID-19 - Longitudinal analysis of coping strategies and the role of trait mindfulness in mental well-being. Pers. Individ. Dif. 2021:110695Götmann A, Bechtoldt MN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33531724 133. The relationships between resilience of the adults affected by the covid pandemic in Turkey and Covid-19 fear, meaning in life, life satisfaction, intolerance of uncertainty and hope. Pers. Individ. Dif. 2021; 172:110592Karataş Z, Tagay Ö. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518871 134. COVID-19 Conspiracy Beliefs: Relations with Anxiety, Quality of Life, and Schemas. Pers. Individ. Dif. 2021:110704Leibovitz T, Shamblaw AL, Rumas R, Best MW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531727 135. Follow or not follow?: The relationship between psychological entitlement and compliance with preventive measures to the COVID-19. Pers. Individ. Dif. 2021; 174:110678Li H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518873 136. Meaning making helps cope with COVID-19: A longitudinal study. Pers. Individ. Dif. 2021; 174:110670Yang Z, Ji LJ, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518865 137. Mindfulness training on the resilience of adolescents under the COVID-19 epidemic: A latent growth curve analysis. Pers. Individ. Dif. 2021; 172:110560Yuan Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518868 138. Big Five Traits as Predictors of Perceived Stressfulness of the COVID-19 Pandemic. Pers. Individ. Dif. 2021; 175:110694Zacher H, Rudolph CW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531723 139. Secondary traumatic stress in nurses working with patients with suspected/confirmed COVID-19 in Turkey. Perspect. Psychiatr. Care 2021; Erkin Ö, Konakçı G, Duran S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522626 140. COVID-19 suicide and its causative factors among the healthcare professionals: Case study evidence from press reports. Perspect. Psychiatr. Care 2021; Jahan I, Ullah I, Griffiths MD, Mamun MA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547666 141. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Where Will the Drugs Come From? Pharmacol. Res. 2021:105465Toogood PL, Clau DJ, Phadke S, Hoffman D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529750 142. Transformation and operation of a uniform psychiatric ward dedicated to COVID-19 patients during the pandemic. Psychiatr. Pol. 2020; 54:865-875Pilecki M, Dimter A, Siwek M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529274 143. Characteristics of Behavioral Urgent Care Centers: A National Study During the COVID-19 Pandemic. Psychiatr. Serv. 2021; 72:235Du K, Hsiang W, Schmutte T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517688 144. Mental Health and Psychosocial Characteristics Associated With COVID-19 Among U.S. Adults. Psychiatr. Serv. 2021:appips202000540Tsai J, Huang M, Elbogen E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530731 145. Trajectories of depression, anxiety and pandemic experiences; A longitudinal study of youth in New York during the Spring-Summer of 2020. Psychiatry Res 2021; 298:113778Hawes MT, Szenczy AK, Olino TM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550176 146. Prospective prediction of PTSD and depressive symptoms during social unrest and COVID-19 using a brief online tool. Psychiatry Res 2021; 298:113773Wong SM, Hui CL, Wong CS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545423 147. Lessons to be learnt from the COVID-19 public health response in Mauritius. Public Health Pract (Oxf) 2020; 1:100023Chan Sun M, Lan Cheong Wah CB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521737 148. Call them COVIDiots: Exploring the effects of aggressive communication style and psychological distance in the communication of COVID-19. Public Underst Sci 2021:963662521989191Chu H, Yuan S, Liu S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517854 149. Dental personnel in Israel, Canada, and France during the COVID-19 pandemic: attitudes, worries, emotional responses, and posttraumatic growth. Quintessence Int. 2021; 0:0Uziel N, Gilon E, Meyerson J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533236 150. Attitude, anxiety and perceived mental health care needs among parents of children with Autism Spectrum Disorder (ASD) in Saudi Arabia during COVID- 19 pandemic. Res. Dev. Disabil. 2021; 111:103873Althiabi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540358 151. Mental health interventions for healthcare workers during the COVID-19 pandemic in Spain. Rev Psiquiatr Salud Ment 2021; Priede A, López-Álvarez I, Carracedo-Sanchidrián D, González-Blanch C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549828 152. On Ambiguity Reduction and the Role of Decision Analysis during the Pandemic. Risk Anal. 2021; Rode DC, Fischbeck PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534949 153. Magnitude and Associated Factors for Attitude and Practice Toward COVID-19 and Its Prevention Among the Residents of Gedeo Zone, Southern Ethiopia: A Community-Based Cross-Sectional Study. Risk Manag. Healthc. Policy 2021; 14:253-262Mola S, Aweke Z, Jemal B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519250 154. Does High Public Trust Amplify Compliance with Stringent COVID-19 Government Health Guidelines? A Multi-country Analysis Using Data from 102,627 Individuals. Risk Manag. Healthc. Policy 2021; 14:293-302Pak A, McBryde E, Adegboye OA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542664 155. Analysis of the Public Health Functions of the Chinese Government in the Prevention and Control of COVID-19. Risk Manag. Healthc. Policy 2021; 14:237- 246Zhang P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519248 156. Effects of Fear of COVID-19 on Mental Well-Being and Quality of Life among Saudi Adults: A Path Analysis. Saudi J Med Med Sci 2021; 9:24-30Alyami M, de Albuquerque JV, Krägeloh CU et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519340 157. Sleep and mental health in athletes during COVID-19 lockdown. Sleep 2021; Facer-Childs ER, Hoffman D, Tran JN et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535229 158. Orchestration of dreams: a possible tool for enhancement of mental productivity and efficiency. Sleep Biol. Rhythms 2021:1-7Krishnan D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526967 159. Relationships between the changes in sleep patterns and sleep quality among Chinese people during the 2019 coronavirus disease outbreak. Sleep Med. 2021; Lin Y, Liu S, Li S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541805 160. Financial hardship and health risk behavior during COVID-19 in a large US national sample of women. SSM Popul Health 2021; 13:100734Sampson L, Ettman CK, Abdalla SM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521228 161. Factors associated with psychological distress among patients with breast cancer during the COVID-19 pandemic: a cross-sectional study in Wuhan, China. Support. Care Cancer 2021:1-10Chen X, Wang L, Liu L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527226 162. Substance use and substance use disorder, in relation to COVID-19: protocol for a scoping review. Syst Rev 2021; 10:48Kumar N, Janmohamed K, Nyhan K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536070 163. Evaluating the accessibility of public health websites: An exploratory cross- country study. Univers Access Inf Soc 2021:1-19Alajarmeh N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526996 164. Facing the Threat of COVID-19 in Pakistan: A Nation's Dilemma. Value Health Reg Issues 2021; 24:90-95Habib M, Abbas M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524901 165. Psychological Impact of the COVID-19 Pandemic in Patients with Allergic Diseases. World Allergy Organ J 2021:100510Gonzalez-Diaz SN, Martin B, Villarreal-Gonzalez RV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520081 166. Analysis of the influence of the psychology changes of fear induced by the COVID-19 epidemic on the body: COVID-19. World J Acupunct Moxibustion 2020; 30:85-89Liu QW, Zhao GZ, Ji B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519137

Meta-analyses - systematic reviews (21 articles)

1. Intubation rate of patients with hypoxia due to COVID-19 treated with awake proning: A meta-analysis. Am J Emerg Med 2021; 43:88-96Cardona S, Downing J, Alfalasi R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550104 2. Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies. Anaesthesia 2021; Armstrong RA, Kane AD, Kursumovic E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525063 3. Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis. Ann Palliat Med 2021; Xiang G, Xie L, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549005 4. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta- analysis. Ann Palliat Med 2021; Xie J, Wang Q, Xu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548996 5. Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis. Cancer Med 2021; Li P, Li L, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547886 6. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis. Cerebrovasc. Dis. 2021:1-9Honardoost M, Janani L, Aghili R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530081 7. Clinical outcome of renin-angiotensin-aldosterone system blockers in treatment of hypertensive patients with COVID-19: a systematic review and meta-analysis. Egypt Heart J 2021; 73:13Laurentius A, Mendel B, Prakoso R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544293 8. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur. J. Clin. Pharmacol. 2021:1- 6Kow CS, Hasan SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532896 9. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. Eur. J. Pharmacol. 2021:173926Rezagholizadeh A, Khiali S, Sarbakhsh P, Entezari-Maleki T. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549577 10. COVID-19-Related Fatalities and Intensive-Care-Unit Admissions by Age Groups in Europe: A Meta-Analysis. Front Med (Lausanne) 2020; 7:560685Cohen JF, Korevaar DA, Matczak S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521004 11. Incubation period of COVID-19: a meta-analysis. Int J Infect Dis 2021; Elias C, Sekri A, Leblanc P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548553 12. Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis. J. Clin. Apher. 2021; Vegivinti CTR, Pederson JM, Saravu K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544910 13. "Diagnostic Features Of Sars-Covid-2 Positive Patients: A Rapid Review And Meta-Analysis". J. Clin. Nurs. 2021; Anderson G, Casasanta D, Cocchieri A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527510 14. Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis. J Ophthalmic Vis Res 2021; 16:103-112Nasiri N, Sharifi H, Bazrafshan A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520133 15. The Incidence, Prognosis and Laboratory Indicators of Venous Thromboembolism in Hospitalized Patients with COVID-19: A Systematic Review and Meta-analysis. J Vasc Surg Venous Lymphat Disord 2021; Liu Y, Cai J, Wang C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529719 16. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2020; Du Y, Zhou N, Zha W, Lv Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549450 17. A meta-meta-analysis: Evaluation of meta-analyses published in the effectiveness of cardiovascular comorbidities on the severity of COVID-19. Obes Med 2021; 22:100323Naeini MB, Sahebi M, Nikbakht F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521379 18. Predictors of emotional distress during the COVID-19 pandemic; a Croatian study. Pers. Individ. Dif. 2021; 175:110691Margetić B, Peraica T, Stojanović K, Ivanec D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518867 19. Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection. Probiotics Antimicrob Proteins 2021:1-19Patra S, Saxena S, Sahu N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537958 20. Clinical Manifestations and Outcomes of Coronavirus Disease-19 in Heart Transplant Recipients: A Multicenter Case Series with a Systematic Review and Meta-Analysis. Transpl Int 2021; Granger C, Guedeney P, Arnaud C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539616 21. Thirty-day mortality of patients with hip fracture during COVID-19 pandemic and pre-pandemic periods: A systematic review and meta-analysis. World J Orthop 2021; 12:35-50Tripathy SK, Varghese P, Panigrahi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520680

Mortality (39 articles)

1. Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study. Age Ageing 2021. http://www.ncbi.nlm.nih.gov/pubmed/? term=33543243 2. COVID-19 deaths by occupation, Massachusetts, March 1-July 31, 2020. Am. J. Ind. Med. 2021; Hawkins D, Davis L, Kriebel D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522627 3. Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies. Anaesthesia 2021; Armstrong RA, Kane AD, Kursumovic E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525063 4. Clinical characteristics and risk factors for mortality in patients with coronavirus disease 2019 in intensive care unit: a single- center, retrospective, observational study in China. Ann Palliat Med 2021; Sai F, Liu X, Li L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548994 5. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID- 19: a retrospective cohort study in a university hospital. BMC Infect. Dis. 2021; 21:148Acar HC, Can G, Karaali R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546639 6. Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19. Clin Imaging 2021; 75:119-124Satici C, Cengel F, Gurkan O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545439 7. BCG Vaccination Program mitigates COVID19 Related Mortality: A Reality check. Curr. Pharm. Biotechnol. 2021; Pandita A, Bhat A, Koul A, Singh SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530904 8. Died with or Died of? Development and Testing of a SARS CoV-2 Significance Score to Assess the Role of COVID-19 in the Deaths of Affected Patients. Diagnostics (Basel) 2021; 11Giorgetti A, Orazietti V, Busardò FP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525705 9. Meteorological factors, COVID-19 cases, and deaths in top 10 most affected countries: an econometric investigation. Environ. Sci. Pollut. Res. Int. 2021; Sharma GD, Bansal S, Yadav A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547610 10. Hip fracture care and mortality among patients treated in dedicated COVID-19 and non-COVID-19 circuits. Eur. Geriatr. Med. 2021; Ojeda-Thies C, Cuarental- García J, García-Gómez E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550563 11. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur. J. Clin. Pharmacol. 2021:1- 6Kow CS, Hasan SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532896 12. Age, neutrophil lymphocyte ratio, and radiographic assessment of the quantity of lung edema (RALE) score to predict in-hospital mortality in COVID- 19 patients: a retrospective study. F1000Res 2020; 9:1286Sensusiati AD, Amin M, Nasronudin N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537125 13. COVID-19-Related Fatalities and Intensive-Care-Unit Admissions by Age Groups in Europe: A Meta-Analysis. Front Med (Lausanne) 2020; 7:560685Cohen JF, Korevaar DA, Matczak S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521004 14. Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic. Healthcare (Basel) 2021; 9Alamer AA, Almulhim AS, Alrashed AA, Abraham I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525596 15. Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle- aged adult population. Infect Dis Now 2021; Lapidus N, Paireau J, Levy-Bruhl D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521775 16. COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020. Infect Dis Poverty 2021; 10:11Undurraga EA, Chowell G, Mizumoto K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531085 17. Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China. Innovation (N Y) 2020; 1:100022Wu R, Ai S, Cai J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521759 18. Risk factors for mortality of critically ill patients with COVID-19 receiving invasive ventilation. Int. J. Med. Sci. 2021; 18:1198-1206Tu Y, Yang P, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526981 19. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Intern Emerg Med 2021; Bahl A, Johnson S, Chen NW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547620 20. A pilot randomized controlled trial of a group intervention via Zoom to relieve loneliness and depressive symptoms among older persons during the COVID- 19 outbreak. Internet Interv 2021; 24:100368Shapira S, Yeshua-Katz D, Cohn- Schwartz E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527072 21. Initial experiences regarding COVID19 mortality in Punjab-A mixed method analysis. J Family Med Prim Care 2020; 9:5689-5694Chaudhary A, Bansal P, Gupta VK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532415 22. Development and Validation of Clinical Prediction Models to Estimate the Probability of death in Hospitalized Patients with COVID-19: Insights from a Nationwide Database. J Med Virol 2021; Tanboğa IH, Canpolat U, Çetin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527474 23. Development and validation of clinical prediction model to estimate the probability of death in hospitalized patients with COVID-19: Insights from a nationwide database. J Med Virol 2021; Tanboğa IH, Canpolat U, Çetin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527474 24. Palliative Care in Toronto during the COVID-19 pandemic. J Pain Symptom Manage 2021; Wentlandt K, Cook R, Morgan M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549737 25. Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection. J Racial Ethn Health Disparities 2021:1- 11Muhammad R, Ogunti R, Ahmed B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33538998 26. Mortality is Not Increased in SARS-CoV-2 Infected Persons With Hepatitis C Virus Infection. Liver Int 2021; Butt AA, Yan P, Chotani RA, Shaikh OS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534931 27. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Med (N Y) 2021; Liu H, Chen J, Yang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521746 28. Mortality of COVID-19 patients with vascular thrombotic complications. Med Clin (Engl Ed) 2021; 156:112-117Gonzalez-Fajardo JA, Ansuategui M, Romero C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521296 29. Statistical data analysis of risk factor associated with mortality rate by COVID- 19 pandemic in India. Model Earth Syst Environ 2021:1-11Halder B, Bandyopadhyay J, Banik P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527084 30. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2020; Du Y, Zhou N, Zha W, Lv Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549450 31. Population perspective comparing COVID-19 to all and common causes of death during the first wave of the pandemic in seven European countries. Public Health Pract (Oxf) 2021; 2:100077Olabi B, Bagaria J, Bhopal SS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521739 32. A fatal outcome from SARS-CoV-2 infection: One case report of a young man with multiple organ damage. Radiol Infect Dis 2020; 7:208-212Zeng Y, Zhou X, Gang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521222 33. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost 2021; 5:132-141von Meijenfeldt FA, Havervall S, Adelmeijer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537537 34. Predicting mortality risk in patients with COVID-19 using machine learning to help medical decision-making. Smart Health (Amst) 2021; 20:100178Pourhomayoun M, Shakibi M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521226 35. Spatial statistical analysis of pre-existing mortalities of 20 diseases with COVID-19 mortalities in the continental United States. Sustain Cities Soc 2021; 67:102738Mollalo A, Rivera KM, Vahabi N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532175 36. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res 2020; 199:143-148. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535120 37. Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality. Viruses 2021; 13Dumonteil E, Fusco D, Drouin A, Herrera C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540576 38. BIN1 rs744373 SNP and COVID-19 mortality. World Acad Sci J 2021; 3Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521641 39. Thirty-day mortality of patients with hip fracture during COVID-19 pandemic and pre-pandemic periods: A systematic review and meta-analysis. World J Orthop 2021; 12:35-50Tripathy SK, Varghese P, Panigrahi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520680

Online – IT – Apps (92 articles)

1. Medical students' perception of the reliability, usefulness and feasibility of unproctored online formative assessment tests. Adv. Physiol. Educ. 2021; 45:84-88Snekalatha S, Marzuk SM, Meshram SA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529145 2. Continuation of telemedicine in otolaryngology post-COVID-19: Applications by subspecialty. Am. J. Otolaryngol. 2021; 42:102928Samarrai R, Riccardi AC, Tessema B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545447 3. Remote E-exams during Covid-19 pandemic: A cross-sectional study of students' preferences and academic dishonesty in faculties of medical sciences. Ann Med Surg (Lond) 2021; 62:326-333Elsalem L, Al-Azzam N, Jum'ah AA, Obeidat N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520225 4. Comparison between camcorder, frontal head and temporal mounted action- cam in digestive surgery: Documentation and educational alternative during COVID-19 pandemic. Ann Med Surg (Lond) 2021; 62:347-352Yuda Handaya A, Fauzi AR, Andrew J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520226 5. Social media effectiveness as a humanitarian response to mitigate influenza epidemic and COVID-19 pandemic. Ann Oper Res 2021:1-29Kumar S, Xu C, Ghildayal N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531729 6. Topic detection and sentiment analysis in Twitter content related to COVID-19 from Brazil and the USA. Appl Soft Comput 2021; 101:107057Garcia K, Berton L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519326 7. Real-time measurement of the uncertain epidemiological appearances of COVID-19 infections. Appl Soft Comput 2021; 101:107039Gupta M, Jain R, Taneja S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519324 8. Automated medical diagnosis of COVID-19 through EfficientNet convolutional neural network. Appl Soft Comput 2020; 96:106691Marques G, Agarwal D, de la Torre Díez I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519327 9. COVID-19 X-ray images classification based on enhanced fractional-order cuckoo search optimizer using heavy-tailed distributions. Appl Soft Comput 2021; 101:107052Yousri D, Abd Elaziz M, Abualigah L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519325 10. Managing patients using telerheumatology: Lessons from a pandemic. Best Pract. Res. Clin. Rheumatol. 2021:101662Bateman J, Cleaton N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526324 11. Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease. BMC Med. Inform. Decis. Mak. 2021; 21:34Schiffer L, Gertges R, Nöhre M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522934 12. Knowledge, attitude and practice of the Sudanese people towards COVID-19: an online survey. BMC Public Health 2021; 21:274Mohamed AAO, Elhassan EAM, Mohamed AO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535995 13. Media representations of COVID-19 public health policies: assessing the portrayal of essential health services in Canadian print media. BMC Public Health 2021; 21:273Ogbogu U, Hardcastle L. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535996 14. Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic. BMJ Sex Reprod Health 2021; Reynolds-Wright JJ, Johnstone A, McCabe K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542062 15. The current situation of COVID-19 in India. Brain Behav Immun Health 2021; 11:100200Jabaris SS, V A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521689 16. Patient perspective: Wearable and digital health tools to support managing our health during the COVID-19 pandemic and beyond. Cardiovasc Digit Health J 2021; Dohse H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521766 17. Comparison of deep learning approaches to predict COVID-19 infection. Chaos Solitons Fractals 2020; 140:110120Alakus TB, Turkoglu I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519109 18. A fractional-order SIRD model with time-dependent memory indexes for encompassing the multi-fractional characteristics of the COVID-19. Chaos Solitons Fractals 2021; 143:110632Jahanshahi H, Munoz-Pacheco JM, Bekiros S, Alotaibi ND. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519121 19. Automatic Screening of COVID-19 Using an Optimized Generative Adversarial Network. Cognit. Comput. 2021:1-16Goel T, Murugan R, Mirjalili S, Chakrabartty DK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520007 20. Privacy Concerns Can Explain Unwillingness to Download and Use Contact Tracing Apps When COVID-19 Concerns are High. Comput. Human Behav. 2021; 119:106718Chan EY, Saqib NU. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526957 21. Data on media use and mental health during the outbreak of COVID-19 in China. Data Brief 2021; 35:106765Xue D, Liu T, Chen X et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537381 22. Implementation of a digital semester for ophthalmology during the COVID-19 pandemic. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2021; Müller A, Wagner FM, Matlach J et al. 23. Digital teaching with, during and after COVID-19. Der Radiologe 2021; 61:64- 66Molwitz I, Othman A, Brendlin A et al. 24. The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia. Diabetes Res Clin Pract 2021:108682Alharthi SK, Alyusuf EY, Alguwaihes AM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539868 25. Use and perception of telemedicine in people with type 1 diabetes during the COVID-19 pandemic-Results of a global survey. Endocrinol Diabetes Metab 2021; 4:e00180Scott SN, Fontana FY, Züger T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532617 26. Ambulatory care for epilepsy via telemedicine during the COVID-19 pandemic. Epilepsy Behav. 2021; 116:107740Datta P, Barrett W, Bentzinger M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545652 27. Community Informatics for Sustainable Management of Pandemics in Developing Countries: A Case Study of COVID-19 in Nigeria. Ethics Med Public Health 2021:100632Eze PU, Ezenkwu CP, Etteh CC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532534 28. Patient and otolaryngologist perceptions of telemedicine during COVID-19 pandemic. Eur Arch Otorhinolaryngol 2021:1-5Lechien JR, Radulesco T, Distinguin L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523283 29. 30 Years of Translational Mobility Medicine: 2020 Padua Muscle Days go virtual from Euganean Hills, November 19th to 21st. Eur. J. Transl. Myol. 2020; 30:9437Carraro U. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520146 30. Proposed Design of a Real-Time COVID-19 Pandemic Contact Tracing Using Mobile Phone. Eur Sci J 2020; 16:1-7Nwawudu E, Ikwu A, Ikwu U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519994 31. Continuity of Care During COVID-19 Lockdown: A Survey on Stakeholders' Experience With Telerehabilitation. Front. Neurol. 2020; 11:617276Assenza C, Catania H, Antenore C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519697 32. Cognitive Telerehabilitation for Older Adults With Neurodegenerative Diseases in the COVID-19 Era: A Perspective Study. Front. Neurol. 2020; 11:623933Bernini S, Stasolla F, Panzarasa S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519704 33. COVID-19 Pandemic as the Beginning of a Golden Era for Telepsychiatry in Poland's Healthcare System. Front Psychiatry 2020; 11:555559Zadka Ł, Olajossy M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519538 34. The Influence of Coronavirus Diseases 2019 (COVID-19) Pandemic and the Quarantine Practices on University Students' Beliefs About the Online Learning Experience in Jordan. Front Public Health 2020; 8:595874Almomani EY, Qablan AM, Atrooz FY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520916 35. Telemedicine for Tobacco Cessation and Prevention to Combat COVID-19 Morbidity and Mortality in Rural Areas. Front Public Health 2020; 8:598905Merianos AL, Fevrier B, Mahabee-Gittens EM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537274 36. Harnessing machine learning for development of microbiome therapeutics. Gut Microbes 2021; 13:1-20McCoubrey LE, Elbadawi M, Orlu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522391 37. A quality improvement pathway to rapidly increase telemedicine services in a gynecologic oncology clinic during the COVID-19 pandemic with patient satisfaction scores and environmental impact. Gynecol Oncol Rep 2021; 36:100708Mojdehbakhsh RP, Rose S, Peterson M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521218 38. Purview of 3D printing in medical applications during COVID-19. Health Policy Technol 2020; Kumar S, Khanna V, Singh BP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520637 39. Smartphone overuse: A hidden crisis in COVID-19. Health Policy Technol 2021; Ratan ZA, Zaman SB, Islam SMS, Hosseinzadeh H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520635 40. Web Search Engine Misinformation Notifier Extension (SEMiNExt): A Machine Learning Based Approach during COVID-19 Pandemic. Healthcare (Basel) 2021; 9Shams AB, Hoque Apu E, Rahman A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546110 41. [Electronic learning for otorhinolaryngology students using the content management system ILIAS]. HNO 2021:1-8van Bonn SM, Grajek JS, Großmann W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537879 42. Healthcare Delivery through Telemedicine during the COVID-19 Pandemic: Case Study from a Tertiary Care Center in South India. Hosp. Top. 2021:1- 10D'Souza B, Suresh Rao S, Hisham S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528313 43. Turn to the Internet First? Using Online Medical Behavioral Data to Forecast COVID-19 Epidemic Trend. Inf. Process. Manag. 2021; 58:102486Huang W, Cao B, Yang G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519039 44. Teleconsultation and Teletreatment Protocol to Diagnose and Manage Patients with Benign Paroxysmal Positional Vertigo (BPPV) during the COVID-19 Pandemic. Int Arch Otorhinolaryngol 2021; 25:e141-e149Barreto RG, Yacovino DA, Teixeira LJ, Freitas MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542764 45. Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT- logs study. Int J Cardiol 2021; Maille B, Wilkin M, Millon M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524462 46. Remote Monitoring for Heart Failure Management during COVID-19. Int J Cardiol Heart Vasc 2021; 32:100724Bertagnin E, Greco A, Bottaro G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532544 47. Remote monitoring for heart failure management during COVID-19 pandemic. Int J Cardiol Heart Vasc 2021; 32:100724Bertagnin E, Greco A, Bottaro G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532544 48. Young Adults View Smartphone Tracking Technologies for COVID-19 as Acceptable: The Case of Taiwan. Int J Environ Res Public Health 2021; 18Garrett PM, Wang Y, White JP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540628 49. The role of blockchain technology in telehealth and telemedicine. Int. J. Med. Inform. 2021; 148:104399Ahmad RW, Salah K, Jayaraman R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540131 50. 'Weighty woes': Impact of fat talk and social influences on body dissatisfaction among Indian women during the pandemic. Int J Soc Psychiatry 2021:20764021992814Ahuja KK, Khandelwal A, Banerjee D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541182 51. Telepractice as a Reaction to the COVID-19 Crisis: Insights from Croatian SLP Settings. Int J Telerehabil 2020; 12:93-104Kraljević JK, Matić A, Dokoza KP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520098 52. A pilot randomized controlled trial of a group intervention via Zoom to relieve loneliness and depressive symptoms among older persons during the COVID- 19 outbreak. Internet Interv 2021; 24:100368Shapira S, Yeshua-Katz D, Cohn- Schwartz E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527072 53. Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations during the COVID-19 Pandemic. J Allergy Clin Immunol Pract 2021; Mustafa SS, Vadamalai K, Ramsey A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33548516 54. Communicating Effectively via Tele-oncology (Comskil TeleOnc): a Guide for Best Practices for Communication Skills in Virtual Cancer Care. J. Cancer Educ. 2021:1-6Banerjee SC, Staley JM, Howell F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544315 55. Remote monitoring temporal trends during COVID-19 pneumonia in patients with implanted defibrillators. J Cardiol Cases 2021; Mascioli G, Lucca E, Annunziata L, Giacopelli D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520021 56. A low-cost solution for converting existing stethoscope into tele-stethoscope in resource-constrained setting for COVID-19 pandemic. J Family Med Prim Care 2020; 9:5435-5436Kalra S, Mutreja P, Goyal A, Dixit A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532374 57. A Virtual Ward Model of Care for Patients With COVID-19: Retrospective Single-Center Clinical Study. J Med Internet Res 2021; 23:e25518Ferry OR, Moloney EC, Spratt OT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529157 58. Considerations When Using Telemedicine As the Advanced Practice Registered Nurse. J. Nurse Pract. 2021; Frey MB, Chiu SH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519314 59. Anticipated health effects and proposed countermeasures following the immediate introduction of telework in response to the spread of COVID-19: The findings of a rapid health impact assessment in Japan. J Occup Health 2021; 63:e12198Nagata T, Ito D, Nagata M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527667 60. Rapid Transition to Virtual Care during the COVID-19 Epidemic: Experience of a Supportive Care Clinic at a Tertiary Care Cancer Center. J. Palliat. Med. 2021; Reddy A, Arthur J, Dalal S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535019 61. The Future of Telehealth in School-Based Health Centers: Lessons from COVID-19. J. Pediatr. Health Care 2021; Goddard A, Sullivan E, Fields P, Mackey S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518441 62. The emergence of virtual education during the COVID-19 pandemic: The past, present, and future of the plastic surgery education. J. Plast. Reconstr. Aesthet. Surg. 2021; Cho MJ, Hong JP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33541826 63. The impact of telemedicine on patients with uncontrolled type 2 diabetes mellitus during the COVID-19 pandemic in Saudi Arabia: Findings and implications. J Telemed Telecare 2021:1357633x20985763A MT, T JA, Rsheed AMB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525952 64. 'Online therapy' to reduce caregiver's distress and to stimulate post-severe acquired brain injury motor and cognitive recovery: A Sicilian hospital experience in the COVID era. J Telemed Telecare 2021:1357633x21990195De Luca R, Rifici C, Pollicino P et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535914 65. Using telemedicine to facilitate social distancing in otolaryngology: A systematic review. J Telemed Telecare 2021:1357633x20985391Moentmann MR, Miller RJ, Chung MT, Yoo GH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535916 66. Comparing telehealth to traditional office visits for patient management in the COVID-19 pandemic: A cross-sectional study in a respiratory assessment clinic. J Telemed Telecare 2021:1357633x21990197Phillips JC, Lord RW, Davis SW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525950 67. The COVID-19 pandemic and follow-up for shoulder surgery: The impact of a shift toward telemedicine on validated patient-reported outcomes. J Telemed Telecare 2021:1357633x21990997Sabbagh R, Shah N, Jenkins S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525951 68. Robotics in Simulated COVID-19 Patient Room for Health Care Worker Effector Tasks: Preliminary, Feasibility Experiments(a). Mayo Clin Proc Innov Qual Outcomes 2020; Freeman WD, Sanghavi DK, Sarab MS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521585 69. Managing patients in the COVID-19 pandemic: A Virtual Multidisciplinary Approach. Mayo Clin Proc Innov Qual Outcomes 2020; Ganesh R, Salonen BR, Bhuiyan MN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521583 70. Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019. Mayo Clin Proc Innov Qual Outcomes 2020; Jose T, Warner DO, O'Horo JC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521582 71. Remote Medical Education: Adapting Kern's Curriculum Design to Tele- teaching. Med Sci Educ 2021:1-8Said JT, Schwartz AW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520396 72. Thermal Sensors for Contactless Temperature Measurements, Occupancy Detection, and Automatic Operation of Appliances during the COVID-19 Pandemic: A Review. Micromachines (Basel) 2021; 12Moisello E, Malcovati P, Bonizzoni E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546478 73. Machine learning techniques to detect and forecast the daily total COVID-19 infected and deaths cases under different lockdown types. Microsc. Res. Tech. 2021; Saba T, Abunadi I, Shahzad MN, Khan AR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522669 74. PSO-Blockchain-based image steganography: towards a new method to secure updating and sharing COVID-19 data in decentralised hospitals intelligence architecture. Multimed Tools Appl 2021:1-25Mohsin AH, Zaidan AA, Zaidan BB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519293 75. Telerehabilitation: from the virtual world to reality—Medicine in the twenty-first century: Video-assisted treatment in times of COVID-19. Nervenarzt 2021; Meyding-Lamadé U, Bassa B, Tibitanzl P et al. 76. Harnessing SmartPhones to Personalize Nutrition in a Time of Global Pandemic. Nutrients 2021; 13Zmora N, Elinav E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525593 77. CoVerifi: A COVID-19 news verification system. Online Soc Netw Media 2021; 22:100123Kolluri NL, Murthy D. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521412 78. How Threat Perceptions Relate to Learning and Conspiracy Beliefs About COVID-19: Evidence From a Panel Study. Pers. Individ. Dif. 2021:110672Heiss R, Gell S, Röthlingshofer E, Zoller C. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518866 79. Public attention about COVID-19 on social media: An investigation based on data mining and text analysis. Pers. Individ. Dif. 2021; 175:110701Hou K, Hou T, Cai L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536695 80. COVID-19 Conspiracy Beliefs: Relations with Anxiety, Quality of Life, and Schemas. Pers. Individ. Dif. 2021:110704Leibovitz T, Shamblaw AL, Rumas R, Best MW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531727 81. MaskedFace-Net - A dataset of correctly/incorrectly masked face images in the context of COVID-19. Smart Health (Amst) 2021; 19:100144Cabani A, Hammoudi K, Benhabiles H, Melkemi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521223 82. Smart homes that detect sneeze, cough, and face touching. Smart Health (Amst) 2021; 19:100170Miller E, Banerjee N, Zhu T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521224 83. COVID-19 cases prediction by using hybrid machine learning and beetle antennae search approach. Sustain Cities Soc 2021; 66:102669Zivkovic M, Bacanin N, Venkatachalam K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520607 84. Using input-output analysis to model the impact of pandemic mitigation and suppression measures on the workforce. Sustain Prod Consum 2020; 23:249- 255Santos J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521216 85. Technology-based health solutions for cancer caregivers to better shoulder the impact of COVID-19: a systematic review protocol. Syst Rev 2021; 10:43Su Z, McDonnell D, Liang B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526095 86. Threat or opportunity? A case study of digital-enabled redesign of entrepreneurship education in the COVID-19 emergency. Technol Forecast Soc Change 2021; 166:120565Secundo G, Mele G, Vecchio PD et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518821 87. The changes in the effects of social media use of Cypriots due to COVID-19 pandemic. Technol Soc 2020; 63:101380Kaya T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518848 88. Attitudes and Perceptions Toward Virtual Health in Eye Care During Coronavirus Disease 2019. Telemed J E Health 2021; Capitena Young CE, Patnaik JL, Seibold LK, Kahook MY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524299 89. A Novel Large Scale Integrated Telemonitoring Program for COVID-19. Telemed J E Health 2021; Shaw JG, Sankineni S, Olaleye CA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544043 90. Factors influencing home-based telework in Hanoi (Vietnam) during and after the COVID-19 era. Transportation (Amst) 2021:1-32Nguyen MH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518829 91. Evaluating the accessibility of public health websites: An exploratory cross- country study. Univers Access Inf Soc 2021:1-19Alajarmeh N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526996 92. Continuity of cancer care in the era of COVID-19 pandemic: Role of social media in low- and middle-income countries. World J Clin Cases 2021; 9:291- 295Yadav SK, Yadav N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521097

Other – Miscellaneous (75 articles)

1. ECONOMIC CRISES AS A MOTIVE FOR CHANGE IN HEALTH CARE SYSTEMS - A HISTORICAL PERSPECTIVE WITH REFERENCE TO THE COVID-19 PANDEMIC. Acta Med. Hist. Adriat. 2021; 18:355-374Kaštelan S, Kasun B, Kaštelan U et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535767 2. Air quality and the COVID-19 outbreak in China. Allergol. Immunopathol. (Madr.) 2021; 49:165-167Gan WT, Zhou MY, Cheng YR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528946 3. Promoting Ethical Payment in Human Infection Challenge Studies. Am. J. Bioeth. 2021:1-45Lynch HF, Darton TC, Levy J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541252 4. Racial and ethnic equality is also about healthcare. Am. J. Health Syst. Pharm. 2021; Scott BE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543249 5. "I Couldn't Have Asked for a Better Quarantine Partner!": Experiences with Companion Dogs during Covid-19. Animals (Basel) 2021; 11Bussolari C, Currin- McCulloch J, Packman W et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33525673 6. A retrospective analysis of the impact of the COVID-19 restrictions on energy consumption at a disaggregated level. Appl Energy 2021; 287:116547García S, Parejo A, Personal E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536699 7. Impacts of COVID-19 on energy demand and consumption: Challenges, lessons and emerging opportunities. Appl Energy 2021; 285:116441Jiang P, Fan YV, Klemeš JJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519038 8. Impacts of COVID-19 pandemic on user behaviors and environmental benefits of bike sharing: A big-data analysis. Appl Energy 2021; 285:116429Shang WL, Chen J, Bi H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519037 9. Waste respirator processing system for public health protection and climate change mitigation under COVID-19 pandemic: Novel process design and energy, environmental, and techno-economic perspectives. Appl Energy 2021; 283:116129Zhao X, You F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519036 10. A consensus model to manage the non-cooperative behaviors of individuals in uncertain group decision making problems during the COVID-19 outbreak. Appl Soft Comput 2021; 99:106879Li X, Liao H, Wen Z. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519328 11. Stopping exploitation: Properly remunerating healthcare workers for risk in the COVID-19 pandemic. Bioethics 2021; Giubilini A, Savulescu J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550626 12. Will the COVID-19 outbreak be a turning point for China's wildlife protection: New developments and challenges of wildlife conservation in China. Biol. Conserv. 2021; 254:108937Huang Q, Wang F, Yang H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518771 13. The effect of occupant distribution on energy consumption and COVID-19 infection in buildings: A case study of university building. Build. Environ. 2021; 190:107561Mokhtari R, Jahangir MH. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519043 14. The Indirect Costs of the SARS-CoV-2 Pandemic: A Case of Severe Malaria in Brooklyn. Cureus 2020; 12:e12331Fleischman E, Hutchinson AH, Paracha NZ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520529 15. COVID-19's impact on China's economy: a prediction model based on railway transportation statistics. Disasters 2021; Wang Y, Fang Z, Gao W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538045 16. Environmental impacts of pre/during and post-lockdown periods on prominent air pollutants in France. Environ Dev Sustain 2021:1-22Ikhlasse H, Benjamin D, Vincent C, Hicham M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519298 17. Air quality and health impact of 2019-20 Black Summer megafires and COVID- 19 lockdown in Melbourne and Sydney, Australia. Environ Pollut 2021; 274:116498Ryan RG, Silver JD, Schofield R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524649 18. Impact of COVID-related lockdowns on environmental and climate change scenarios: A case study of New Delhi in India. Environ. Res. 2021:110839Bhat SA, Bashir O, Bilal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549623 19. On the usefulness of the bioclimatic correlative models of SARS-CoV-2. Environ. Res. 2021:110818Gutiérrez-Hernández O, García LV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548299 20. Econometric analysis of COVID-19 cases, deaths, and meteorological factors in South Asia. Environ. Sci. Pollut. Res. Int. 2021:1-17Jain M, Sharma GD, Goyal M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543434 21. Meteorological factors, COVID-19 cases, and deaths in top 10 most affected countries: an econometric investigation. Environ. Sci. Pollut. Res. Int. 2021; Sharma GD, Bansal S, Yadav A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547610 22. COVID-19, prevention and treatment with herbal medicine in the herbal markets of Salé Prefecture, North-Western Morocco. Eur J Integr Med 2021; 42:101285Chaachouay N, Douira A, Zidane L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520016 23. Road traffic injuries in Nepal during COVID-19 lockdown. F1000Res 2020; 9:1209Sedain B, Pant PR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520194 24. Are we Athens or Florence? COVID-19 in historical context. Fam Med Community Health 2021; 9Doolittle BR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526435 25. The impact of COVID-19 on industry-related characteristics and risk contagion. Financ Res Lett 2021:101931Li ZF, Zhou Q, Chen M, Liu Q. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519308 26. The only certainty is uncertainty: An analysis of the impact of COVID-19 uncertainty on regional stock markets. Financ Res Lett 2021:101945Szczygielski JJ, Bwanya PR, Charteris A, Brzeszczyński J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519309 27. Panic Buying in Bangladesh: An Exploration of Media Reports. Front Psychiatry 2020; 11:628393Arafat SMY, Yuen KF, Menon V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536953 28. An Evaluation of the Impact of Monetary Easing Policies in Times of a Pandemic. Front Public Health 2020; 8:627001Li Y, Sun Y, Chen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520925 29. The Impact of Covid-19 on Women's Experiences of and Through Football in Buenos Aires. Front Sports Act Living 2020; 2:624055Lozano JR, Santino M, Wood D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537668 30. An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants. Front Vet Sci 2020; 7:586637Siddique F, Abbas RZ, Mansoor MK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521076 31. Viral Heroism: What the Rhetoric of Heroes in the COVID-19 Pandemic Tells Us About Medicine and Professional Identity. HEC Forum 2021; Hopkins PD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550499 32. COVID-19 and nutritional deficiency: a review of existing knowledge. Horm. Mol. Biol. Clin. Investig. 2021; Muthuvattur Pallath M, Ahirwar AK, Chandra Tripathi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544528 33. COVID-19 and the Political Economy of Mass Hysteria. Int J Environ Res Public Health 2021; 18Bagus P, Peña-Ramos JA, Sánchez-Bayón A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546144 34. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market. Int J Environ Res Public Health 2021; 18Lee KJ, Lu SL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546396 35. Public Perception of the First Major SARS-Cov-2 Outbreak in the Suceava County, Romania. Int J Environ Res Public Health 2021; 18Lucheș D, Saghin D, Lupchian MM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546326 36. Situating the Pandemic: Welfare Capitalism and Canada's Liberal Regime. Int J Health Serv 2021:20731420987079Aquanno SM, Bryant T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525955 37. The effect of COVID-19 pandemic on domestic tourism: A DEMATEL method analysis on quarantine decisions. Int J Hosp Manag 2021; 92:102719Altuntas F, Gok MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519015 38. Sensing the virus. How social capital enhances hoteliers' ability to cope with COVID-19. Int J Hosp Manag 2021; 94:102820Visentin M, Reis RS, Cappiello G, Casoli D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519017 39. The impact of national culture on the increase of COVID-19: A cross-country analysis of European countries. Int J Intercult Relat 2021; 81:1-8Gokmen Y, Baskici C, Ercil Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518841 40. Managing COVID-19 Lockdown Impacts: Sustaining GLP Compliance and Man Material Medium (MMM) Strategy for Augmenting Prevention of Workplace Infections. Int. J. Toxicol. 2021:1091581820987540Wangikar P, Giridhar TR, Shanmugam PST. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530813 41. COVID-19 pandemic and stock market response: A culture effect. J Behav Exp Finance 2021; 29:100454Fernandez-Perez A, Gilbert A, Indriawan I, Nguyen NH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520663 42. COVID-19 and American Attitudes toward U.S.-China Disputes. J Chin Polit Sci 2021:1-30Lin HY. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519173 43. Preventive aspect of ayurveda and yoga towards newly emerging disease COVID-19. J Complement Integr Med 2021; Sawant RS, Zinjurke BD, Binorkar SV. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544526 44. When COVID-19 and guns meet: A rise in shootings. J Crim Justice 2021; 73:101783Kim DY, Phillips SW. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518825 45. How do equity markets react to COVID-19? Evidence from emerging and developed countries. J. Econ. Bus. 2020:105966Harjoto MA, Rossi F, Lee R, Sergi BS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518845 46. COVID-19: Environment concern and impact of Indian medicinal system. J Environ Chem Eng 2020; 8:104144Kumar V, Singh SB, Singh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520648 47. Post-COVID healthcare reform in India: What to expect? J Family Med Prim Care 2020; 9:5427-5431Bhaduri SD. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532372 48. Community-Based Resistance Strategies among a Group of Trans Women in Lima, Peru during the COVID-19 Pandemic. J. Homosex. 2021:1-10Garcia- Rabines D, Bencich B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544655 49. Protecting healthcare workers in conflict zones during the COVID-19 pandemic: northwest Syria. J Infect 2021; Almhawish N, Karah N, Elferruh Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545168 50. Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19. J Law Biosci 2020; 7:lsaa083Edmonds S, MacGregor A, Doll A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537149 51. Verification results for age-structured models of economic-epidemics dynamics. J Math Econ 2020:102455Fabbri G, Gozzi F, Zanco G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519025 52. Early Crowdfunding Response to the COVID-19 Pandemic: Cross-sectional Study. J Med Internet Res 2021; 23:e25429Saleh SN, Lehmann CU, Medford RJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523826 53. A Geographically Distinct Case of Fatal Methanol Toxicity from Ingestion of a Contaminated Hand Sanitizer Product During the COVID-19 Pandemic. J. Med. Toxicol. 2021:1-4Overbeek DL, Watson CJ, Castañeda NR, Ganetsky M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33528767 54. COVID and crime: An early empirical look. J Public Econ 2021; 194:104344Abrams DS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518828 55. Impact of COVID-19 on corticosteroids and antibiotics prescribing in England: an interrupted time series analysis. J Public Health (Oxf) 2021; Chalitsios CV, McKeever TM, Langley TE, Shaw DE. http://www.ncbi.nlm.nih.gov/pubmed/? term=33539527 56. Bias in Medicine: Lessons Learned and Mitigation Strategies. JACC Basic Transl Sci 2021; 6:78-85Hammond MEH, Stehlik J, Drakos SG, Kfoury AG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532668 57. Effect of nation-wide lock-down due to Covid-19 over industrial pollution in Delhi, India. Mater Today Proc 2021; Kumar H, Arora R, Kumar Arora P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520675 58. Addressing the Challenge of COVID-19: One Health Care Site's Leadership Response to the Pandemic. Mayo Clin Proc Innov Qual Outcomes 2020; Zorn CK, Pascual JM, Bosch W et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521584 59. Climate effects on the COVID-19 outbreak: a comparative analysis between the UAE and Switzerland. Model Earth Syst Environ 2021:1-14Mansouri Daneshvar MR, Ebrahimi M, Sadeghi A, Mahmoudzadeh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521243 60. The Novel Coronavirus and Undocumented Farmworkers in the United States. New Solut. 2021:1048291121989000Matthew OO, Monaghan PF, Luque JS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517834 61. The nurse COVID and historical epidemics literature repository: Development, description, and summary. Nurs. Outlook 2021; Loresto FL, Jr., Nunez L, Tarasenko L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526252 62. The Impact of COVID-19 on Rural Food Supply and Demand in Australia: Utilising Group Model Building to Identify Retailer and Customer Perspectives. Nutrients 2021; 13Whelan J, Brown AD, Coller L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525558 63. Should children of cancer patients attend daycare centers or schools during the COVID-19 pandemic? Onkologe 2021; Bremen R, Petermann-Meyer A, Ernstmann N et al. 64. Covid-19 Conspiracy Beliefs And Containment-Related Behaviour: The Role Of Political Trust. Pers. Individ. Dif. 2021; 175:110697Karić T, Međedović J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531725 65. Ethical Dilemma: An Unprecedented Strike by Health care Workers in Early February 2020 in Hong Kong. Public Health Nurs. 2021; Cheng FK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538355 66. The intersection of climate change with the era of COVID-19. Public Health Nurs. 2021; Zang SM, Benjenk I, Breakey S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521994 67. COVID-19 as a recognized work-related disease: The current situation worldwide. Saf Health Work 2021; Sandal A, Yildiz AN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520326 68. [Physical and sports activities, management of the COVID-19 pandemic, Ségur for health and Ségur for public health: For a winning trinomial]. Sci. Sports 2021; Bréchat PH, Krim F, Leprêtre PM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519058 69. Eyes on coronavirus. Stem Cell Res 2021; 51:102200Li YP, Ma Y, Wang N, Jin ZB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535156 70. The concentration of major air pollutants during the movement control order due to the COVID-19 pandemic in the Klang Valley, Malaysia. Sustain Cities Soc 2021; 66:102660Latif MT, Dominick D, Hawari N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520606 71. Built environment and early infection of COVID-19 in urban districts: A case study of Huangzhou. Sustain Cities Soc 2021; 66:102685Li B, Peng Y, He H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520609 72. Manufacturing and service supply chain resilience to the COVID-19 outbreak: Lessons learned from the automobile and airline industries. Technol Forecast Soc Change 2021; 163:120447Belhadi A, Kamble S, Jabbour CJC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518818 73. Professional football clubs and empirical evidence from the COVID-19 crisis: Time for sport entrepreneurship? Technol Forecast Soc Change 2021; 165:120572Hammerschmidt J, Durst S, Kraus S, Puumalainen K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518819 74. COVID-19 and Transport: Findings from a World-wide Expert Survey. Transp Policy (Oxf) 2021; Zhang J, Hayashi Y, Frank LD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519127 75. Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:109Adler UC, Adler MS, Hotta LM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522951

Pathology (10 articles)

1. Placental pathology and fetal demise at 35 weeks of gestation in a woman with SARS-CoV-2 infection: A case report. Case Rep Womens Health 2021; 30:e00289Poisson TM, Pierone G, Jr. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527073 2. Can erythrocytes behavior in microcirculation help the understanding the physiopathology and improve prevention and treatment for covid-19? Clin. Hemorheol. Microcirc. 2021; Farber PL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33523046 3. International publication activity during the COVID-19 pandemic. Der Pathologe 2021; Strobl S, Roth W. 4. An overview of COVID-19 for diagnostic pathologists: clinicopathological correlation and diagnostic techniques. Diagn. Histopathol. (Oxf.) 2020; 26:529- 536Ghosh A, Colling R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519973 5. Autopsy in the time of COVID. Diagn. Histopathol. (Oxf.) 2021; Griffin KJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519971 6. Pandemics and pathology: a reflection on influenza, HIV/AIDS and SARS (COVID-19) pandemic infections. Diagn. Histopathol. (Oxf.) 2020; Lucas S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519972 7. [Course of Revision of the Diagnosis and Treatment Protocol for COVID-19 and the Forensic Contribution]. Fa Yi Xue Za Zhi 2020; 36:841-847Zhang L, Kong LJ, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550733 8. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021; 18Fisicaro F, Di Napoli M, Liberto A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546463 9. Impact of COVID-19 on small biopsy diagnostic procedures and cancer resection surgeries in the North-West of Ireland. J. Clin. Pathol. 2021; O'Connor E, O'Dowd G, Phelan S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542109 10. [Histological pulmonary features due to the Sars-CoV-2]. Rev Francoph Lab 2021; 2021:30-35Hofman P, Copin MC. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519990

Protection (58 articles)

1. The impact of face masks on children - a mini review. Acta Paediatr 2021; Martin E, Stefan O, Reinhold K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533522 2. Quantitative Assessment of Viral Dispersion Associated with Respiratory Support Devices in a Simulated Critical Care Environment. Am J Respir Crit Care Med 2021; Avari H, Hiebert RJ, Ryzynski AA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534659 3. Aerosol Transmission of SARS-CoV-2: Inhalation as Well as Exhalation Matters for COVID-19. Am J Respir Crit Care Med 2021; Philip KEJ, Lewis A, Buttery SC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529544 4. Presence of SARS-CoV-2 in the air of public places and transportation. Atmos Pollut Res 2021; Hadei M, Mohebbi SR, Hopke PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519256 5. Mitigating saliva aerosol contamination in a dental school clinic. BMC Oral Health 2021; 21:52Yang M, Chaghtai A, Melendez M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546674 6. Compliance with COVID-19 safety measures: A test of an objectification theory model. Body Image 2021; 37:6-13Earle M, Prusaczyk E, Choma B, Calogero R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548665 7. Aerosol-generating procedures in home care. Br. J. Community Nurs. 2021; 26:76-80Payne D, Peache M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539241 8. Investigation of potential aerosol transmission and infectivity of SARS-CoV-2 through central ventilation systems. Build. Environ. 2021:107633Pease LF, Wang N, Salsbury TI et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531734 9. Preventing epidemics by wearing masks: An application to COVID-19. Chaos Solitons Fractals 2021; 143:110599Gondim JAM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519118 10. A Year of Living Dangerously: Challenges and Recommendations for Safely Performing Ophthalmic Surgery During the COVID-19 Pandemic, from Start to Finish. Clin. Ophthalmol. 2021; 15:261-278Salica JP, Potilinski C, Querci M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519188 11. Droplet and Bone Dust Contamination from High-speed Drilling During Mastoidectomy. Clin. Otolaryngol. 2021; Markey AL, Leong SC, Vaughan C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533176 12. What level of photoprotection can be obtained using facial mask? Determining effectiveness using an in vitro method. Dermatol Ther 2021:e14837Couteau C, Paparis E, Coiffard L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527577 13. COVID-19 related masks increase severity of both acne (Maskne) and rosacea (Mask rosacea): Multi-center, real-life, telemedical, observational prospective study. Dermatol Ther 2021:e14848Damiani G, Gironi LC, Grada A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533563 14. Mask-Induced Koebner phenomenon and its clinical phenotypes: a multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics. Dermatol Ther 2021:e14823Damiani G, Gironi LC, Kridin K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527560 15. Mask-induced Koebner phenomenon and its clinical phenotypes: A multicenter, real-life study focusing on 873 dermatological consultations during COVID-19 pandemics. Dermatol Ther 2021:e14823Damiani G, Gironi LC, Kridin K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527560 16. Face Masks for All and All for Face Masks in the COVID-19 Pandemic: Community Level Production to Face the Global Shortage and Shorten the Epidemic - Corrigendum. Disaster Med Public Health Prep 2021:1Missoni E, Armocida B, Formenti B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531100 17. Adaptive wall-based attachment ventilation: A comparative study on its effectiveness in airborne infection isolation rooms with negative pressure. Engineering (Beijing) 2021; Zhang Y, Han O, Li A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520328 18. COVID-19 infection rate among tertiary referral center otorhinolaryngology healthcare workers. Eur Arch Otorhinolaryngol 2021:1-8Rasmussen KMB, Andersen PA, Channir HI et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544196 19. Exercise testing in COVID-19 ERA: Clinical profile, results and feasibility wearing a facemask. Eur. J. Clin. Invest. 2021:e13509Barbeito-Caamaño C, Bouzas-Mosquera A, Peteiro J et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33548060 20. The enforcement of statewide mask wearing mandates to prevent COVID-19 in the US: an overview. F1000Res 2020; 9:1100Jacobs P, Ohinmaa AP. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520192 21. The public perception of food and non-food related risks of infection and trust in the risk communication during COVID-19 crisis: A study on selected countries from the Arab region. Food Control 2021; 121:107617Faour-Klingbeil D, Osaili TM, Al-Nabulsi AA et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519101 22. Risk Perception and Protective Behaviors During the Rise of the COVID-19 Outbreak in Italy. Front. Psychol. 2020; 11:577331Savadori L, Lauriola M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519593 23. Face Masks During the COVID-19 Pandemic: A Simple Protection Tool With Many Meanings. Front Public Health 2020; 8:606635Martinelli L, Kopilaš V, Vidmar M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520918 24. Different Correlates of COVID-19-Related Adherent and Dysfunctional Safety Behavior. Front Public Health 2020; 8:625664Weismüller B, Schweda A, Dörrie N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520924 25. Prolonged Use of n95 Mask a Boon or Bane to Healthcare Workers During Covid-19 Pandemic. Indian J Otolaryngol Head Neck Surg 2021:1-4Kumar S, Singh A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520688 26. Rationale and process for N95 respirator sanitation and re-use in the COVID- 19 pandemic. Infect Control Hosp Epidemiol 2021:1-20Golladay GJ, Leslie KA, Zuelzer WA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526158 27. Asymptomatic SARS COV-2 carriers among nursing home staff: A source of contamination for residents? Infect Dis Now 2021; Bayle C, Cantin D, Vidal JS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521774 28. The "double eights mask brace" improves the fit and protection of a basic surgical mask amidst COVID-19 pandemic. J Am Coll Emerg Physicians Open 2021; 2:e12335Runde DP, Harland KK, Van Heukelom P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521786 29. Heat inactivation of the severe acute respiratory syndrome coronavirus 2. J Biosaf Biosecur 2021; 3:1-3Batéjat C, Grassin Q, Manuguerra JC, Leclercq I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521591 30. Surgical Performance Is Not Negatively Impacted by Wearing a Commercial Full-Face Mask with Ad Hoc 3D-Printed Filter Connection as a Substitute for Personal Protective Equipment during the COVID-19 Pandemic: A Randomized Controlled Cross-Over Trial. J Clin Med 2021; 10Felinska EA, Chen ZW, Fuchs TE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540811 31. Hospital transmission rates of the SARS-CoV 2 disease amongst orthopaedic in-patients in a secondary care centre: A quantitative review. J Clin Orthop Trauma 2021; 16:43-48Holmes N, Virani S, Relwani J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519136 32. AEROSOLS GENERATED DURING ENDODONTIC TREATMENTS: A SPECIAL CONCERN DURING COVID-19 PANDEMIC. J Endod 2021; Bahador M, Alfirdous RA, Alquria TA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548332 33. Aerosol and spatter mitigation in dentistry: Analysis of the effectiveness of 13 setups. J Esthet Restor Dent 2021; Comisi JC, Ravenel TD, Kelly A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522677 34. Comparison of droplet spread in standard and laminar flow operating theatres: SPRAY study group. J Hosp Infect 2021; Newsom R, Amara A, Hicks A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549768 35. UVB radiation alone may not explain sunlight inactivation of SARS-CoV-2. J Infect Dis 2021; Luzzatto-Fegiz P, Temprano-Coleto F, Peaudecerf FJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544845 36. Comparative Analysis of Intravenous Pumps Relocation for Critically Ill Isolated COVID-19 Patients From Bedside to Outside the Patient Room. J. Intensive Care Med. 2021:885066621989920Shah A, Xu J, Friedman S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530822 37. Single-use surgical face masks, as a potential source of microplastics: Do they act as pollutant carriers? J. Mol. Liq. 2021; 326:115247Anastopoulos I, Pashalidis I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518855 38. Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease. J. Mol. Liq. 2021; 322:114999Somboon T, Mahalapbutr P, Sanachai K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518853 39. COVID-19 pathway signage for operating theatres. J Perioper Pract 2021:1750458920982168Hayman G, Britton CR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544660 40. Novel approach to reduce SARS-CoV-2 transmission during trans-oral robotic surgery. J. Robot. Surg. 2021; Chow VL, Chan JY, Wong MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547981 41. How frequently do ordinary citizens practice hand hygiene at appropriate moments during the COVID-19 pandemic in Japan. Jpn. J. Infect. Dis. 2021; Machida M, Nakamura I, Saito R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518620 42. SARS-COV-2 transmission rate is low when following a COVID+ patient in the operating room. Langenbecks Arch. Surg. 2021; Axiotakis LG, Jr., Boyett DM, Youngerman BE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547483 43. Electrospun ultrafine fibers for advanced face masks. Mater. Sci. Eng. R Rep. 2021; 143:100594Zhang Z, Ji D, He H, Ramakrishna S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519094 44. A mathematical model for the impacts of face mask, hospitalization and quarantine on the dynamics of COVID-19 in India: deterministic vs. stochastic. Math Biosci Eng 2020; 18:182-213Srivastav AK, Tiwari PK, Srivastava PK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525087 45. Isolation precautions, diagnostics and organization in German emergency departments during the 2020 COVID-19 pandemic. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2021; Finke M, Pin M, Bernhard M et al. 46. Use of masks by children to prevent infection with SARS-CoV-2: Consensus statement of the German Society for Pediatric Infectious Diseases (DGPI), the Professional Association of Pediatricians (BVKJ), the German Society for Pediatric and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Society for Social Pediatrics and Adolescent Medicine (DGSPJ), the Southern German Society for Pediatric and Adolescent Medicine (SGKJ) and the German Society for Pediatric and Adolescent Psychiatry, Psychosomatics and Psychotherapy (DGKJP). Monatsschr. Kinderheilkd. 2021; 169:52-56Huppertz HI, Berner R, Schepker R et al. 47. Face masks and nanotechnology: Keep the blue side up. Nano Today 2021; 37:101077Palmieri V, De Maio F, De Spirito M, Papi M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519950 48. Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation. Pharmaceutics 2021; 13Joyce M, McGrath JA, Mac Giolla Eain M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540764 49. USPHS Corps Care : Force Health Protection for Public Health Officers During the Ebola and COVID-19 Responses. Public Health Rep. 2021:33354920984775Myles IA, Johnson DR, Pham H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541219 50. Impact of Face Masks on 6-Minute Walk Test in Healthy Volunteers. Pulm Circ 2021; 11:2045894020988437Swiatek KM, Lester C, Ng N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532062 51. Technological review on thermochemical conversion of COVID-19-related medical wastes. Resour Conserv Recycl 2021; 167:105429Purnomo CW, Kurniawan W, Aziz M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519084 52. Risk of aerosol formation by high flow nasal cannula treatment in critically-ill patients. Respir. Care 2021; Bem RA, van Mourik N, Klein-Blommert R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536316 53. The use of personal protection equipment does not impair the quality of cardiopulmonary resuscitation: A prospective triple-cross over randomised controlled non-inferiority trial. Resuscitation 2021; Kienbacher CL, Grafeneder J, Tscherny K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524489 54. Factors Affecting the Decontamination Process in Hospitals in Saudi Arabia. Risk Manag. Healthc. Policy 2021; 14:357-363Felemban EM, Youssef HAM, Al Thobaity A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542666 55. Safety on demand: A case study for the design and manufacturing-on-demand of personal protective equipment for healthcare workers during the COVID-19 pandemic. Saf Sci 2021; 136:105162Sterman Y, Tarazi E, Berman O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519093 56. Basic sanitation: a new indicator for the spread of COVID-19? Trans. R. Soc. Trop. Med. Hyg. 2021; Silva RR, Ribeiro CJN, Moura TR et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547895 57. A survey of laboratory biosafety and protective measures in blood transfusion departments during the COVID-19 pandemic. Vox Sang 2021; Liu H, Liu L, Zhang J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529377 58. Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases—relative all clear through consistent testing. Z. Rheumatol. 2021; Andreica I, Guminski B, Sokolar J et al.

Pulmonary disease (5 articles)

1. The ongoing impact of COVID-19 on asthma and pediatric emergency health- seeking behavior in the Bronx, an epicenter. Am J Emerg Med 2021; 43:109- 114Levene R, Fein DM, Silver EJ et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550101 2. COVID-19 impact on pulmonary care in rural community - a commentary. Hosp Pract (1995) 2021; Sharma S, Stansbury R, Marsh C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539217 3. COVID-19 and Pediatric Asthma: Clinical and Management Challenges. Int J Environ Res Public Health 2021; 18Boechat JL, Wandalsen GF, Kuschnir FC, Delgado L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530624 4. Aging of the lungs and immune system as hellmark in the pathogenesis of idiopathic pulmonary fibrosis and COVID-19. Pneumologe 2021; Stieglitz S, Frohnhofen H. 5. Preexisting respiratory diseases and clinical outcomes in COVID-19: a multihospital cohort study on predominantly African American population. Respir Res 2021; 22:37Lohia P, Sreeram K, Nguyen P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546658

Renal disease (13 articles)

1. COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications. Ann. Hematol. 2021:1-8Al Mahmasani L, Hodroj MH, Finianos A, Taher A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527161 2. Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids. Int J Mol Sci 2021; 22Ahmad Mulyadi Lai HI, Chou SJ, Chien Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525682 3. COVID-19 in chronic kidney disease: a retrospective, propensity score- matched cohort study. Int. Urol. Nephrol. 2021; Dirim AB, Demir E, Yadigar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548044 4. Emergency Department Management of Severe Hypoxemic Respiratory Failure in Adults With COVID-19. J. Emerg. Med. 2020; Wilcox SR, Condella A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526308 5. SARS-CoV-2-specific humoral and cellular immunity in two renal transplant and two haemodialysis patients treated with convalescent plasma. J Med Virol 2021; Lindemann M, Krawczyk A, Dolff S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527424 6. SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma. J Med Virol 2021; Lindemann M, Krawczyk A, Dolff S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527424 7. COVID-19-related collapsing glomerulopathy revealing a rare risk variant of APOL1: lessons for the clinical nephrologist. J Nephrol 2021; Laboux T, Gibier JB, Pottier N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548053 8. Acute Peritoneal Dialysis With Percutaneous Catheter Insertion for COVID-19- Associated Acute Kidney Injury in Intensive Care: Experience From a UK Tertiary Center. Kidney Int Rep 2020; Bowes E, Joslin J, Braide-Azikiwe DCB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521400 9. Coronavirus Disease 2019 in Patients with End-Stage Kidney Disease on Hemodialysis in Guatemala. Kidney Int Rep 2021; Sosa R, Garcia P, Cipriano EO et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532670 10. SARS-CoV-2 Antibody Point-of-Care Testing in Dialysis and Kidney Transplant Patients With COVID-19. Kidney Med 2021; 3:54-59.e51Prendecki M, Clarke C, McKinnon T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521621 11. Impact of Covid-19 on kidney transplant and waiting list patients: Lessons from the first wave of the pandemic. Nephrol. Ther. 2021; Couzi L, Manook M, Caillard S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541842 12. COVID-19 and renal transplantation. Nephrologe 2021; Regele F, Oberbauer R. 13. Renal resistive index is associated with acute kidney injury in COVID-19 patients treated in the intensive care unit. Ultrasound J 2021; 13:3Renberg M, Jonmarker O, Kilhamn N et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544258

Reviews (43 articles)

1. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 2021; 11:94Ratre YK, Kahar N, Bhaskar L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520580 2. Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review. Adv Clin Exp Med 2021; 30:109-114Czubak J, Stolarczyk K, Orzeł A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529514 3. Total gastric necrosis following acute pancreatitis in a patient with COVID -19: Case report and literature review. Ann Med Surg (Lond) 2021; 62:362-364Bouali M, Ouchane M, Elbakouri A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520227 4. Remote E-exams during Covid-19 pandemic: A cross-sectional study of students' preferences and academic dishonesty in faculties of medical sciences. Ann Med Surg (Lond) 2021; 62:326-333Elsalem L, Al-Azzam N, Jum'ah AA, Obeidat N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520225 5. Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review. Biol. Proced. Online 2021; 23:5Choudhary J, Dheeman S, Sharma V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526007 6. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth 2021; 21:108Servante J, Swallow G, Thornton JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546624 7. Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature. Brain Behav Immun Health 2021; 12:100210Pizzanelli C, Milano C, Canovetti S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521691 8. Antivirals for COVID-19: A critical review. Clin Epidemiol Glob Health 2021; 9:90- 98Frediansyah A, Tiwari R, Sharun K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521390 9. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput. Biol. Med. 2021; 130:104210Suri JS, Agarwal S, Gupta SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550068 10. An overview of COVID-19 for diagnostic pathologists: clinicopathological correlation and diagnostic techniques. Diagn. Histopathol. (Oxf.) 2020; 26:529- 536Ghosh A, Colling R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519973 11. The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review. Diagnostics (Basel) 2021; 11Hartmann J, Ergang A, Mason D, Dias JD. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530346 12. The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19. Diagnostics (Basel) 2021; 11Miftode RS, Petriș AO, Onofrei Aursulesei V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530550 13. Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions. Drugs Context 2021; 10Anderson SL, Bassetti M, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542739 14. COVID-19-Associated Cytokine Storm Syndrome and Diagnostic Principles: An Old and New Issue. Emerg Microbes Infect 2021:1-30Xi Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522893 15. Clinical spectrum of ischaemic arterial diseases associated with COVID-19: a series of four illustrative cases. Eur Heart J Case Rep 2021; 5:ytaa488Guillet H, Gallet R, Pham V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542975 16. Chloroquine: autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check? Eur. J. Pharmacol. 2021; 897:173928Sharma P, McAlinden KD, Ghavami S, Deshpande DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545161 17. A review on human body fluids for the diagnosis of viral infections: scope for rapid detection of COVID-19. Expert Rev Mol Diagn 2021:1-12Adigal SS, Rayaroth NV, John RV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523770 18. Is Guillain-Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence. Front. Neurol. 2020; 11:566308Abdullahi A, Candan SA, Soysal Tomruk M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519663 19. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. Front Public Health 2020; 8:582932Mehta OP, Bhandari P, Raut A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520910 20. COVID-19: What you need to know. Gene Rep 2020; 20:100756Hilal El Idrissi H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521383 21. A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives. Health Sci Rep 2021; 4:e237Ramani VK, Naik R. http://www.ncbi.nlm.nih.gov/pubmed/? term=33532600 22. Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets. Heliyon 2021; 7:e06001Illian DN, Siregar ES, Sumaiyah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532640 23. COVID-19 and nutritional deficiency: a review of existing knowledge. Horm. Mol. Biol. Clin. Investig. 2021; Muthuvattur Pallath M, Ahirwar AK, Chandra Tripathi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544528 24. COVID-19 and cardiovascular disease: a review of current knowledge. Horm. Mol. Biol. Clin. Investig. 2021; Pal A, Ahirwar AK, Sakarde A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544511 25. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines. Hum Vaccin Immunother 2021:1-18Bhatta M, Nandi S, Dutta S, Saha MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545014 26. COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review. Int Immunopharmacol 2021; 93:107397Tehrani HA, Darnahal M, Vaezi M, Haghighi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524803 27. Impact of COVID-19 on management of urogynaecology patients: a rapid review of the literature. Int Urogynecol J 2021:1-16Loganathan J, Doumouchtsis SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533991 28. COVID-19: a Review of the Literature Regarding African American Patient Outcomes. J Afr Am Stud (New Brunsw) 2021:1-10Mangum VE. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519320 29. Stroke in patients infected by the novel coronavirus and its causal mechanisms: A narrative review. J Am Coll Emerg Physicians Open 2021; 2:e12332de Oliveira RMF, de Souza Aguiar PHC, de Paula R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521783 30. Coronavirus disease 2019 and extra-pulmonary tuberculosis co-infection - A case report and review of literature. J Clin Tuberc Other Mycobact Dis 2021; 22:100213Gerstein S, Khatri A, Roth N, Wallach F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521333 31. Novel coronavirus (COVID-19) and its potential G.I. manifestation: A review. J Family Med Prim Care 2020; 9:5474-5479Deep A, Verma K, Swaroop S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532381 32. Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms. J Inflamm Res 2021; 14:175-189Khan MA, Khan ZA, Charles M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519225 33. A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature. J Med Case Rep 2021; 15:41Dai Y, Liu S, Zhang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522942 34. Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data. J. Neurol. 2021; Beyrouti R, Best JG, Chandratheva A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547527 35. Potential mechanisms of cerebrovascular diseases in COVID-19 patients. J. Neurovirol. 2021:1-17Lou M, Yuan D, Liao S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534131 36. COVID-19 presenting as intussusception in infants: A case report with literature review. J Pediatr Surg Case Rep 2021; 66:101779Athamnah MN, Masade S, Hamdallah H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520650 37. Current diagnostic and therapeutic strategies for COVID-19. J Pharm Anal 2021; Chen BB, Liu ML, Huang CZ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520327 38. Thermal Sensors for Contactless Temperature Measurements, Occupancy Detection, and Automatic Operation of Appliances during the COVID-19 Pandemic: A Review. Micromachines (Basel) 2021; 12Moisello E, Malcovati P, Bonizzoni E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546478 39. Narrative review of the immune response against coronavirus: An overview, applicability for SARS-COV-2, and therapeutic implications. An Pediatr (Engl Ed) 2020; 93:60.e61-60.e67García-Salido A. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521168 40. Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology 2021; Visca D, Ong CWM, Tiberi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547029 41. A Systematic Review of Systematic Reviews on the COVID-19 Pandemic. SN Compr Clin Med 2021:1-18Hatmi ZN. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521564 42. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review. Transfus. Apher. Sci. 2021:103071Focosi D, Franchini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518427 43. Innovations in otorhinolaryngology in the age of COVID-19: a systematic literature review. World J Otorhinolaryngol Head Neck Surg 2021; McCarty EB, Soldatova L, Brant JA, Newman JG. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520334

Risk factors (72 articles)

1. Hematologic changes predict clinical outcome in recovered patients with COVID-19. Ann. Hematol. 2021:1-15Mao J, Dai R, Du RC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523290 2. Clinical risk factors for mortality of hospitalized patients with COVID-19: systematic review and meta-analysis. Ann Palliat Med 2021; Xiang G, Xie L, Chen Z et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549005 3. Implications of the Emergence of a New Variant of SARS-CoV-2, VUI- 202012/01. Arch Med Res 2021; Rahimi F, Talebi Bezmin Abadi A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526352 4. The prognostic effect of brain natriuretic peptide levels on outcomes of hospitalized patients with COVID-19. Avicenna J Med 2021; 11:20-26Abdeen Y, Kaako A, Alnabulsi M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520785 5. An easy-to-use nomogram for predicting in-hospital mortality risk in COVID- 19: a retrospective cohort study in a university hospital. BMC Infect. Dis. 2021; 21:148Acar HC, Can G, Karaali R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546639 6. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study. BMC Infect. Dis. 2021; 21:147Cai H, Yang L, Lu Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546633 7. Characteristics and prognostic factors of COVID-19 among infected cases: a nationwide Tunisian analysis. BMC Infect. Dis. 2021; 21:140Harizi C, Cherif I, Najar N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535971 8. Validating the RISE UP score for predicting prognosis in patients with COVID- 19 in the emergency department: a retrospective study. BMJ Open 2021; 11:e045141van Dam PM, Zelis N, Stassen P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550267 9. Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report. Brain Behav Immun Health 2021:100212Bonaccorso S, Ricciardi A, Ouabbou S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527097 10. Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study. Cancers (Basel) 2021; 13Lee J, Park SS, Kim TY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530509 11. A distinct innate immune signature marks progression from mild to severe COVID-19. Cell Rep Med 2021; 2:100166Chevrier S, Zurbuchen Y, Cervia C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521697 12. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis. Cerebrovasc. Dis. 2021:1-9Honardoost M, Janani L, Aghili R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530081 13. Can erythrocytes behavior in microcirculation help the understanding the physiopathology and improve prevention and treatment for covid-19? Clin. Hemorheol. Microcirc. 2021; Farber PL. http://www.ncbi.nlm.nih.gov/pubmed/? term=33523046 14. Mediastinal lymphadenopathy may predict 30-day mortality in patients with COVID-19. Clin Imaging 2021; 75:119-124Satici C, Cengel F, Gurkan O et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545439 15. Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients. Clin Immunol 2021:108682Núñez I, Priego-Ranero Á A, García-González HB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549831 16. Admission COVID-19 clinical risk assessment for guiding patient placement and diagnostic testing strategy. Clin Med (Lond) 2021; Jones NK, Ramsay I, Moore E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541910 17. Predictors of Poor Outcomes for COVID-19-Associated Pneumonia in a Minority Population. Cureus 2021; 13:e12431Omore I, Brimah I, Tijani S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542878 18. Prognostic bioindicators in severe COVID-19 patients. Cytokine 2021; 141:155455Bergantini L, Bargagli E, d'Alessandro M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548798 19. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID- 19. Cytokine 2021; 141:155428Sayah W, Berkane I, Guermache I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550165 20. Predictive value of the preliminary findings in the severity of COVID-19 disease and the effect on therapeutic approaches. Dermatol Ther 2021:e14828Khayat Kashani HR, Hajijafari M, Khayat Kashani F, Salimi S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527692 21. Risk factors associated with intensive care unit (ICU) admission and in- hospital death among adults hospitalized with COVID-19: a two-center retrospective observational study in tertiary care hospitals. Emerg Radiol 2021:1-7Shayganfar A, Sami R, Sadeghi S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534017 22. Meteorological factors, COVID-19 cases, and deaths in top 10 most affected countries: an econometric investigation. Environ. Sci. Pollut. Res. Int. 2021; Sharma GD, Bansal S, Yadav A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547610 23. COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU. Exp Hematol Oncol 2021; 10:6Zheng R, Zhou J, Song B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522958 24. Age, neutrophil lymphocyte ratio, and radiographic assessment of the quantity of lung edema (RALE) score to predict in-hospital mortality in COVID- 19 patients: a retrospective study. F1000Res 2020; 9:1286Sensusiati AD, Amin M, Nasronudin N et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537125 25. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic. Biol. Med. 2021; 165:184-190Gadotti AC, Lipinski AL, Vasconcellos FT et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524532 26. Does Angiotensin II Peak in Response to SARS-CoV-2? Front. Immunol. 2020; 11:577875Xavier LL, Neves PFR, Paz LV et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519802 27. Comparison of Liver Biomarkers in 288 COVID-19 Patients: A Mono-Centric Study in the Early Phase of Pandemic. Front Med (Lausanne) 2020; 7:584888Fan H, Cai J, Tian A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521010 28. Susceptibility Factors of Stomach for SARS-CoV-2 and Treatment Implication of Mucosal Protective Agent in COVID-19. Front Med (Lausanne) 2020; 7:597967Zhang M, Feng C, Zhang X et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521016 29. Predictive Value of Prognostic Nutritional Index on COVID-19 Severity. Front Nutr 2020; 7:582736Wang ZH, Lin YW, Wei XB et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521032 30. Which Factors, Smoking, Drinking Alcohol, Betel Quid Chewing, or Underlying Diseases, Are More Likely to Influence the Severity of COVID-19? Front. Physiol. 2020; 11:623498Zhong R, Chen L, Zhang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536941 31. Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Geriatrics (Basel) 2021; 6Yu Y, Travaglio M, Popovic R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530357 32. Risk factors of developing critical conditions in Iranian patients with COVID- 19. Glob Epidemiol 2021; 3:100046Arman A, Tajik M, Nazemipour M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521624 33. The atherogenic index of plasma as a predictor of mortality in patients with COVID-19. Heart Lung 2021; 50:329-333Turgay Yıldırım Ö, Kaya Ş. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524862 34. Air pollution and cardiovascular diseases. Herz 2021; Münzel T, Hahad O, Daiber A, Lelieveld J. 35. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. Hum Genomics 2021; 15:10Hu J, Li C, Wang S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536081 36. Predictive immunogenetic markers in COVID-19. Hum. Immunol. 2021; Leite MM, Gonzalez-Galarza FF, Silva B et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33546902 37. ABO phenotype and SARS-CoV-2 infection: Is there any correlation? Infect Genet Evol 2021:104751Mathew A, Vignesh Balaji E, Pai SRK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540085 38. Predictive Model and Risk Factors for Case Fatality of COVID-19: A Cohort of 21,392 Cases in Hubei, China. Innovation (N Y) 2020; 1:100022Wu R, Ai S, Cai J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521759 39. The male disadvantage in life expectancy: can we close the gender gap? Int Health 2021; Hossin MZ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533409 40. Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19. Int. J. Med. Sci. 2021; 18:1207-1215Ding R, Yang Z, Huang D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526982 41. Risk factors for mortality of critically ill patients with COVID-19 receiving invasive ventilation. Int. J. Med. Sci. 2021; 18:1198-1206Tu Y, Yang P, Zhou Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526981 42. Signs, Symptoms, and Comorbidities Associated With Poor Outcomes Among Residents of a Skilled Nursing Facility With SARS-CoV-2 Infection-King County, Washington. J. Am. Med. Dir. Assoc. 2021; Tobolowsky FA, Bardossy AC, Currie DW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549565 43. Association between periodontitis and severity of COVID-19 infection: a case- control study. J. Clin. Periodontol. 2021; Marouf N, Cai W, Said KN et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527378 44. Dysregulated innate and adaptive immune responses discriminate disease severity in COVID-19. J Infect Dis 2021; Janssen NAF, Grondman I, de Nooijer AH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524124 45. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death. J. Leukoc. Biol. 2021; Belaid B, Lamara Mahammad L, Mihi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527487 46. The Association of Viral load and Disease Severity in Children with COVID-19. J Med Virol 2021; Aykac K, Cura Yayla BC, Ozsurekci Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547815 47. Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein. J Med Virol 2021; Koh H, Moh AMC, Yeoh E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527464 48. Development and Validation of Clinical Prediction Models to Estimate the Probability of death in Hospitalized Patients with COVID-19: Insights from a Nationwide Database. J Med Virol 2021; Tanboğa IH, Canpolat U, Çetin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527474 49. Development and validation of clinical prediction model to estimate the probability of death in hospitalized patients with COVID-19: Insights from a nationwide database. J Med Virol 2021; Tanboğa IH, Canpolat U, Çetin E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527474 50. Genetic Variation, Diet, Inflammation, and the Risk for COVID-19. Lifestyle Genom 2021:1-6Simopoulos AP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530084 51. Impact of liver enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-19. Liver Res 2021; Higuera-de la Tijera F, Servín-Caamaño A, Reyes-Herrera D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520337 52. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Med (N Y) 2021; Liu H, Chen J, Yang Q et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521746 53. Risk of severe COVID-19 in hypertensive patients treated with renin- angiotensin-aldosterone system inhibitors. Med Clin (Engl Ed) 2020; 155:488- 490Golpe R, Pérez-de-Llano LA, Dacal D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521300 54. Risk stratification nomogram for COVID-19 patients with interstitial pneumonia in the emergency department: A retrospective multicenter study. Medizinische Klinik - Intensivmedizin und Notfallmedizin 2021; Pfeifer N, Zaboli A, Ciccariello L et al. 55. The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metabol Open 2021; 9:100079Moin ASM, Sathyapalan T, Atkin SL, Butler AE. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521617 56. Dynamics of a Dual SARS-CoV-2 Lineage Co-Infection on a Prolonged Viral Shedding COVID-19 Case: Insights into Clinical Severity and Disease Duration. Microorganisms 2021; 9Pedro N, Silva CN, Magalhães AC et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540596 57. Obesity as a risk factor for hospitalization in COronaVirus Disease-19 (COVID- 19) patients: Analysis of the Tuscany regional database. Nutr. Metab. Cardiovasc. Dis. 2020; Bellini B, Cresci B, Cosentino C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549434 58. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis. Nutr. Metab. Cardiovasc. Dis. 2020; Du Y, Zhou N, Zha W, Lv Y. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549450 59. Obesity as a risk factor for unfavourable outcomes in critically ill patients affected by Covid 19. Nutr. Metab. Cardiovasc. Dis. 2020; Rossi AP, Gottin L, Donadello K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549439 60. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19. Obes Med 2020:100317AbdelMassih A, Yacoub E, Husseiny RJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521378 61. COVID-19: Does the blood type determine how severe disease progression is? Pneumologie 2021; 75:14. 62. Fever as a predictor of adverse outcomes in COVID-19. QJM 2021; Ws Chew N, Nicholas Ngiam J, Meng Tham S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533902 63. Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality. Res Pract Thromb Haemost 2021; 5:132-141von Meijenfeldt FA, Havervall S, Adelmeijer J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537537 64. Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients. Respir. Med. 2021; 178:106313Mendy A, Wu X, Keller JL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550152 65. Predicting mortality risk in patients with COVID-19 using machine learning to help medical decision-making. Smart Health (Amst) 2021; 20:100178Pourhomayoun M, Shakibi M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521226 66. Built environment and early infection of COVID-19 in urban districts: A case study of Huangzhou. Sustain Cities Soc 2021; 66:102685Li B, Peng Y, He H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520609 67. A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome. Virology 2021; 556:79-86Detsika MG, Ampelakiotou K, Grigoriou E et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33550117 68. Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality. Viruses 2021; 13Dumonteil E, Fusco D, Drouin A, Herrera C. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540576 69. Association of the ABO blood group with SARS-CoV-2 infection in a community with low infection rate. Vox Sang 2021; Kotila TR, Alonge TO, Fowotade A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529391 70. BIN1 rs744373 SNP and COVID-19 mortality. World Acad Sci J 2021; 3Lehrer S, Rheinstein PH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521641 71. Severity of COVID-19 in hospitalized patients with and without atopic disease. World Allergy Organ J 2021; 14:100508Timberlake DT, Narayanan D, Ogbogu PU et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520082 72. Risk factors associated with acute respiratory distress syndrome in COVID-19 patients outside Wuhan: A double-center retrospective cohort study of 197 cases in Hunan, China. World J Clin Cases 2021; 9:344-356Hu XS, Hu CH, Zhong P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521102

Safety (18 articles)

1. Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era. Actas Urol. Esp. 2020; García-Rojo E, Manfredi C, Santos-Pérez-de-la-Blanca R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546905 2. Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany. Allergol Select 2021; 5:72-76Worm M, Bauer A, Wedi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521511 3. Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States. Am. J. Health Syst. Pharm. 2021; Rhodes NJ, Dairem A, Moore WJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537767 4. Clozapine Intoxication in COVID-19. Am. J. Psychiatry 2021; 178:123-127Tio N, Schulte PFJ, Martens HJM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33517757 5. Steroid harms if given early in COVID-19 viraemia. BMJ Case Rep. 2021; 14Arora K, Panda PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541971 6. Should Antipyretics be used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? Chest 2021; Etminan M, Sodhi M, Ganjizadeh-Zavareh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549598 7. Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure. Clin Pharmacol Ther 2021; Stanke- Labesque F, Concordet D, Djerada Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547636 8. Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology. Drug Deliv 2021; 28:325-342Liu F, Li Y, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33517789 9. Immune Checkpoint Inhibition in COVID-19: Risks and Benefits. Expert Opin Biol Ther 2021; Pezeshki PS, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33543652 10. Migraine treatment and COVID-19 vaccines: no cause for concern. Headache 2021; Gelfand AA, Poland G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543775 11. Mortality, Severity, and Hospital Admission among COVID-19 Patients with ACEI/ARB Use: A Meta-Analysis Stratifying Countries Based on Response to the First Wave of the Pandemic. Healthcare (Basel) 2021; 9Alamer AA, Almulhim AS, Alrashed AA, Abraham I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525596 12. mTOR inhibition: a double-edged sword in patients with COVID-19? Hum. Cell 2021:1-2Ghasemnejad-Berenji M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527306 13. The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection. J Cannabis Res 2020; 2:23Sainz-Cort A, Heeroma JH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526121 14. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. J. Clin. Invest. 2021; 131Bolouri H, Speake C, Skibinski D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529167 15. Efficacy and Safety Assessment of Severe COVID-19 Patients with Chinese Medicine: a Retrospective Case Series Study at Early Stage of the COVID-19 Epidemic in Wuhan, China. J. Ethnopharmacol. 2021:113888Huang L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529638 16. Reported orofacial adverse effects of COVID-19 vaccines: the knowns and the unknowns. J Oral Pathol Med 2021; Cirillo N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527524 17. Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection. Med Clin (Engl Ed) 2020; 155:448-453Herrera-Lasso Regás V, Dordal Culla MT, Lleonart Bellfill R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521297 18. Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune- Depleting Therapies. Vaccines (Basel) 2021; 9Sellner J, Rommer PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525459

Treatment options (107 articles)

1. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 2021; 11:94Ratre YK, Kahar N, Bhaskar L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520580 2. Nitric oxide and Covid-19: dose, timing and how to administer it might be crucial. Acta Anaesthesiol. Scand. 2021; Frostell CG, Hedenstierna G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533477 3. A Comprehensive Summary of the Knowledge on COVID-19 Treatment. Aging Dis 2021; 12:155-191Peng Y, Tao H, Satyanarayanan SK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532135 4. Interferon Stimulates ACE2 Expression in Pediatric Airway Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2021; Salka K, Abutaleb K, Chorvinsky E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544656 5. Native High-Density Lipoproteins (HDL) with Higher Paraoxonase Exerts a Potent Antiviral Effect against SARS-CoV-2 (COVID-19), While Glycated HDL Lost the Antiviral Activity. Antioxidants (Basel) 2021; 10Cho KH, Kim JR, Lee IC, Kwon HJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535459 6. Genetic Conservation of SARS-CoV-2 RNA Replication Complex in Globally Circulating Isolates and Recently Emerged Variants from Humans and Minks Suggests Minimal Pre-Existing Resistance to Remdesivir. Antiviral Res 2021:105033Martin R, Li J, Parvangada A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549572 7. Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study. Appl Soft Comput 2021; 103:107135Meng Y, Jin M, Tang X, Xu J. http://www.ncbi.nlm.nih.gov/pubmed/? term=33519322 8. DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End? Arch. Immunol. Ther. Exp. (Warsz.) 2021; 69:1Krejner-Bienias A, Grzela K, Grzela T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527308 9. Choppy Waters: The Importance of Accounting for Shifting Drug Utilization During the COVID-19 Pandemic in Future Observational Drug-related Studies. Basic Clin. Pharmacol. Toxicol. 2021; Shakeri A, Gomes T, Suda K, Tadrous M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548160 10. Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2). Biocatal Agric Biotechnol 2021; 32:101924Neupane NP, Karn AK, Mukeri IH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527003 11. Molecular dynamics analysis of phytochemicals from Ageratina adenophora against COVID-19 main protease (M(pro)) and human angiotensin-converting enzyme 2 (ACE2). Biocatal Agric Biotechnol 2021; 32:101924Neupane NP, Karn AK, Mukeri IH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527003 12. IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. Bioeng Transl Med 2021; 6:e10196Blasiak A, Lim JJ, Seah SGK et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532594 13. Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review. Biol. Proced. Online 2021; 23:5Choudhary J, Dheeman S, Sharma V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526007 14. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines. Biomed. Pharmacother. 2021; 137:111330Awadasseid A, Wu Y, Tanaka Y, Zhang W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550043 15. De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning. BMC Chem 2021; 15:8Santana MVS, Silva-Jr FP. http://www.ncbi.nlm.nih.gov/pubmed/? term=33531083 16. Steroid harms if given early in COVID-19 viraemia. BMJ Case Rep. 2021; 14Arora K, Panda PK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541971 17. Convalescent plasma for COVID-19 - encouraging signals of efficacy. Br. J. Haematol. 2021; Casadevall A, Tobian AAR. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524158 18. Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency. Cell Rep Med 2021; 2:100164Honjo K, Russell RM, Li R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521696 19. Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? Cells 2021; 10Elgohary S, Elkhodiry AA, Amin NS et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540625 20. Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study. Chem. Phys. Lett. 2020; 754:137751Mpiana PT, Ngbolua KT, Tshibangu DST et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518775 21. Antivirals for COVID-19: A critical review. Clin Epidemiol Glob Health 2021; 9:90- 98Frediansyah A, Tiwari R, Sharun K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521390 22. Neglecting plasma protein binding in COVID-19 patients leads to a wrong interpretation of lopinavir overexposure. Clin Pharmacol Ther 2021; Stanke- Labesque F, Concordet D, Djerada Z et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33547636 23. An Urgent Industrial Scheme both for Total Synthesis, and for Pharmaceutical Analytical Analysis of Umifenovir as an Anti-Viral API for Treatment of COVID- 19. Comb. Chem. High Throughput Screen. 2021; Dadras A, Rezvanfar MA, Beheshti A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538665 24. From Genomes to Molecular Dynamics - a Bottom Up Approach in Extrication of SARS CoV-2 Main Protease Inhibitors. Comput Toxicol 2021:100156Aishwarya S, Gunasekaran K, Sagaya Jansi R, Sangeetha G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532671 25. High Dose Steroid Therapy to Prevent Severe Hypoxia in COVID-19 Patients: A Potential Solution for Low Resource Clinical Setting. Cureus 2020; 12:e12330Edara L, Suvvari TK, Kutikuppala LVS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520528 26. Successful Treatment of Elderly Male With COVID-19 Infection With Severe Acute Respiratory Distress Syndrome Using Multimodal Therapy, Including Immune Modulation Therapy. Cureus 2020; 12:e12402Jitsuiki K, Katayama I, Iida T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532160 27. The History of Methylprednisolone, Ascorbic Acid, Thiamine, and Heparin Protocol and I-MASK+ Ivermectin Protocol for COVID-19. Cureus 2020; 12:e12403Turkia M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532161 28. Molecular Elucidation and Therapeutic Targeting for combating COVID19: Current Scenario and Future Prospective. Curr. Mol. Med. 2021; Suchita W, Tilotma S, Saurabh S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535951 29. Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19. Curr. Pharm. Des. 2021; Chauhan PS, Yadav D, Dubey A, Jin JO. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535945 30. Targeting NSP16 Methyltransferase for the Broad-Spectrum Clinical Management of Coronaviruses: Managing the Next Pandemic. Diseases 2021; 9Alshiraihi IM, Klein GL, Brown MA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535388 31. Study on mechanism of matrine in treatment of COVID-19 combined with liver injury by network pharmacology and molecular docking technology. Drug Deliv 2021; 28:325-342Liu F, Li Y, Yang Y et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33517789 32. Perspectives on Repurposed Drugs Based on Globally Accepted Therapeutic Guidelines to Combat SARS-CoV-2 Infection. Drug Healthc Patient Saf 2021; 13:11-18Rosalia R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536792 33. Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions. Drugs Context 2021; 10Anderson SL, Bassetti M, Mangoni AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542739 34. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. Emerg Microbes Infect 2021:1-38Ye ZW, Yuan S, Chan JF et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538646 35. The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials. Eur. J. Clin. Pharmacol. 2021:1- 6Kow CS, Hasan SS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532896 36. Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools. Eur J Integr Med 2020; 40:101241Xiong H, Dong Z, Lou G et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520015 37. RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. Eur. J. Med. Chem. 2021; 213:113201Tian L, Qiang T, Liang C et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33524687 38. Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis. Eur. J. Pharmacol. 2021:173926Rezagholizadeh A, Khiali S, Sarbakhsh P, Entezari-Maleki T. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549577 39. Chloroquine: autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check? Eur. J. Pharmacol. 2021; 897:173928Sharma P, McAlinden KD, Ghavami S, Deshpande DA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545161 40. PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia. Exp. Lung Res. 2021:1-12Beute J, Boermans P, Benraad B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544007 41. Immune Checkpoint Inhibition in COVID-19: Risks and Benefits. Expert Opin Biol Ther 2021; Pezeshki PS, Rezaei N. http://www.ncbi.nlm.nih.gov/pubmed/? term=33543652 42. In silico Screening of Natural Compounds as Potential Inhibitors of SARS- CoV-2 Main Protease and Spike RBD: Targets for COVID-19. Front Mol Biosci 2020; 7:599079Teli DM, Shah MB, Chhabria MT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542917 43. Methylene Blue Inhibits the SARS-CoV-2 Spike-ACE2 Protein-Protein Interaction-a Mechanism that can Contribute to its Antiviral Activity Against COVID-19. Front. Pharmacol. 2020; 11:600372Bojadzic D, Alcazar O, Buchwald P. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519460 44. A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection. Front. Pharmacol. 2020; 11:589044Remali J, Aizat WM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519449 45. Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond. Front. Pharmacol. 2020; 11:579548Vuorio A, Kovanen PT. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542685 46. Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives. Front. Pharmacol. 2020; 11:606097Yang CW, Lee YZ, Hsu HY et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519469 47. The right immune-modulation at the right time: thymosin α1 for prevention of severe COVID-19 in cancer patients. Future Oncol 2021; Bersanelli M, Giannarelli D, Leonetti A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33538178 48. The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19. Gene 2021:145471Saburi E, Abazari M, Hasannia H et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33549712 49. Harnessing machine learning for development of microbiome therapeutics. Gut Microbes 2021; 13:1-20McCoubrey LE, Elbadawi M, Orlu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522391 50. ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon 2021; 7:e06133Al-Mulla F, Mohammad A, Al Madhoun A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532652 51. Potential compounds from several Indonesian plants to prevent SARS-CoV-2 infection: A mini-review of SARS-CoV-2 therapeutic targets. Heliyon 2021; 7:e06001Illian DN, Siregar ES, Sumaiyah S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532640 52. mTOR inhibition: a double-edged sword in patients with COVID-19? Hum. Cell 2021:1-2Ghasemnejad-Berenji M. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527306 53. COVID-19 intervention models: An initial aggressive treatment strategy for controlling the infection. Infect Dis Model 2021; 6:351-361Oduro B, Magagula VM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521408 54. Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease. Inform Med Unlocked 2021; 23:100515Balmeh N, Mahmoudi S, Fard NA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521241 55. Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: synthesis and characterization. Inorg. Chem. Commun. 2021; 126:108472Refat M, Sedayo AA, Sayqal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531865 56. Aurintricarboxylic acid and its metal ion complexes in comparative virtual screening versus Lopinavir and Hydroxychloroquine in fighting COVID-19 pandemic: Synthesis and characterization. Inorg. Chem. Commun. 2021; 126:108472Refat MS, Sedayo AA, Sayqal A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531865 57. Therapeutic efficacy, mechanical ventilation, length of hospital stay, and mortality rate in severe COVID-19 patients treated with tocilizumab. Int J Clin Pract 2021:e14079Sarhan RM, Madney YM, Abou Warda AE, Boshra MS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550688 58. Remdesivir and Systemic Corticosteroids for the Treatment of COVID-19: A Bayesian Reanalysis. Int J Infect Dis 2021; Lee TC, McDonald EG, Butler-Laporte G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33540128 59. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery. Int J Mol Sci 2021; 22Qian L, Tcw J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530458 60. Application of Nanotechnology in the COVID-19 Pandemic. Int J Nanomedicine 2021; 16:623-649Yang D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531805 61. A commentary on "Diagnosis and treatment of coronavirus disease 2019 (COVID-19) Laboratory, PCR, and chest CT imaging findings". Int J Surg 2021; 86:64-65Shuang Wu MM, Xiaofei Li MM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33535086 62. Timing of corticosteroids impacts mortality in hospitalized COVID-19 patients. Intern Emerg Med 2021; Bahl A, Johnson S, Chen NW. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547620 63. A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids. J Am Soc Nephrol 2021; Wysocki J, Ye M, Hassler L et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33526471 64. COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun 2021; 118:102598Acosta-Ampudia Y, Monsalve DM, Rojas M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524876 65. How glycobiology can help us treat and beat the COVID-19 pandemic. J Biol Chem 2021:100375Lardone RD, Garay YC, Parodi P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548227 66. Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS- CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis. J Biomol Struct Dyn 2021:1-32Gupta A, Ahmad R, Siddiqui S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33526003 67. Efficacy of convalescent plasma therapy for COVID-19: A systematic review and meta-analysis. J. Clin. Apher. 2021; Vegivinti CTR, Pederson JM, Saravu K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544910 68. Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding. J. Clin. Exp. Hepatol. 2020; Shalimar, Vaishnav M, Elhence A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519132 69. Efficacy and Safety Assessment of Severe COVID-19 Patients with Chinese Medicine: a Retrospective Case Series Study at Early Stage of the COVID-19 Epidemic in Wuhan, China. J. Ethnopharmacol. 2021:113888Huang L. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529638 70. Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19. J Infect Chemother 2021; Kutsuna S, Asai Y, Matsunaga A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33531292 71. Evaluating the potency of Sulawesi propolis compounds as ACE-2 inhibitors through molecular docking for COVID-19 drug discovery preliminary study. J King Saud Univ Sci 2021; 33:101297Khayrani AC, Irdiani R, Aditama R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519145 72. Raloxifene as a treatment option for viral infections. J. Microbiol. 2021; 59:124- 131Hong S, Chang J, Jeong K, Lee W. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527314 73. Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19. J. Mol. Struct. 2021; 1231:129979Hussein RK, Elkhair HM. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518801 74. In silico assessment and sonochemical synthesis of 2-alkynyl 3- chloropyrazines as prospective ligands for SARS-CoV-2. J. Mol. Struct. 2021; 1231:129981Satyanarayana MV, Reddy AG, Yedukondalu M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518802 75. Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? J. Neuroimmune Pharmacol. 2021:1-6Chaves Filho AJM, Gonçalves F, Mottin M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534108 76. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. J. Neuroimmune Pharmacol. 2021:1-19Machhi J, Shahjin F, Das S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544324 77. Current diagnostic and therapeutic strategies for COVID-19. J Pharm Anal 2021; Chen BB, Liu ML, Huang CZ. http://www.ncbi.nlm.nih.gov/pubmed/? term=33520327 78. Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach. J Tradit Complement Med 2021; Rangsinth P, Sillapachaiyaporn C, Nilkhet S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520685 79. Integrating Integrins: A New Way to Increase Our COVID-19 Armamentarium? JACC Basic Transl Sci 2021; 6:9-11Ross RS. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521397 80. Dromedary camels as a natural source of neutralizing nanobodies against SARS-CoV-2. JCI Insight 2021; Chouchane L, Grivel JC, Farag E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529170 81. Nasopharyngeal SARS-CoV-2 Viral Load Response among COVID-19 Patients Receiving Favipiravir. Jpn. J. Infect. Dis. 2021; Manosuthi W, Jeungsmarn S, Okada P et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518623 82. Inactivation of SARS-CoV-2 by Catechins from Green Tea. Jpn. J. Infect. Dis. 2021; Nishimura H, Okamoto M, Dapat I et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33518628 83. FDA Recommended Potent Drugs against Covid-19: Insight through Molecular Docking. Mater Today Proc 2021; Gumber K, Pomila. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520672 84. Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection. Med Clin (Engl Ed) 2020; 155:448-453Herrera-Lasso Regás V, Dordal Culla MT, Lleonart Bellfill R. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521297 85. Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine. Med Clin (Engl Ed) 2021; Tejada Cifuentes F, Lloret Callejo Á, Tirado Peláez MJ et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521293 86. AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate. Med Drug Discov 2021; 9:100077Delijewski M, Haneczok J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521623 87. Tocilizumab administration in COVID-19 patients: Water on the fire or gasoline? Med Mycol Case Rep 2021; Deana C, Vetrugno L, Bassi F, De Monte A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520634 88. Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study. Microb. Pathog. 2021; 152:104762Khan AA, Baildya N, Dutta T, Ghosh NN. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524563 89. Comprehensive and systemic optimization for improving the yield of SARS- CoV-2 spike pseudotyped virus. Mol Ther Methods Clin Dev 2021; 20:350-356Fu X, Tao L, Zhang X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521163 90. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Molecules 2021; 26Muhseen ZT, Hameed AR, Al-Hasani HMH et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525411 91. Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV- 2 Druggable Targets. Molecules 2021; 26Romeo I, Mesiti F, Lupia A, Alcaro S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530467 92. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021; 36:101051Bonam SR, Kotla NG, Bohara RA et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519949 93. Herbal Medication to Enhance or Modulate Viral Infections. Nurs. Clin. North Am. 2021; 56:79-89Tahmasbi SF, Revell MA, Tahmasebi N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549288 94. Vitamin D Supplementation to Prevent COVID-19 Infections and Deaths- Accumulating Evidence from Epidemiological and Intervention Studies Calls for Immediate Action. Nutrients 2021; 13Brenner H. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525447 95. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? Nutrition 2020; 85:111115Balmant BD, Torrinhas RS, Rocha IM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545540 96. Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis. Open Forum Infect Dis 2021; 8:ofaa598Ignatius EH, Wang K, Karaba A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537364 97. Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid. Respir Investig 2021; Takumida H, Izumi S, Sakamoto K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547007 98. Fighting against the second wave of COVID-19: Can honeybee products help protect against the pandemic? Saudi J. Biol. Sci. 2020; Al Naggar Y, Giesy JP, Abdel-Daim MM et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519274 99. In-silico network-based analysis of drugs used against COVID-19: Human well- being study. Saudi J. Biol. Sci. 2021; Attique Z, Ali A, Hamza M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519272 100. Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia. Saudi J Med Med Sci 2021; 9:16-23AlShehry N, Zaidi SZA, AlAskar A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519339 101. Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. Saudi Pharm J 2021; 29:1- 11Quispe-Cañari JF, Fidel-Rosales E, Manrique D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519270 102. Gut microbiota in antiviral strategy from bats to humans: a missing link in COVID-19. Sci China Life Sci 2021:1-15Luo J, Liang S, Jin F. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521857 103. Mesenchymal stromal cell delivery via an ex vivo bioreactor preclinical test system attenuates clot formation for intravascular application. Stem Cells Transl Med 2021; O'Rourke B, Nguyen S, Tilles AW et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527780 104. COVID-19 neutralizing antibody-based therapies in humoral immune deficiencies: A narrative review. Transfus. Apher. Sci. 2021:103071Focosi D, Franchini M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518427 105. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Trials 2021; 22:111Mariani J, Tajer C, Antonietti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522946 106. Convalescent plasma therapy for COVID-19 patients: a protocol of a prospective meta-analysis of randomized controlled trials. Trials 2021; 22:112Szakó L, Farkas N, Kiss S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522939 107. In silico virtual screening-based study of nutraceuticals predicts the therapeutic potentials of folic acid and its derivatives against COVID-19. Virusdisease 2021:1-9Kumar V, Kancharla S, Jena MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532517

Trials (10 articles)

1. Modifiable lifestyle factors and severe COVID-19 risk: a Mendelian randomisation study. BMC Med. Genomics 2021; 14:38Li S, Hua X. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536004 2. COVID-19 vaccine trials: The use of active controls and non-inferiority studies. Clin. Trials 2021:1740774520988244Fleming TR, Krause PR, Nason M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535811 3. Clinical trials in a COVID-19 pandemic: Shared infrastructure for continuous learning in a rapidly changing landscape. Clin. Trials 2021:1740774520988298Hedlin H, Garcia A, Weng Y et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535821 4. Self-collected saliva for SARS-CoV-2 detection: a prospective study in the emergency room. J Med Virol 2021; Echavarria M, Reyes NS, Rodriguez PE et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527375 5. A Prospective Cohort of SARS-CoV-2-Infected Health Care Workers: Clinical Characteristics, Outcomes, and Follow-up Strategy. Open Forum Infect Dis 2021; 8:ofaa592Nicolás D, Camós-Carreras A, Spencer F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537362 6. The use of personal protection equipment does not impair the quality of cardiopulmonary resuscitation: A prospective triple-cross over randomised controlled non-inferiority trial. Resuscitation 2021; Kienbacher CL, Grafeneder J, Tscherny K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33524489 7. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials 2021; 22:115Aflaki M, Flannery A, Ferreira JP et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546734 8. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL). Trials 2021; 22:111Mariani J, Tajer C, Antonietti L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522946 9. Convalescent plasma therapy for COVID-19 patients: a protocol of a prospective meta-analysis of randomized controlled trials. Trials 2021; 22:112Szakó L, Farkas N, Kiss S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522939 10. Remote data collection during COVID-19 restrictions: an example from a refugee and asylum-seeker participant group in the UK. Trials 2021; 22:117Walker L, Bailey D, Churchill R, Peckham E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546716

Vaccines (44 articles)

1. Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the Post-COVID-19 era. Actas Urol. Esp. 2020; García-Rojo E, Manfredi C, Santos-Pérez-de-la-Blanca R et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546905 2. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev 2021; Korkmaz E, Balmert SC, Sumpter TL et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539853 3. Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany. Allergol Select 2021; 5:72-76Worm M, Bauer A, Wedi B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521511 4. Professionally Responsible COVID-19 Vaccination Counseling of Obstetric/Gynecologic Patients: Counseling Patients about COVID-19 Vaccination. Am J Obstet Gynecol 2021; Chervenak FA, Mc CL, Bornstein E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539825 5. Inclusion of pregnant individuals among priority populations for COVID-19 vaccination for all 50 US States. Am J Obstet Gynecol 2021; GrÜnebaum A, Mc CL, Litvak A, Chervenak FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545113 6. Racial and geographic disparities in influenza vaccination in the U.S. among individuals with atherosclerotic cardiovascular disease: Renewed importance in the setting of COVID-19. Am J Prev Cardiol 2021; 5:100150Al Rifai M, Khalid U, Misra A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521756 7. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol 2021; Barrière J, Gal J, Hoch B et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529740 8. Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines. Biomed. Pharmacother. 2021; 137:111330Awadasseid A, Wu Y, Tanaka Y, Zhang W. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550043 9. Targets and strategies for vaccine development against SARS-CoV-2. Biomed. Pharmacother. 2021; 137:111254Malik JA, Mulla AH, Farooqi T et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550049 10. The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya. BMC Med 2021; 19:35Mburu CN, Ojal J, Chebet R et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33531015 11. Should the SARS-CoV-2 vaccine be mandatory for nurses? An ethical debate. Br J Nurs 2021; 30:116-121Osbourne RM, Clark SJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33529104 12. Challenges and Opportunities for COVID-19 Vaccines in Patients with Cancer. Cancer Invest. 2021:1-19Kuderer NM, Hill JA, Carpenter PA, Lyman GH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33534645 13. Should Antipyretics be used to Relieve Acute Adverse Events Related to COVID-19 Vaccines? Chest 2021; Etminan M, Sodhi M, Ganjizadeh-Zavareh S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549598 14. COVID-19 vaccination intent and perceptions among patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2021; Dalal RS, McClure E, Marcus J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33549869 15. COVID-19 vaccine is here: practical considerations for clinical imaging applications. Clin Imaging 2021; 76:38-41Katal S, Pouraryan A, Gholamrezanezhad A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548891 16. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine. Clin Infect Dis 2021; 72:513-514Canaday DH, Gravenstein S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527123 17. COVID-19 vaccine trials: The use of active controls and non-inferiority studies. Clin. Trials 2021:1740774520988244Fleming TR, Krause PR, Nason M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535811 18. BCG Vaccination Program mitigates COVID19 Related Mortality: A Reality check. Curr. Pharm. Biotechnol. 2021; Pandita A, Bhat A, Koul A, Singh SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33530904 19. Post-Vaccination COVID-19 among Healthcare Workers, Israel. Emerg Infect Dis 2021; 27Amit S, Beni SA, Biber A et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33522478 20. Cross-Immunization Against Respiratory Coronaviruses May Protect Children From SARS-CoV2: More Than a Simple Hypothesis? Front Pediatr 2020; 8:595539Piccaluga PP, Malerba G, Navari M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537261 21. STIKO vaccination recommendations: Vaccination of immunodeficient patients and vaccination against COVID-19. Hautarzt 2021; 72:92-99Bogdan C. 22. Migraine treatment and COVID-19 vaccines: no cause for concern. Headache 2021; Gelfand AA, Poland G. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543775 23. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines. Hum Vaccin Immunother 2021:1-18Bhatta M, Nandi S, Dutta S, Saha MK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545014 24. An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination. Hum Vaccin Immunother 2021:1-10Chen M, Li Y, Chen J et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522405 25. Strategy drives implementation: COVID vaccination in Israel. Isr J Health Policy Res 2021; 10:9Glied S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33522945 26. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates. J Infect Dis 2021; 223:189-191Behr MA, Divangahi M, Schurr E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535239 27. Reply to: Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy. J Med Virol 2021; Rossotti R, Molteni SN, Faccini M, Puoti M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527415 28. Reported orofacial adverse effects of COVID-19 vaccines: the knowns and the unknowns. J Oral Pathol Med 2021; Cirillo N. http://www.ncbi.nlm.nih.gov/pubmed/?term=33527524 29. COVID-19 Vaccination for Persons with Parkinson's Disease: Light at the End of the Tunnel? J. Parkinsons Dis. 2021; Bloem BR, Trenkwalder C, Sanchez-Ferro A et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523021 30. A Booster Dose Enhances Immunogenicity of the COVID-19 Vaccine Candidate ChAdOx1 nCoV-19 in Aged Mice. Med (N Y) 2020; Silva-Cayetano A, Foster WS, Innocentin S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33521747 31. Not in my backyard: COVID-19 vaccine development requires someone to be infected somewhere. Med. J. Aust. 2021; Heriot GS, Jamrozik E. http://www.ncbi.nlm.nih.gov/pubmed/?term=33550606 32. Corona vaccine: What should be observed in handling? - Cold chain challenge. MMW-Fortschritte der Medizin 2021; 163:70Geissel W. 33. COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution. Open Med (Wars) 2021; 16:134-138Yu Z, Wang G, Goldman E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521319 34. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr. Med. J. 2021; 38:3Afolabi AA, Ilesanmi OS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520072 35. Fearing the disease or the vaccine: The case of COVID-19. Pers. Individ. Dif. 2021; 172:110590Karlsson LC, Soveri A, Lewandowsky S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518869 36. COVID-19 Vaccine: A neutrosophic MCDM approach for determining the priority groups. Results Phys 2021; 20:103654Hezam IM, Nayeem MK, Foul A, Alrasheedi AF. http://www.ncbi.nlm.nih.gov/pubmed/?term=33520620 37. Evolution of SARS-CoV-2: A prediction on the lineages and vaccine effectiveness. Travel Med Infect Dis 2021:101983Priyanka, Choudhary OP, Singh I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33548551 38. Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries. Vaccine 2021; 39:1027Gurwitz D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546810 39. Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2. Vaccine X 2021; 7:100084Mast TC, Heyman D, Dasbach E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521625 40. COVID-19 Vaccination: From Interesting Agent to the Patient. Vaccines (Basel) 2021; 9Daou A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546347 41. The Strategies to Support the COVID-19 Vaccination with Evidence-Based Communication and Tackling Misinformation. Vaccines (Basel) 2021; 9Rzymski P, Borkowski L, Drąg M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535716 42. Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune- Depleting Therapies. Vaccines (Basel) 2021; 9Sellner J, Rommer PS. http://www.ncbi.nlm.nih.gov/pubmed/?term=33525459 43. COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines (Basel) 2021; 9Shekhar R, Sheikh AB, Upadhyay S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546165 44. [Current state of vaccination against SARS-CoV-2]. Z. Rheumatol. 2021:1-7Iking- Konert C, Specker C, Krüger K et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33528655

Women – pregnancy (47 articles)

1. Psychological impact and social support in pregnant women during lockdown due to SARS-CoV2 pandemic: A cohort study. Acta Obstet Gynecol Scand 2021; Brik M, Sandonis MA, Fernández S et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33533051 2. Clinical Characteristics of Mother-Infant Dyad and Placental Pathology in COVID-19 Cases in Predominantly African American Population. AJP Rep 2021; 11:e15-e20Jani S, Jacques SM, Qureshi F et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542856 3. Professionally Responsible COVID-19 Vaccination Counseling of Obstetric/Gynecologic Patients: Counseling Patients about COVID-19 Vaccination. Am J Obstet Gynecol 2021; Chervenak FA, Mc CL, Bornstein E et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539825 4. Inclusion of pregnant individuals among priority populations for COVID-19 vaccination for all 50 US States. Am J Obstet Gynecol 2021; GrÜnebaum A, Mc CL, Litvak A, Chervenak FA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545113 5. Balancing Risks: Making Decisions for Maternal Treatment without Data on Fetal Safety. Am J Obstet Gynecol 2021; Minkoff H, Ecker J. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539824 6. Covid-19 changes to maternity care: Experiences of Australian doctors. Aust N Z J Obstet Gynaecol 2021; Szabo RA, Wilson AN, Homer C et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33547637 7. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth 2021; 21:108Servante J, Swallow G, Thornton JG et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33546624 8. Guidelines and best practice recommendations on reproductive health services provision amid COVID-19 pandemic: scoping review. BMC Public Health 2021; 21:276Tolu LB, Feyissa GT, Jeldu WG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33536001 9. Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic. BMJ Sex Reprod Health 2021; Reynolds-Wright JJ, Johnstone A, McCabe K et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33542062 10. Placental pathology and fetal demise at 35 weeks of gestation in a woman with SARS-CoV-2 infection: A case report. Case Rep Womens Health 2021; 30:e00289Poisson TM, Pierone G, Jr. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527073 11. Placental pathology and fetal demise at 35 weeks of gestation in a woman with SARS-CoV-2 infection: A case report. Case Rep Womens Health 2021; 30:e00289Poisson TM, Pierone G, Jr. http://www.ncbi.nlm.nih.gov/pubmed/? term=33527073 12. Clinical implications of coronavirus disease 2019 in neonates. Clin Exp Pediatr 2021; Kim DH. http://www.ncbi.nlm.nih.gov/pubmed/?term=33539697 13. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019. Clin. Ther. 2021; Benarroch Y, Juttukonda L, Sabharwal V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33541739 14. Takayasu's Arteritis in Pregnancy: Challenges During the Ongoing Coronavirus Disease 2019 Pandemic for Optimal Maternal and Neonatal Outcomes. Cureus 2020; 12:e12386Singh S, Pati A, Mohakud S, Behera DR. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532151 15. Postpartum depression during COVID-19. Eur J Midwifery 2020; 4:19Almasidou ME. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537621 16. COVID's collateral damage on women's health: How to resume the path of improvement. Eur J Midwifery 2020; 4:26Escuriet R, Arribas AM, Vélez OC. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537627 17. Impact of COVID-19 on antenatal care provision. Eur J Midwifery 2020; 4:16Esegbona-Adeigbe S. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537618 18. Evaluation of mode of delivery in pregnant women infected with COVID-19. Eur J Midwifery 2020; 4:28Giaxi P, Maniatelli E, Vivilaki VG. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537629 19. Postnatal virtual and home visits by midwives during COVID-19 pandemic. Eur J Midwifery 2020; 4:13Gjoni M, Alevizou EM. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537615 20. The COVID-19 pandemic and kangaroo mother care: What should we do? Eur J Midwifery 2020; 4:17Hakimi S. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537619 21. Basic tips for pregnant women during the COVID-19 pandemic. Eur J Midwifery 2020; 4:34Papari I. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537635 22. Antenatal visit model in low-risk pregnancy during pandemic COVID-19: A call for adjustments. Eur J Midwifery 2020; 4:15Sklaveniti D. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537617 23. Impact of COVID-19 on neonatal health: Are we causing more harm than good? Eur J Midwifery 2020; 4:9Smith HA. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537611 24. The impact of COVID-19 pandemic on the healthcare of premature babies. Eur J Midwifery 2020; 4:21Vavouraki E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537623 25. The European Midwives Association call for action to protect our midwives in delivering best care amidst the COVID-19 pandemic. Eur J Midwifery 2020; 4:10Vermeulen J, Jokinen M. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537612 26. Respectful midwifery care during the COVID-19 pandemic. Eur J Midwifery 2020; 4:8Vivilaki VG, Asimaki E. http://www.ncbi.nlm.nih.gov/pubmed/? term=33537610 27. Breastfeeding during the COVID-19 pandemic. Eur J Midwifery 2020; 4:31Yurtsal ZB. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537632 28. Homebirth and homecare during COVID-19. Eur J Midwifery 2020; 4:14Ziogou R, Zografou K. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537616 29. EBCOG position statement - Simulation-based training for obstetrics and gynaecology during the COVID-19 pandemic. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; Zimmerman E, Martins NN, Verheijen RHM, Mahmood T. http://www.ncbi.nlm.nih.gov/pubmed/?term=33518409 30. A single-center observational study on clinical features and outcomes of 21 SARS-CoV-2-infected neonates from India. Eur. J. Pediatr. 2021:1-12Nanavati R, Mascarenhas D, Goyal M et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33544233 31. Case Report: Late-Onset Congenital Adrenal Hyperplasia and Acute Covid-19 Infection in a Pregnant Woman: Multidisciplinary Management. Front. Endocrinol. (Lausanne) 2020; 11:602535Giavoli C, Iurlaro E, Morelli V et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519712 32. The male disadvantage in life expectancy: can we close the gender gap? Int Health 2021; Hossin MZ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533409 33. Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women. Int. J. Gen. Med. 2021; 14:279-284Fesler MC, Stricker RB. http://www.ncbi.nlm.nih.gov/pubmed/? term=33542646 34. Consequences of the COVID-19 pandemic on the postpartum course: Lessons learnt from a large-scale comparative study in a teaching hospital. Int J Gynaecol Obstet 2021; Kugelman N, Toledano-Hacohen M, Karmakar D et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33523481 35. Impact of COVID-19 on management of urogynaecology patients: a rapid review of the literature. Int Urogynecol J 2021:1-16Loganathan J, Doumouchtsis SK. http://www.ncbi.nlm.nih.gov/pubmed/?term=33533991 36. Managing pregnancy in COVID-19 pandemic: A review article. J Family Med Prim Care 2020; 9:5468-5473Singh V, Trigunait P, Majumdar S et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33532380 37. The effects of COVID-19 lockdown on lifestyle and emotional state in women undergoing Assisted Reproductive Technology: Results of an Italian Survey. J Gynecol Obstet Hum Reprod 2021:102079Cirillo M, Rizzello F, Badolato L et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33545410 38. Perinatal outcomes in pregnant women with COVID-19 in Siberia and the Russian Far East. J Matern Fetal Neonatal Med 2021:1-4Artymuk NV, Belokrinitskaya TE, Filippov OS et al. http://www.ncbi.nlm.nih.gov/pubmed/? term=33530804 39. Risk factors for severe and critical Covid-19 in pregnant women in a single center in Brazil. J Matern Fetal Neonatal Med 2021:1-4Tutiya C, Mello F, Chaccur G et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33535850 40. Comparison of hematological parameters and perinatal outcomes between COVID-19 pregnancies and healthy pregnancy cohort. J. Perinat. Med. 2021; 49:141-147Erol Koç EM, Fındık RB, Akkaya H et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544531 41. SARS-CoV-2 in pregnancy: maternal and perinatal outcome data of 34 pregnant women hospitalised between May and October 2020. J. Perinat. Med. 2021; 49:138-140Hall M, Endress D, Hölbfer S, Maier B. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544532 42. The Crisis of Perinatal Mental Health in the Age of Covid-19. Matern Child Health J 2021:1-4Osborne LM, Kimmel MC, Surkan PJ. http://www.ncbi.nlm.nih.gov/pubmed/?term=33543374 43. Effects of COVID-19 on male fertility. MMW-Fortschritte der Medizin 2021; 163:50- 51Köhn FM, Schuppe HC. 44. Epidemiology, management and risk of SARS-CoV-2 transmission in a cohort of newborns born to mothers diagnosed with COVID-19 infection. An Pediatr (Engl Ed) 2021; Solís-García G, Gutiérrez-Vélez A, Pescador Chamorro I et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33521167 45. COVID-19 Pandemic and Infertility: Gynecological Dilemma from an Indian Perspective. Reprod. Sci. 2021; Sarkar A, Saha PK, Arora A. http://www.ncbi.nlm.nih.gov/pubmed/?term=33544338 46. Potential impacts of COVID-19 on reproductive health: Scientific findings and social dimension. Saudi J. Biol. Sci. 2020; Hashem NM, Abdelnour SA, Alhimaidi AR, Swelum AA. http://www.ncbi.nlm.nih.gov/pubmed/?term=33519273 47. Aging- and gender-related modulation of RAAS: potential implications in COVID-19 disease. Vasc Biol 2021; 3:R1-r14Monteonofrio L, Florio MC, AlGhatrif M et al. http://www.ncbi.nlm.nih.gov/pubmed/?term=33537555

to subscribe click here

mailing address is: [email protected]

© P.J. Lansberg